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ABSTRACT 
Human Mesenchymal Stromal Cells (hMSC) have the potential to differentiate 
into  lineages  of  mesoderm  origin,  such  as  osteogenic,  chondrogenic,  and 
adipogenic lineages, presenting a promising potential for autologous regenerative 
medicine  applications.  However,  one  of  the  major  challenges  associated  with 
delivering hMSC to the clinic is the propagation of  undifferentiated cells in vitro 
in order to reach the quantity required for therapeutic applications. This thesis 
investigates  the  effect  of  environmental  parameters  that  impact  cell  growth 
characteristics of hMSC in microwell plates, for the design of an automated cell 
expansion  process  in  a  robotic  platform.  As  a  result  of  this  work,  the  main 
parameters  that  can  be  used  to  control  the  growth  rate  and  differentiation 
potential of hMSC at all stages of the cell expansion process have been identified. 
A mathematical model has also been developed to forward predict the cell growth 
characteristic of hMSC for an individual donor, allowing for a patient specific 
bioprocess  design  that  will  ensure  enough  cells  can  be  supplied  back  to  the 
patient in a timely manner while assuring the quality of the final product. 
Process  parameters  for  the  cell  expansion  process  of  hMSC  in  automated 
microwells have been characterised. Optimum values for inoculation cell density 
and medium exchange strategies have been proven to reduce the overall time of 
the cell expansion process for hMSC in an undifferentiated state for their use in 
regenerative medicine therapies. These parameters were implemented in the cell 
expansion in an automated platform for the duration of one passage, proving the 
potential of such technology for the delivery of hMSC to the clinic. 
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1  INTRODUCTION 
Stem cells are undifferentiated cells that have the ability to generate multiple cell 
lineages and the potential to contribute to tissue homeostasis by replenishment of 
cells or regeneration of tissue after injury (Woodward et al., 2005; Liu et al., 
2005;  Li  et  al.,  2005).  Biological  advances  in  the  last  decade  have  made  it 
possible to study the path of differentiation and the effect of different parameters 
in  stem  cell proliferation for regenerative medicine applications.  Regenerative 
medicine is an emerging field, aiming at the study of restoration of tissues and 
organs that have been injured or diseased. These can be achieved by constructing 
tissue-engineered organs in vitro for transplantation, by transplanting stem cells 
into the patient to regenerate the tissue in vivo, or by using stem cells as gene 
delivery carriers (Haseltine, 2001; Mironov et al., 2004).  
With an increasingly aging population, the demand for regenerative medicine has 
been rising in the last few years and it is expected to increase in the coming 
decades. The lack of donors for transplantation and the limited existing therapies 
to treat degenerative diseases such as cancer, Parkinsons, or Alzheimer, is driving 
extensive research in the use of stem cells as an alternative source of therapy. The 
advantage  of  the  use  of  stem  cells  versus  drug  therapies  is  that  stem  cell 
treatments aim at the replacement of diseased tissue with healthy new cells, while 
drug therapies tend to alleviate the symptoms of the illness without eliminating 
the damaged tissue or recovering normal function in abnormally behaving cells, 
tissues, or organs. 
Because  of  their  capacity  for  sustained  self-renewal  with  the  potential  to 
differentiate into specialized cell types, stem cells promise a renewable source of 
human  tissue  for  research,  pharmaceutical  testing,  and  cell-based  therapies 
(Mineault  et  al.,  2006).  Adult  or  embryonic  stem  cells  can  be  used  for 
regenerative medicine applications. Although adult stem cells are not as versatile 
as embryonic stem cells in terms of differentiation and proliferation potential, 
they present some advantages over the selection of embryonic stem cells. They 
can be obtained from the patient, making them autologous and eliminating the 
need for immune suppressors. Also, the isolation process for adult stem cells is       Chapter One 
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more robust, and there are no ethical problems posed by the use of cells coming 
from adult donors. 
The main challenge for the success of the use of stem cells in clinical applications 
is the ability to produce enough material to satisfy the demand (Mason et al., 
2006). There are still no effective technological approaches to cultivate stem cells 
in vitro, or to direct differentiation towards a desired lineage. The development of 
a cell expansion process to proliferate stem cells in vitro is complicated by the 
intrinsic  variability  of  the  cell  source,  difficulty  of  isolation  from  the  donor, 
spontaneous  differentiation,  and  the  sensitivity  of  stem  cells  to  micro-
environmental conditions.  
1.1  Stem Cells 
There are three basic categories of cells in the human body: germ cells, somatic 
cells and stem cells. Germ cells give rise to gametes (eggs and sperm), somatic 
cells  include  the  bulk  of  the  cells  that  make-up  the  human  body  in  their 
differentiated  state,  and  stem  cells  have  the  potential  to  give  rise  to  cells  of 
different lineages. Stem cells posses three main characteristics that differentiate 
them from somatic cells (Weissman, 2000): 
  self-renewal, or the ability to generate at least one daughter cell after mitosis 
with identical characteristics to the mother cell 
  multi-lineage differentiation of a single cell into one of the three germ layer 
cells that form an organism 
  in vivo functional reconstitution of a given tissue  
Proliferating stem cells in vitro have the unique capacity to renew themselves and 
the potential to differentiate into cells of different lineages under specific stimuli. 
Unlike a somatic cell, they can divide symmetrically into two identical daughter 
cells or asymmetrically generating an identical daughter cell and a differentiated 
cell. 
Depending  on  their  differential  potential,  stem  cells  can  be  classified  as 
totipotent, pluripotent and multipotent. Totipotent stem cells have the ability to       Chapter One 
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form all cell types, and the capability to form a whole organism. Pluripotent stem 
cells have the ability to differentiate into cells of all three germ layers (ectoderm, 
mesoderm and endoderm) but cannot form a whole organism. Multipotent stem 
cells have the potential of giving rise to a limited range of cells and tissues, and 
are lineage committed. Therefore, a multipotent stem cell such skin stem cell 
would give rise to the various types of skin cells (Bongso et al., 2004). Stem cells 
can also be classified into two categories according to their origin: embryonic and 
adult. 
1.1.1 Embryonic Stem Cells 
Embryonic stem cell lines are derived from the inner cell mass of the blastocyst 
that  originates  five  days  after  the  fertilization  of  a  female  egg  with  a 
spermatozoid.  These  cells  can  be  propagated  in  vitro  while  maintaining 
pluripotency  for  extended  periods  of  time.  Their  differentiation  potential  is 
characterised by their ability to transform into cells of the three germ layers that 
give rise to an organism: endoderm, ectoderm, and mesoderm. Embryonic cells 
were  first  obtained  from  mouse,  but  it  was  not  until  1998  when J. Thomson 
derived the first line of human embryonic stem cells (Thomson et al., 1998). 
Human embryonic stem cells cultured in vitro possess the three characteristics 
that define stem cells (Weissman, 2000), and have been maintained in culture for 
more than 300 doublings. However, embryonic stem cell lines are an artefact of 
tissue engineering techniques, since they do not remain as such in vivo. The cells 
that constitute the blastocyst differentiate quickly into different lineages to form 
tissues and organs for the development of an organism. Embryonic stem cells can 
also be propagated in vitro for months while retaining self-renewal potential and 
pluripotent  characteristics.  However,  the  conditions  that  regulate  the  cell 
propagation  and  differentiation  process  of  embryonic  stem  cells  is  not  well 
understood. As a result of the culture conditions for the propagation of embryonic 
stem cells in vitro, changes in karyotype and gene expression have been reported 
recently such as mitotic errors in chromosome 21 (Katz-Jaffe et al., 2004) and 
gain of chromosomes 17 and 12 (Drapper et al., 2004). Until we understand the 
cues  that  make  an  embryonic  stem  cell  decide  its  fate,  being  division,       Chapter One 
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differentiation,  apoptosis,  or  adaptation,  it  will  not  be  possible  to  implement 
clinical applications for cell or tissue replacement. 
1.1.2 Adult Stem Cells 
Adult stem cells of limited differentiation potential are found in many organs and 
tissues in the body including brain, bone marrow, peripheral blood, blood vessels, 
skeletal muscle, skin, teeth, heart, gut, liver, ovarian epithelium, and testis. They 
are thought to reside in a specific area of each tissue, called a "stem cell niche". 
They still possess stem cell characteristics of self-renewal and differentiation, but 
they have limited proliferation potential in vitro (DiGirolamo et al., 1999). Their 
self-renewal potential is maintained in the body, since these cells are involved in 
the maintenance and repair of tissues and organs throughout the life span of the 
individual (Young et al., 2004). Typically, there is a very small number of stem 
cells in each tissue, and once removed from the body, their capacity to divide is 
limited, making generation of large quantities of stem cells difficult. 
Some examples of differentiation pathways of adult stem cells are hematopoietic 
stem cells that give rise to all type of blood cells, mesenchymal stem cells that 
mature into cells of mesoderm lineage, epithelial stem cells that give rise to cells 
in the lining of the digestive tract, and neural stem cells that give rise to neurons, 
astrocytes and oligodendrocytes (D'Amour et al., 2005). 
Stem cells that mature into cells of mesoderm origin have been isolated following 
different techniques which has given rise to the discovery of several cell lines 
with particular characteristics such as mesenchymal stromal cells, MIAMI cells 
and MAPC. 
1.1.2.1 Human Mesenchymal Stromal Cells 
Human  Mesenchymal  Stromal  Cells  (hMSC)  are  the  precursors  for  cells  of 
mesoderm origin such as osteocytes, adipocytes, and chondrocytes (Pittenger et 
al., 1999; Jaiswal et al., 2000). Although the richest source of hMSC in the adult 
body is the bone marrow (Wexler et al., 2003), they have been isolated from a 
variety of tissues including umbilical  cord (Romanov et al., 2003), peripheral       Chapter One 
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blood (Wexler et al., 2003), placenta (in't Anker et al., 2004), adipose tissue (Zuk 
et al., 2001), and skeletal muscle (Sinanan et al., 2004). 
hMSC  were  isolated  initially  by  Friedenstein  et  al.  in  1976  based  on  their 
adherence to tissue culture surfaces. Following a bone marrow extraction from 
the patient through the iliac crest, mononucleated cells can be isolated from the 
mixture of blood, adipose tissue and bone marrow obtained from the extraction. 
The mononucleated cells can be isolated from this bone marrow sample by a 
density gradient centrifugation. Red blood cells sediment at the bottom, platelets 
at the top, and the mononucleated portion of cells remains in the inter-phase. The 
mononucleated cells are plated in a T-flask, and hMSC are isolated on the basis 
of their adherence to the plastic culture (Gronthos et al, 1994). hMSC have been 
expanded in vitro for up to 50 population doublings before senescing, showing 
average telomere lengths and normal karyotype but exhibiting poor proliferation 
beyond 30 population doublings (Reyes et al., 2001). In spite of not losing their 
normal  karyotype  and  telomerase  activity  after  extensive  subcultivation,  other 
results have shown that hMSC can only be expanded for 15 doublings, while 
others cease replicating after four cell doublings after which signs of senesce 
and/or apoptosis appear (Conget et al., 1999; Bruder et al., 1997; DiGirolamo et 
al., 1999; Phinney et al., 1999). 
While the terminology  of human Mesenchymal Stem Cells  (hMSC) has  been 
used  to  describe  the  plastic-adherent  cells  isolated  from  bone  marrow  with 
multipotent  differentiation  capacity,  some  investigators  decided  to  omit  any 
reference to stem cells when publishing clinical and pre-clinical studies due to the 
difficulty in their characterisation as stem cells and the scientific implications of 
use of such a term (Pereira et al., 1998; Keating et al., 1998, Horwitz et al., 1999). 
The term 'Mesenchymal Stromal Cells' was proposed by Horwitz in 2003 and it 
has been widely used since, with the advantage of having the same acronym for 
the continuation of the scientific discourse. 
One of the major challenges for the expansion of hMSC remains the fact that they 
have  not  yet  been  fully  characterised.  It  is  difficult  to  determine  if  the  cell 
population  remains  as  a  homogeneous  culture  of  hMSC  after  isolation  and       Chapter One 
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extensive  subcultivation,  or  if  a  mixed  population  of  committed  progenitors 
together with hMSC from the bone marrow aspirates are present in the culture. 
Many molecular markers expressed in hMSC are also found on other cell types 
such as fibroblast with which they share identical morphology (Ishii et al., 2005), 
and a combination of different markers is normally used to determine the identity 
of the population. In spite of the biological challenges still unresolved in order to 
fully  characterise  hMSC  during  routine  subcultivation  and  extrapolate  such 
analysis to future functional success in the clinic, these cells provide a promising 
alternative for the use in regenerative medicine applications. 
1.1.2.2  MIAMI 
A  novel  way  to  isolate  and  proliferate  adherent  dependent  cells  from  bone 
marrow has been reported to produce a new population of progenitor cells, named 
MIAMI for marrow-isolated adult multilineage inducible cells. This population of 
progenitor cells express Oct-4, SSEA4, and Rex-1, which are embryonic stem 
cell markers, and differentiate into germ layers of mesodermal, ectodermal, and 
endodermal origin. They also differ from hMSC in that they show self-renewal 
capability in vitro for up to more than 50 population doublings, with doubling 
times ranging from 20 to 36 hour as indicated in the International Patent WO 
2004/06172A2 describing the derivation and uses of MIAMI cells (Schiller et al., 
2004). MIAMI cells are identified by the unique set of markers shown in Table 
1.1. Interestingly, these cells do not express HLA markers, which would make 
them potentially resistant to immune rejection and an attractive source of readily-
available pluripotent cells for regenerative medicine applications with no need for 
patient-specific  cell  expansion  processes.  Worth  noticing  is  that  the  isolation 
process by which MIAMI cells are selected only on the basis of their adherence 
to a culture surface plate, does not prove that a heterogeneous population is the 
result  of this  isolation.  As with  hMSC, it remains  to  be determined if a mix 
population of progenitor cells carried over from the isolation from bone marrow 
may  be  responsible  for  the  pluripotent  behaviour  of  these  cells.  Single-cell 
derived colonies or retroviral marking strategies should be completed to address 
the homogeneity and clonal identity of MIAMI cells.       Chapter One 
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Table 1.1. Representative MIAMI Cell Markers (Schiller et al., 2004, p. 18). 
Marker  MIAMI Cell 
Expression 
Marker  MIAMI Cell 
Expression 
CD10  +  CD117 (cKit)  - 
CD13  -  CD122 (IL-2R)  + 
CD29  +  CD133  - 
CD34  -  CD156  + 
CD36  -  CD164  + 
CD44  +  BMP-receptor 1B  + 
CD45  -  CNTFR  + 
CD49b  -  HGF Receptor (c-Met)  + 
CD49e  +  Class I-HLA  - 
CD54(ICAM-1)  -  HLA-DR  - 
CD56 (NCAM)  -  hTERT  + 
CD63  +  NTRK3  + 
CD71  -  POU4F1 (Oct-4)  + 
CD81 (TAPA-1)  +  Rex-1  + 
CD90  +  SSEA4  + 
 
The isolation and culture conditions used to select MIAMI  cells,  mimics the 
microenvironment  of  adult  stem  cells  in  their  original  niche,  including  low 
oxygen levels (3-5% O2), co-culture with non-adherent cells from bone marrow, 
and fibronectin-coated culture surfaces. The cells isolated under physiological 
conditions were later selected according to their adherence to the culture plate, 
resulting in this new population named MIAMI cells (D‟Ippolito et al., 2004).  
Their differential potential, extended proliferation life in vitro, and fast doubling 
time,  demonstrate  these  cells  to  be  a  promising  cell  source  for  regenerative 
medicine applications. However, this work has not been reproduced by any other 
group yet, and the clinical performance of MIAMI cells remains to be proven. 
1.1.2.3  MAPC 
Catherine  Verfaille‟s  group  in  the  University  of  Minnesota,  isolated  a  new 
population of adult stem cells while attempting to isolate MSC from human and 
rat  bone  marrow.  This  distinct  cell  population,  named  multipotent  adult 
progenitor cells or MAPC, differ from MSC in that they appear to proliferate       Chapter One 
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without senescence and in their pluripotent differentiation ability in vitro and in 
vivo.  They  have  been  shown  to  expand  in  vitro  for  up  to  150  population 
doublings, and to differentiate into cells of not just mesenchymal lineage, but also 
endothelium and endoderm (Jiang et al., 2002).  
Some modifications to the well-established protocol for the isolation of hMSC 
from bone marrow resulted in the discovery of this new population of progenitor 
cells. The main change to this protocol consists in an antibody negative selection 
for CD45 and glycophorin A (hematopoietic markers) expressing cells by means 
of  micromagnetic  beads,  after  the  density  gradient  centrifugation  step  that 
separates mononucleated cells from the bone marrow sample. The cell expansion 
of  these  cells  play  a  crucial  role  on  the  maintenance  of  the  characteristic  of 
MAPC,  and  it  is  based  on  tight  control  over  cell  density  at  inoculation  and 
harvest, CO2 concentration, and pH of the medium. Unlike hMSC, MAPC do not 
express major histocompability (MHC) class I antigens, and are CD105 (or SH2) 
negative, but as hMSC they do not express any of the hematopoietic markers 
(Jiang et al., 2002; Reyes et al., 2002; Schwartz et al, 2002). 
From the work published up to now, MAPC show great potential as a cell source 
for regenerative medicine. However, there is no evidence that these cells exist as 
such in vivo, and further studies on the mechanism of isolation of MAPC need to 
be  done  since  no  other  group  has  been  able  to  reproduce  this  work.  The 
implications  of  transplanting  these  cells  into  patients  before  further 
characterisation of karyotype changes, functionality, and gene expression over 
time in vitro and in vivo need to be addressed before a clinical application can be 
envisaged.  
1.1.3 Clinical Applications of hMSC 
Mesenchymal stem cells can be isolated, expanded in culture, and differentiated 
into bone, cartilage, muscle, tendon, fat, and a variety of other connective tissues. 
This,  together  with  the  fact  that  the  cells  can  be  isolated  from  the  patient 
eliminating the risk of immune rejection, makes hMSC an ideal candidate for 
stem  cell  therapy  and  tissue-engineered  organs  for  implantation  (Ishii  et  al., 
2005).       Chapter One 
30 
Stem cell transplantation has been used a routine therapy for leukemia patients, 
where bone marrow mononucleated cells are injected from a donor to a patient to 
replenish hematopoietic stem cells. For mesenchymal stem cells, a few clinical 
studies show promise of safety and efficacy for future applications. Allogeneic 
bone marrow transplantation in osteogenesis imperfecta patients resulted in 1.5% 
to  2.0%  engraftment  of  donor  osteoblasts,  suggesting  that  mesenchymal 
precursors present in the marrow may have a potential therapeutic role (Horwitz 
et al., 1999). In a canine model of chronic myocardial ischemia, canine MSC 
injected  intravenously  caused  a  reversal  of  reduced  left  ventricular  ejection 
fraction, which was fatal in control animals. In a goat model, injected MSC into 
the knee joint appeared to slow development of osteoarthritis. In humans, co-
transplantation  of  hMSC  with  HLA-identical  sibling  hematopoietic  stem  cells 
appeared to decrease the incidence of graft-versus-host disease and to improve 
disease-free survival (Deans et al., 2000). hMSC have also been propagated in 
vitro  together  with  amnion  epithelial  cells  to  develop  a  tissue-engineered 
membrane to restore the fetal membrane integrity after spontaneous premature 
rupture of membranes, which complicates 1% of all pregnancies (Ochsenbien-
Kolble et al., 2003).  
One of the most promising studies is the use of MSC to remodel and restore 
performance of infracted hearts. To overcome the poor cell viability associated 
with  transplantation  in  vivo,  Mangi  et  al.  in  2003  genetically  engineered  rat 
mesenchymal stem cells using ex vivo retroviral transduction to over express the 
pro-survival  gene  Akt1.  Transplantation  of  5x10
6  cells  into  the  ischemic  rat 
myocardium repaired the infracted myocardium, and nearly normalized cardiac 
performance. 
The discovery of differentiation of hMSC into astrocytes and neurons shows the 
potential  clinical  applications  in  treating  a  variety  of  central  nervous  system 
disorders,  such  as  brain  injury,  stroke,  Parkinson‟s  disease,  and  other 
neurodegenerative disorders (Kopen et al., 1999; Sanchez-Ramos et al., 2000; 
Mezey et al., 2000). Other applications for hMSC are being explored, including 
their use as feeder layers for the cell expansion of human embryonic stem cells 
(Cheng  et  al.,  2003)  as  a  replacement  for  mouse  fibroblast.  Further  studies       Chapter One 
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ensuring the homogeneity of the hMSC population implanted for these studies 
must follow in order to prove that these findings are reproducible and not an 
artefact  of  precursors  present  after  isolation  or  phenotypic  changes  due  to 
uncontrolled environmental manipulations during cell expansion. 
Safety  considerations  while expanding  hMSC for clinical  application  must be 
taken into account. With the current cell expansion process that is being used by 
most  researchers,  hMSC  can  undergo  spontaneous  transformations  such  as 
mutations in their tumorogenic check points during cell division, that support the 
hypothesis that cancer stem cells originate from adult stem cells, as shown by 
Rubio et al. (2005) and Bapat et al. (2005). The potential of hMSC for different 
clinical applications suggests that in the coming years the demand for processes 
that can successfully propagate these cells in vitro will increase considerably. 
1.1.4 Characterisation of hMSC 
One of the main challenges in the study of stem cells is to be able to characterise 
the population at different stages of proliferation under different  experimental 
conditions. The reason being it is the lack of information on specific markers that 
define  the  cell  types  as  hMSC,  with  the  sole  definition  being  their  ability  to 
differentiate along specific lineages when induced to do so (Tuan et al., 2003). 
Because of the lack of a definitive set of surface markers that would determine 
the identity of hMSC, several analyses are needed to determine the characteristics 
of the population as a stem cell population. Most analyses are sacrificial, and 
require large amounts of cells to collect statistically significant data. Considering 
the limited number of stem cells obtained after isolation, it is a major challenge to 
acquire enough data throughout the cell expansion life of a stem cell population, 
especially for those with limited proliferation potential. Because the cells are the 
product and the number of cells obtained from one isolation is limited, there is 
frequently not enough cellular material from a given donor to characterise the 
phenotype of the population, nor to determine the karyotype, tumorogenicity, and 
functionality in vivo after undergoing a cell expansion in the laboratory.  
At the moment, the minimum analyses required to characterise and analyse a 
population of stem cells include flow cytometry for surface markers (Table 1.2),       Chapter One 
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Q-PCR for gene expression, telomerase activity, telomere length, karyotype, and 
functionality test  to  differentiate stem  cells  into different  germ layers.  Not as 
widely used, but in need of further studies are cell cycle analysis, metabolism, 
apoptosis, and senesce of the population over the extent of the cell expansion 
process. 
At present, characterisation of hMSC is widely accomplished by flow-cytometry 
analysis  of  surface  markers.  They  are  positive  for  CD34  upon  bone  marrow 
extraction, although they lose the expression of this marker soon after isolation 
and during subcultivation. Stro-1 has been identified as a marker for cells that can 
differentiate  into  multiple  mesenchymal  lineages  by  Gronthos  et  al.  (1995). 
However, findings by Ishii et al., (2005) suggested that Stro-1 was not essential 
for  the  differentiation  potential  of  hMSC.  Furthermore,  Fickert  et  al.  (2004) 
showed that a CD9/CD90/CD166 triple positive subpopulation of hMSC showed 
multipotency  for  chondrogenic,  osteogenic  and  adipogenic  differentiation 
providing a basis for identification of hMSC. Expression of CD166 is indicative 
of multipotency in hMCS. However, the level of expression has been shown to 
decrease with increasing cell density in culture and regained during inoculation of 
successive passages (Yeh et al., 2005). Expression levels of CD90 and CD105 
(SH2) are maintained over sequential passages and they can be important for 
validating cultures of hMSC intended for therapy (Honczarenkoa et al., 2006). A 
good indication of hMSC identity can be reached by expression of CD90, CD105 
and CD166 as a minimum set of surface markers. A more extensive list has been 
compiled  from  results  obtained  by  different  groups  (Table  1.2),  showing  the 
different  surface  marker  expression  in  three  adult  progenitor  cell  populations. 
This table of surface marker expression across hMSC-like stem cells highlights 
the  differences  in  surface  marker  expression  for  different  populations  derived 
from bone marrow: human mesenchymal stem cells, multipotent adult progenitor 
cells (discussed in 1.1.2.3), and a subpopulation of agranualar rapidly dividing 
cells isolated from hMSC identified by Prockop et al. (1997) and named RS-1.       Chapter One 
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Table 1.2. Surface Antigen Comparison Among hMSC-like Cells: Mesenchymal 
Stromal Cells (MSCs), Multipotent Adult Progenitor Cells (MAPCs), Recycling 
Stem (RS-1) Cells - small agranular and rapidly dividing subpopulation of hMSC 
(modified from Pittenger et al, 2004) 
 
1.1.5 Plasticity and Reprograming 
The term 'plasticity' has been introduced recently in the adult stem cell research 
community  to  indicate  the  greater  differentiation  potential  in  post-natal  adult 
progenitor cells than previously thought (Verfaillie, 2002). Up to now, it was 
believed that stem cells followed one direction of differentiation from pluripotent 
or multipotent to a lineage-committed precursor, and from there to a somatic cell 
type. However, different investigators have shown that adult stem cells may have 
the potential to differentiate into cells of different lineage than the one they are 
precursors for (Krause et al., 2001; Horwitz, 2003) or that they can change their 
phenotype  according  to  microenvironment  conditions  (Ferrari  et  al.,  1998; 
Sanchez-Ramos et al, 2000). 
Stem cell plasticity has been defined as “the ability of a stem cell from a specific 
tissue or organ to acquire the phenotype of another cell from a different tissue or 
organ, and in some cases, to switch between somatic mesodermal, ectodermal, 
Surface antigen  MSCs  MAPCs  RS-1  Surface antigen  MSCs  MAPCs  RS-1 
CD9  +      CD50 ICAM3  -  -   
CD10    -  -  CD54 ICAM1  +     
CD11a,b  -    -  CD62E E-selectin  -  -   
CD13  +  +    CD71 trasferrin rec  +    + 
CD14  -    -  CD73 SH3  +     
CD18 integrin 2  -      CD90 Thy-1  +  +  +/- 
CD29  +      CD105 SH2  +     
CD31 PECAM  -  -  -/+  CD106 VCAM  +  -   
CD34  -  -  -  CD117  -  -   
CD44  +    +  CD133  -  +  - 
CD45  -  -  -  CD166 ALCAM  +     
CD49b integrin 
2 
+  +    HLA ABC  +  -  +/- 
CD49d integrin 
4 
-      HLA DR  -  -  - 
CD49e integrin 
5 
+    +  SSEA-4  +  +         Chapter One 
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neural  crest  and  endodermal  lineages”  (Martin-Rendon  et  al.,  2003).  Cell 
plasticity has been shown for hematopoietic cells, indicating that they can trans-
differentiate  into  different  lineages  and  that  their  engraftment  and  progenitor 
phenotypes vary inversely with cell cycle transit (Quesenberry et al., 2002).  
Possible explanations for the perceived plasticity of adult stem cells include: the 
heterogeneity of the population, cell fusion of transplanted cells with host cells, 
trans  de-/re-differentiation  of  cells  when  removed  from  their  niche,  and 
conservation of pluripotency during adulthood (Verfaillie, 2002).  
The argument that plasticity is an artefact of a non homogeneous population of 
stem cells, where tissue committed cells within the cell population are responsible 
for the differentiation into different lineages, and not the plasticity of lineage-
committed stem cells has been studied by single progeny populations for neural 
stem cells but not for hMSC. It has been suggested that bone marrow contains not 
just hematopoietic and mesenchymal stem cells, but also endothelial stem cells 
(ESC), multipotent adult progenitor cells (MAPC), pluripotent stem cells (PCS) 
as well as tissue committed stem cells (TCSC), identifying the isolation process 
one of the main causes for perceived plasticity (Ratajczad et al., 2004).  
The  difficulty  in  isolation  and  characterisation  of  specific  stem  cell  and 
progenitor cell populations from bone marrow makes either argument difficult to 
prove  until  further  studies  are  able  to  show  clear  characterisation  and 
development of cell fate from bone marrow in vitro and in vivo. 
Pluripotency can also be induced in somatic adult cells by retroviral transduction 
of defined transcription factors such as Oct3/4, Sox2, Klf4, and c-Myc expressed 
in embryonic stem cells (Takahashi et al, 2007). The direct reprogramming of 
somatic  cells  to  give  rise  to  stem  cells  with  induced  pluripotency  is  of  great 
interest and it has the potential to generate a source of patient-specific cells. Other 
strategies of reprogramming somatic cells such as nuclear transplantation, cellular 
fusion, and culture induced reprogramming have been reported previously and 
have been extensively reviewed (Jaenisch et al., 2008), although the advantages 
of  viral-mediated  transduction  of  stem-characteristic  transcription  factors  for       Chapter One 
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therapeutic applications is drawing a lot of attention towards improving the yield 
as well as the safety of this technology. 
1.2  Bioprocess Conditions for Cell Expansion of hMSC 
In vitro expansion of hMSC allows cell proliferation in an undifferentiated state 
for  a  limited  number  of  passages  before  senesce  occurs,  dependent  upon  the 
source of the cells (Hayflick, 1965; DiGirolamo et al.,, 1999; Sekiya et al., 2001). 
Different parameters intrinsic to the nature of the cells affect the proliferation 
potential  of  hMSC  and  the  quality  of  the  cells  produced.  Because  of  the 
variability of cell growth kinetics according to age, sex, health, (Stolzing et al., 
2006, Phinney et al., 1999) and the isolation technique used to separate cells from 
bone marrow, it is a challenge to design a robust expansion protocol that ensures 
enough cells are produced for further clinical applications. 
To  date,  not  much  effort  has  been  directed  towards  controlling  physical 
parameters during the cell expansion process. Most of the research in adult stem 
cells has been targeted towards differentiation potential with the aid of chemical 
additives. Recently Zhao and coworkers have discovered the sensitivity of hMSC 
when cultured under hypoxic conditions that mimic the microenvironment within 
the bone marrow (Zhao et al, 2005). Studies such as this one on hMSC as well as 
in embryonic stem cells investigating the effect of environmental conditions on 
growth  kinetics  and  differentiation  has  turned  attention  to  the  importance  of 
controlled environmental conditions during proliferation of stem cells (Veraitch 
et al., 2008). 
1.2.1 Isolation of hMSC From Bone Marrow Aspirates 
Mesenchymal stem  cells  can be isolated from  bone marrow, blood,  umbilical 
cord,  and  muscle.  Only  1  in  1x10
7  to  1x10
8  cells  in  bone  marrow  is  a 
mesenchymal  stem  cell  (Reyes  et  al.,  2001;  Silva  et  al.,  2003),  therefore  the 
isolation technique used to recover such a small amount of cells is a crucial step 
in the cell expansion protocol.       Chapter One 
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Different  methods  to  select  for  hMSC  within  a  tissue  have  been  reported  in 
literature, such as immunomagnetic selection (Largar'kova et al, 2006) or size-
sieved  isolation  (Hung  et  al.,  2002)  or  flow  cytometry  (Zohar  et  al.,  1997). 
However, the results from different studies with hMSC are variable because there 
is no standardized protocol for preparing and characterising hMSC, and this is 
hindering the development of cell and gene therapies using adult stem cells from 
bone  marrow  (Smith  et  al.,  2004).  A  widely  used  method  of  isolation  is  by 
density gradient centrifugation over a bed of Ficoll (Caplan, 1991; Clark et al., 
1995; Bruder et al, 1997). This separation is not highly selective, recovering all 
mononucleated cells from a mixture of blood and bone marrow. The isolation is 
completed during the first passage on the basis that hMSC are the only cells that 
attach to the surface of a culture vessel. Removal of supernatant after seeding the 
isolate into a culture flask separates hMSC from all other cells. There are several 
variations  in  this  protocol  that can make the separation more efficient or can 
produce cells with better propagation and differentiation potential. 
The process involves several aseptic manipulations and at least two centrifugation 
steps.  Considering  that  the  crude  sample  contains  granulocytes,  debris,  bone 
fragments,  adipose  tissue,  and  macrophages,  it  is  important  to  minimise  the 
processing time to avoid further damage of hMSC during the process. Released 
DNA will bind and make the mixture more viscous making it hard to separate, 
ubiquitin, granulocytes, and macrophages can degrade or engulf other cells as 
well. Also, for samples that have been cryopreserved with DMSO, processing 
time is of importance since this chemical is toxic to the cells at room temperature 
(Horita et al., 1964).   
1.2.2 Culture Vessels for the Cell Expansion Process of hMSC: T-flasks, 
Bioreactors, and Microcarries 
Mesenchymal stem cells are adherent dependent, in that they need a surface to 
adhere to, for survival and proliferation. They are also contact inhibited (Ball et 
al., 2004), which means that they will only grow until they form a monolayer and 
are in contact with other hMSC cells, after which they stop proliferating  and 
apoptosis  or  senesce  occurs.  These  characteristics  make  the  cell  expansion       Chapter One 
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process  more  challenging  than  suspension  cultures  from  an  engineering 
perspective, since large surface areas are needed to scale up the process. 
1.2.2.1 T-flasks 
Laboratory  techniques  used  to  expand  hMSC  are  based  upon  passages  in  T-
flasks,  which  are  convenient  for  research  purposes  since  they  are  easy  to 
manipulate and can provide enough cellular material for characterisation analysis. 
However,  T-flasks  are  a  batch  culture  technique  and  do  not  allow  online 
monitoring and control of metabolites, cell concentration, dissolved gasses, or 
pH,  all  of  which  are  critical  parameters  in  the  development  of  a  robust  cell 
expansion process. T-flasks can easily be scaled up to Nunc Cell Factories, which 
range from one to forty trays of 1250 cm
2 per tray. These culture vessels have 
been  used  for  production  of  large  number  of  cells  for  vaccine  and  protein 
production e.g. Chu et al., 2001. For the purpose of scaling up production of 
hMSC, this technology is impractical, since not so many cells are available from 
an individual patient as to inoculate such large culture surfaces. 
1.2.2.2  Bioreactors 
A bioreactor is a closed system that allows cell expansion of animal cells without 
the need for open aseptic manipulations with their inherent risk of contamination. 
For the propagation of mammalian cells on a large scale, there have been more 
studies undertaken with stirred-tank bioreactors designed for the propagation of 
suspension cultures than for adherence-dependent cell cultures. The main reason 
for this is that there are many more biological products derived from mammalian 
cells cultured in suspension than for those cultured on surfaces. For example, the 
biotechnology industry has thrived in the last twenty years from the production of 
monoclonal  antibodies  in  CHO  or  NSO  cells,  and  most  vaccines  are  also 
produced in suspension cultures. However, stirred-tank bioreactors can also be 
used for adherent cell lines if they are cultured using microcarriers or by cell 
adaptation to suspension culture as demonstrated by Baksh et al. (2003). 
The recent discovery of stem cells, (embryonic and adult), as a new technology 
for  regenerative  medicine  has  driven  interest  in  the  design  of  alternative       Chapter One 
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bioreactors for the cell expansion of adherent cells. An example of this is the 
automated  bioreactor  designed  by  Kino-Oka  et  al.  (2005)  that  can  perform  a 
series of manipulations such as medium exchanges and passages while providing 
process  control  capabilities.  Also,  Koller  et  al.  (1993)  developed  a  perfusion 
culture  bioreactor  for  the  expansion  of  hMSC  and  optimised  the  process  for 
maximum cell growth. Bioreactor as well as automated cultures will enable a 
tighter control of the cell expansion process for hMSC, resulting in a more robust 
process for the commercialisation of adult stem cells for therapeutic applications. 
1.2.2.3 Microcarriers 
Microcarries  are  commonly  used in  the cell expansion of adherent  dependent 
cells. These are porous or non porous particles, which can be spherical or flat, 
that allow attachment of cells on the surface while being kept in suspension in a 
shake  flask  or  stirred-tank  bioreactor.  Nunc  has  recently  designed  flat 
microcarriers with the same polystyrene surface used in T-flasks (Lenglois et al., 
2004; Kenda-Ropson et al., 2001), with the advantage that the surface of the 
microcarriers can be activated by electron beam irradiation allowing the cells to 
detach by lowering the temperature to 20˚C (Kenda-Ropson et al., 2002). The 
principle advantage of microcarriers over T-flask is the larger surface area per 
unit volume of media in the system. The cells have easier access to nutrients and 
oxygen because mass transfer is driven by convection in microcarriers cultures, 
instead  of  diffusion  in  T-flasks.  Because  microcarries  are  maintained  in 
suspension,  the  culture  can  be  expanded  in  bioreactors  which  allows  tighter 
control  over  culture  conditions.  Process  conditions  can  be  optimised  for  cell 
growth using fed batch or perfusion techniques. Cell sampling is also easier and 
the process can be readily scaled up. Shan et al. (2004) demonstrated that hMSC 
proliferation rate was three to five times higher in Cytodex3 microcarriers than in 
T-flasks. Similar improvement in proliferation rates were also observed by Wu et 
al. (2003) while growing hMSC on macroporous CultiSher G microcarriers in 
spinner  flasks  as  opposed  to  T-flasks.  One  of  the  disadvantages  of  using 
microcarriers as a means to extend the surface area for anchorage dependent cell 
cultures is the difficulty on dissociating cells from the surface and the subsequent 
separation of dislodged cells from the microcarriers. The process that is already       Chapter One 
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troublesome to accomplish in the laboratory scale results in yield loses of cells 
that remained entrapped in the higher density microcarrier pellet that settles at the 
bottom of the flask or bioreactor. This difficulty is not of major importance for 
somatic cell lines used in the biotechnology industry since the product is secreted 
from the cells or extracted by cell lysis. For tissue engineering applications where 
the cells are the product, cell yield losses as well as deterioration of cell quality 
due to separation and recovery from microcarrier cultures must be studied and 
optimised further before this technology can be considered as a viable process for 
the expansion of stem cells. 
1.2.3 Effect of Dissolved Oxygen on hMSC Cultures 
hMSC are cultured in vitro at atmospheric pressure and oxygen levels, whilst 
regulating % CO2 to 5% (v/v) to maintain the pH of the media. Temperature is 
the only parameter that mimics  physiological  conditions  at  37˚C. The loss of 
proliferative and differential potential of hMSC in vitro versus in vivo is in part 
due to this change of physical parameters.  
hMSC environmental conditions in vivo include 2-5% dissolved oxygen instead 
of the 20% oxygen that is currently used for culture in vitro. It has been suspected 
that cell proliferation at higher oxygen concentrations has a detrimental effect on 
the growth and differentiation of hMSC in vitro. As an example of the loss of 
differentiation potential due to higher oxygen concentration for osteoblast, it has 
been  shown  that  transient  changes  in  oxygen  tension  inhibit  osteogenic 
differentiation (Salim et al., 2004). Also, Fink et al. (2004) found that hMSC 
exhibited adipocyte-like phenotype when cultured at 1% oxygen, but they did not 
show adipocyte-specific transcription patterns, indicating a change in phenotype 
but not true adipogenic differentiation. 
Growth  of  hMSC  with  20%  oxygen  may  cause  oxidative  stress  and  be 
responsible  for  rapid  erosion  of  the  telomere  length  that  determines  the 
population doubling limit of the cells. To corroborate this theory, oxidative stress, 
telomere length and telomerase activity have been measured for hMSC expanded 
under different oxygen concentrations. Results have shown that cells can reach 60 
population doublings (PD) under 5% oxygen versus 40 PD with 20% oxygen       Chapter One 
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before entering cell arrest. More intracellular oxidants were also found for the 
high oxygen condition, although they were not responsible for telomere erosion 
since telomere length and telomerase activity were found to be similar for both 
conditions (Martin et al., 2004, Moussavi-Harami et al., 2004). In a more recent 
study, it has been shown that hMSC do not exhibit telomerase activity unless 
transfected with hTERT (Zimmermann et al., 2003, Abdallah et al., 2005). 
Studies to date have shown that maintaining hMSC cultures under physiological 
oxygen  concentrations  result  in  a  higher  population  doubling  limit.  However, 
further studies are needed to determine the effect of oxygen in metabolic rates, 
growth rates, viability, gene expression, differentiation potential, and phenotype 
of hMSC.  
1.2.4 Effect of Extracellular pH on hMSC Cultures 
Most  media  formulations  contain  sodium  bicarbonate  as  a  buffering  agent  to 
maintain the pH close to 7.5. Mammalian cell growth starts to decrease below pH 
6.9 and above pH 7.7, but each cell line has an optimum pH within this range that 
maximises growth rate and viability. Optimum pH has been shown for different 
cell lines not just in terms of cell growth, but also in terms of product formation. 
Sometimes optimum pH for cell growth does not correlate with optimum pH for 
antibody  production  or  virus  infectivity,  and  adjustments  need  to  be  made  to 
achieve maximum yield of the desired product (Miller et al., 1988). 
For a given population of stem cells in culture, optimum pH is determined by 
maximum  cell  growth  and  viability  whilst  maintaining  desired  differentiation 
patterns. For instance, for neural stem cells, it has been shown that manipulation 
of environmental pH levels, results in 40% higher densities and 15-20% higher 
viabilities  during  the  dissociation  of  cells  in  bioreactors  (Sen  et  al.,  2004). 
Variations of environmental pH can also affect functionality and differentiation 
patterns  of  stem  cells,  as  shown  for  trophoblast  which  increase  fibronectin 
secretion for ranging from 6 to 8. The study has also been performed for hMSC 
showing no effect on fibronectin secretion due to changes in pH, however, the 
effect  on  cell  growth  or  differentiation  was  not  studied  (Gaus  et  al.,  2002). 
Analysis of optimum pH has not be published for hMSC or embryonic stem cells,       Chapter One 
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but as shown for other stem cell populations it may affect cell characteristics and 
needs to be addressed in the near future. 
1.2.5 Effect of Agitation and Shear on hMSC Cultures 
Mechanical forces also have an impact on stem cell growth and differentiation. 
Mesenchymal stem cells are adherent dependent and only grow once attached to a 
surface. After initial attachment to the culture surface, they can be exposed to 
agitation and shear if grown on microcarriers and during the centrifugation step at 
harvest to remove trypsin before inoculation into a new vessel. The sensitivity of 
hMSC to agitation and shear stress has not been studied. 
Agitation and shear can disrupt the cytoskeleton and plasma membrane of the 
cells, and can also be a trigger for differentiation or gene expression. There are 
studies on the sensitivity of mammalian cells to agitation and shear. However, it 
is well know that stem cells are more sensitive to physical conditions than other 
cell lines, and it is important to understand the impact of such conditions on cell 
growth and differentiation. For example, one study on the effect of mechanical 
strain  on  hMSC  differentiation  indicated  that  strain  levels  modulate 
differentiation to osteogenic but not chondrogenic lineages (Taboas et al., 2003). 
Quantitative  assessment  of  strain  and  stress  levels  applied  to  hMSC  during 
routine subcultivation have not received much attention, and the effect of such 
environmental manipulations on the cells are unknown. 
Currently  subculturing  techniques  used  for  the  propagation  of  hMSC  tend  to 
mimic the protocols that have historically been used for other cell lines such as 
fibroblast, but it is not understood if these protocols utilise the best conditions for 
the proliferation of hMSC.  
1.2.6 Effect of Inoculation Cell Density of hMSC Static Cultures 
Inoculation cell density (ICD) in the context of adherent-dependent cells is the 
number of cells per centimetre squared seeded onto the vessel at the beginning of 
the propagation step into a new culture vessel. If the initial number of cells per 
centimetre square is too high the time taken to cover the surface decreases whilst       Chapter One 
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the frequency of harvest and aseptic manipulations increases for the overall cell 
expansion process. However, if the ICD is too low the cells will not be able to 
sense the cytokines secreted by nearby cells and cell growth may be arrested. 
Most  researchers  studying  hMSC  have  published  results  based  on  an  ICD  of 
5x10
3 cells/cm
2 which has been established as customary for cell propagation of 
hMSC (Friendstein et al., 1976). 
The distance between cells on the culture surface at inoculation is expected to 
have an impact on the time to harvest and length of the passage, but recent studies 
show  that  it  also  affects  the  doubling  time  of  hMSC.  Sekiya  et  al.  (2002) 
demonstrated that the lower the ICD, the lower the doubling time for hMSC. The 
mechanism for why this happens is not well understood, and more studies need to 
be done to observe the implications of ICD in conjunction with other parameters 
on the population doubling limit and differentiation potential of hMSC. 
1.3  Culture Media for the Proliferation of hMSC 
Cell expansions of stem cells in the laboratory have tended to follow the same 
techniques historically used in tissue culture of other adherent cells. The reason 
being  because  the  main  focus  of  study  up  to  now  has  been  the  directed 
differentiation of mesenchymal stem cells and maintenance of the culture in an 
undifferentiated  state.  To  date  not  much  research  has  been  conducted  in  the 
development  of  a  media  formulation  that  would  satisfy  the  requirements  of 
growth for hMSC. Media development is a cost intensive effort that is normally 
undertaken  by  suppliers  to  commercialize  the  product,  but  most  academic 
research laboratories do not focus their attention on this topic. 
1.3.1 Basal medium 
Basal medium is a solution that provides basic nutrients such as amino acids, 
vitamins,  inorganic  salts,  and  a  carbon  source  such  as  glucose,  to  support 
environmental and nutritional requirements for the proliferation of a given cell 
line.  Commercial  media  formulations  are  available  for  cell  proliferation  of 
mammalian cell cultures, and are widely used in all research laboratories for an 
extended  range  of  cell  lines.  Only  a  few  industrial  companies  can  afford  to       Chapter One 
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develop  and  produce  a  custom-made  media  for  a  specific  process.  The 
performance  of  different  commercially  available  media  has  been  studied  and 
found  to  affect  growth  rates,  yields,  and  differentiation  potential  of  hMSC 
(Sotiropoulou et al., 2006). 
Storage and handling of basal medium is extremely important, since some of the 
component ingredients degrade after exposure to light and temperatures higher 
than 4˚C. It has been shown that DMEM generates reactive oxygen species when 
exposed to light in a time-dependent manner. The main components responsible 
for  generation  of  reactive  oxygen  species  are  riboflavin,  tryptophan,  tyrosine, 
pyridoxine, and folic acid (Grzelak et al., 2001). Most laboratory practices do not 
control  the  time  exposure  of  media  to  light,  and  results  generated  from 
experiments using this media may generate erroneous conclusions. 
These media formulations are chemically defined and contain no animal-derived 
products.  However,  some  additions  to  the  basic  media  are  needed  to  support 
growth of hMSC and to increase productivity of the culture by reducing doubling 
times. Most studies for hMSC employ media with different supplements added 
prior to use. The most common supplements added are L-glutamine, antibiotics, 
growth factors, and serum. 
L-glutamine needs to be added immediately prior to use, because otherwise it 
degrades rapidly and it would significantly decrease the shelf-life of the media. 
Studies have shown that the chemical decomposition of glutamine to ammonia 
and  pyrrolidonecarboxylic  acid  is  influenced  not  just  by  temperature,  but  by 
media type and pH (Ozturk et al., 1990). 
Some growth factors are added to improve proliferation rates and also to trigger 
differentiation of hMSC to a desired lineage. An example of this is the addition of 
1 ng/ml FGF (fibroblast growth factor) that has been proven to prolong the life-
span of hMSC to more than 50 doublings whilst maintaining their differentiation 
potential (Bianchi et al., 2003). This effect seems to be dose dependent, and other 
observations  show  that  higher  doses  of  bFGF  (3  ng/ml)  induce  adipogenic 
differentiation (Nerbauer et al., 2004).       Chapter One 
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Most  cell  lines  cannot  sustain  growth  for  consecutive  passages  without  the 
addition  of  serum  in  the  media.  Serum  is  an  animal  derived  component  that 
improves cell growth. Most researchers report the addition of 10% serum to their 
media  formulation  for  the  proliferation  of  hMSC.  Although  serum  addition 
improves growth kinetics, there are several disadvantages for the use of serum as 
discussed  in  Section  1.3.2,  and  major  efforts  are  underway  to  eliminate  this 
supplement and to replace it by chemically defined components. 
1.3.2 Serum 
Serum is the fluid component that remains after centrifugation of blood that has 
been allowed to clot slowly  and lacks the clotting factors and other elements 
which plasma includes. Its addition to culture media allows cells to proliferate 
faster  and  eliminates  some  susceptibility  to  environmental  conditions.  Serum 
contains  over  1,000  compounds  including  proteins,  electrolytes,  lipids, 
carbohydrates, hormones and enzymes, but it has never been fully characterised. 
It also contains growth factors that improve cell proliferation and differentiation 
and other factors that bind and inactivate toxic products such as proteases and 
free radicals. Serum also serves as a carrier for lipids, enzymes, micronutrients, 
and trace elements, improving transport across the cell membrane. Other proteins 
in serum, such as albumin and fetuin, influence physical conditions of the culture 
such as viscosity, osmolality, pH, and gas delivery rates (Bodziak et al., 1985). 
In spite of the advantages of adding serum to culture medium there are several 
adverse implications from a process control and safety point of view that are 
gearing  the  tissue  and  cell  culture  community  to  shift  towards  a  serum-free 
medium, and ideally a chemically defined medium.  
Serum  is  the  most  expensive  additive  to  basal  medium  for  cell  culture 
applications, after some specialized components such as growth factors. Addition 
of serum to the culture media raises the production cost significantly, making 
process changes such as perfusion culture which normally improves yield and 
quality of the product uneconomical. The composition of each lot of serum also 
depends widely on the pool of cattle used for the batch, and consequently have an 
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bioprocesses still using serum in their media formulation, different lots of serum 
are screened for the cell line of interest. In addition to a certificate of analysis 
demonstrating that no adventitious agents are present in the particular batch of 
serum, the screening of a batch includes plating efficiency, growth promotion, 
colony morphology, and toxicity tests for a particular cell line (Evans, 2006). 
Once a lot is  identified for optimum performance in  cell growth  and  product 
yield, the complete lot is purchased to complete several batches of production. 
For  research  at  small  scale  this  is  not  always  an  option,  and  the  addition  of 
different lots of serum to the media may be responsible for difficulties in the 
interpretation and reproducibility of results (Stute et al., 2004). 
Serum can be obtained from humans, but not in quantities large enough to be 
used in the production of cells for most therapeutic applications. Normally serum 
from animal origins is used for the cell proliferation of mammalian cells, and 
FBS (fetal bovine serum) or FCS (fetal calf serum) is used for cell expansion of 
hMSC. However, animal serum has the potential of carrying infectious agents, 
such as mycoplasma, viruses and prions.  
Recently,  a  group  of  researchers  in  San  Diego  reported  expression  of 
immunogenic nonhuman  sialic acid  on the surface of human  embryonic stem 
cells (Martin et al., 2005). This discovery revolutionized the field of embryonic 
stem cell science, since it represented a risk for all future therapeutic applications 
of  stem  cells.  Currently,  human  embryonic  stem  cells  are  subcultured  over  a 
feeder layer of mouse fibroblasts, and the possibility that this protein may have 
come from the feeder layer was examined first. However, a titration experiment 
reducing the amount of serum in medium indicated a dose dependency in the 
levels of expression of this particular nonhuman sialic acid on the cell membrane. 
Many groups are currently working on subculture techniques to propagate human 
embryonic stem cells in chemically defined media with animal-free raw materials 
and without feeder layers. As with all production of biologics, elimination of 
animal-derived components is of great importance in order to reduce the risk of 
transmission  of  adventicious  agents  into  the  product  as  well  as  to  increase 
robustness of the process.       Chapter One 
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Similar problems can be expected with the culture of adult stem cells, although so 
far reports have not shown evidence of the presence of nonhuman sialic acid due 
to the presence of serum in media. 
1.3.3 Trypsin 
Cell detachment of anchorage dependent cells from a culture surface is achieved 
by  enzymatic  dissociation.  Trypsin  is  an  enzyme  commonly  used  to  detach 
adherent  dependent  cells  for  further  use  or  for  subcultivation.  The  most 
commonly used trypsin is porcine derived, although alternative sources of non 
animal-derived trypsin are becoming available such as recombinant rTrypsin or 
Trypzean. Trypsin can also be replaced by non animal-derived proteases such as 
No-zyme or rProtease produced in yeast or bacteria (Keenan et al., 2006). These 
trypsin  replacement  products  are  important  when  culturing  cells  intended  for 
human use, given the risk associated with any animal-derived raw material. As 
for  serum,  any  animal-derived  product  carries  the  risk  of  transmitting  TSE 
(transmissible spongiform encephalopathies) and other adventitious agents into 
the biological product, and eventually the recipient of the therapy. 
This enzyme cleaves focal points formed between the cell membrane and the 
surface achieving detachment in a contact time of 5 to 10 minutes. Longer contact 
times  are  detrimental  for  the  plasma  membrane,  as  trypsin  starts  to  degrade 
surface proteins (Cole and Paul, 1966; Phillips, 1972). As a result, cell death and 
loss of characterisation surface markers occurs after long exposure to trypsin. 
No studies to date have revealed the limiting time of exposure of hMSC to trypsin 
and the detrimental effect of traces of the enzyme in culture due to carry over 
during passaging. Some cell culture processes are designed to remove trypsin 
prior to inoculation in a new vessel by centrifugation, whilst others carry over 
traces  of  trypsin  diluted  with  culture  media.  No  investigations  have  been 
undertaken to determine if the carry over of trypsin is more detrimental to the 
cells than the additional centrifugation step to remove it. However, considering 
the sensitivity of hMSC to external conditions, it may be an important parameter 
to be addressed in future studies.        Chapter One 
47 
1.4  Process Control, Optimisation, and Quality Assurance in the 
Production of hMSC in an Un-Differentiated State 
When designing a process  for the  cell  expansion of  hMSC it is  important  to 
consider  reproducibility,  quality,  and  compliance  with  regulatory  agencies  for 
each  step  of  the  proliferation  scheme.  Just  as  important  as  the  discovery  of 
therapeutic applications for stem cells is the ability to produce enough clinical 
grade material to satisfy large demands in a timely manner. 
Several  parameters  must  be  controlled  and  understood  in  order  to  design  a 
successful process for the production of stem cells as the end product. The main 
possible sources of variability, the impact of process controlled parameters, and 
automation of a cell expansion process are further discussed in this section.  
1.4.1 Sources of Variability in the Expansion of hMSC 
There are some sources of variability in all cell culture processes that need to be 
accounted  for  when  designing  a  cell  expansion  that  would  provide  equally 
acceptable quality material as the end product. There are ways to minimise such 
variations  between  lots  produced  by  controlling  process  parameters  and  by 
screening the raw materials that will be in contact with the cells. There are other 
non controllable parameters such as the source of the cells, which is a challenge 
for regenerative medicine applications for which there is not an established cell 
line for all batches of material. Each cell expansion is produced with cells from a 
different  patient,  with  intrinsic  characteristics  that  result  in  variations  of  cell 
growth patterns and differentiation. 
1.4.1.1  Cell Source 
It is well known that the doubling time of hMSC varies according to the age of 
the patient and the tissues from which they were derived. Some variation on the 
differentiation  potential  and  the  population  doubling  limit  is  also  expected 
according to the donor (Phinney et al., 1999). Other factors such as sample to 
sample variability, sex, age, smoking habits, and other medical conditions of the 
donor  will  have  an  effect  on  the  cell  growth  and  differentiation  potential  of 
hMSC isolated from different tissues of the patient.       Chapter One 
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Understanding the range of variations expected in the growth and differentiation 
potential of hMSC in vitro due to the cell source is important when determining 
ranges for all other controllable parameters in the process. A degree of flexibility 
must be built into the cell expansion process to accommodate longer processing 
times in cases of slower growing cell line, or where larger number of cells may be 
needed to accomplish desired differentiation outcomes. 
1.4.1.2 Raw Materials 
Lot  to  lot  variability  of  some  raw  materials  can  change  cell  growth  rates 
significantly and alter other characteristics of the cells such as metabolic rates, 
surface markers, and gene expression. Some raw materials are more variable than 
others, and some measures can be taken into account to alleviate disruptions in 
the process due to raw material variability. Most variable raw materials for a cell 
expansion process are those that are not chemically defined and specially those 
which are animal-derived, such as serum. Basal media also varies from lot to lot 
due to the source of individual components from which is formulated, or from 
changes  in  the  production  process  such  as  water  supply  or  sterilisation 
techniques.  Individual  additives  that  are  chemically  defined  or  that  have 
undergone more intense separation processes before formulation such as growth 
factors, trace elements, amino acids, vitamins, are expected to be more consistent 
between lots. 
An  approach  to  minimise  variations  between  lots  is  to  screen  the  individual 
components before incorporation into the process. Once the material is found 
acceptable for the cell expansion process, the entire lot is purchased. This will at 
least minimise the variability of media within a single consignment and assure 
reproducibility of the process within a given consignment for a large number of 
batches of desired product. 
Something else to consider is the availability of vendors for a given raw material. 
Some  variability  may  be  expected  from  raw  materials  coming  from  different 
vendors, such is the case for surface culture vessels such as T-flasks from Nunc 
versus Corning. However, it is important to consider an alternative source for a 
critical  material  in  case  quality  or  supply  problems  are  encountered.       Chapter One 
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Understanding the variability between products from different vendors and the 
effect on the process is important for the successful production of cell derived 
products. 
1.4.1.3 Manual Operations 
When  manual  operations  are  needed  for  the  execution  of  a  process,  hiring 
qualified  staff  and  providing  them  with  appropriate  training  is  important  to 
achieve consistency in the cell expansion process. Even when trained technicians 
are in charge of the cell culture manipulations, there are usually some variations 
in the way particular steps are carried out by each operator. There is also a human 
error  factor  to  be  considered.  Small  variations  in  the  aseptic  manipulations 
conducted  under  a  biosafety  cabinet  include;  (i)  the  time  of  operation  and 
consequently exposure of the cells to atmospheric conditions; (ii) pippeting errors 
and (iii) the shaking of the T-flasks during cell harvest, that may cause damage to 
cells or aggregation. 
Process variability due to manual operations can be eliminated by automation. A 
robot  can  conduct  the  same  operations  with  the  same  precision  every  time, 
eliminating  human  error  or  variability  on  each  step  of  the  process.  Although 
implementing an automated process requires a large capital investment and initial 
research in process development, it is more cost effective than paying for the 
training and salaries of a larger number of technicians over a long period of time. 
1.4.1.4 Utilities 
Utilities  include  deionised water, clean steam,  electric power, piping,  and  the 
valves  needed  to  run  a  process.  Changes  in  any  of  the  utility  systems  in  a 
laboratory may affect the process resulting in unexpected results and in some 
instances the source of the variability may be unclear. Examples of such utility 
issues which may affect the results are as follows: 
  Contamination or residues in the pipes may affect the metal content in the 
water or stem, translating into changes in cell growth.        Chapter One 
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  Malfunction  of  a  valve  or  a  gas  regulator  may  supply  an  incorrect 
concentration  of  a  gas  to  an  incubator  resulting  in  an  unregulated  pH 
environment. 
  Power  shortages  if  not  well  controlled  my  result  in  loss  of  material  in 
refrigerators and freezers, and subsequently decrease the rate of cell growth 
during incubation. 
Although  mechanical  problems  cannot  always  be  avoided,  an  appropriate 
maintenance plan and careful placement of controllers and alarms will minimise 
the  disruption  caused  by  abnormalities  in  the  utility  systems.  Maintaining 
accurate  records  of  utilities,  components  and  operators  will  also  make 
indentifying the source of problem easier minimising the need for long atypical 
process report investigations to determine the source of error. 
1.4.2 Measured Process Parameters for Process Control 
Several parameters must be monitored during the expansion of hMSC to properly 
characterise the quality of the product, as per any other biological product. For 
autologous  therapies,  the  cells  being  proliferated  in  vitro  are  the  product. 
Consequently  it  is  the  process  that  becomes  the  product  when  manufacturing 
under cGMP regulations. Tight  control  of the  quality  of the cells  at  different 
stages of the cell expansion process becomes an important issue not just to ensure 
robustness, but also to comply with regulatory agencies. 
1.4.2.1 Experimental and Routine in Process Analysis 
The quality of the cells at different stages of the cell expansion process can be 
monitored by using an  array of assays  as  detailed in  Table 1.3.  Some of the 
assays available are appropriate and necessary to gain a good understanding of 
the  process  and  to  develop  a  robust  cell  expansion  protocol  for  clinical 
applications. A well characterised process in an automated platform for clinical 
applications  will  also  required  the  completion  of  process  characterisation  and 
process  validation  studies  to  satisfy  cGMP  regulations.  For  such  purpose,  a 
detailed understanding of the quality of the cells at different stages of growth will 
require  more  extensive  tests  than  for  routine  in-process  characterisation.  In       Chapter One 
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addition  to  the  assays  highlighted  in  Table  1.3,  these  tests  should  include 
functionality  assays  to  determine  the  differentiation  potential  of  the  cells  at 
different stages of growth. Functionality assays prove that a population of stem 
cells maintains the potential of differentiating into different cell types. 
However, for routine analysis of an established process, the number of sampling 
events and number of cells utilised for such purposes must be reduced in order to 
minimise the risk of contamination and excessive loss of final product, in this 
case of hMSC. Regardless of such considerations, the minimum number of assays 
selected for routine manufacturing of hMSC have to be sufficient to prove that 
the quality of the cells delivered to the clinic comply with the requirements of 
safety and quality for their intended use.  
With the currently on-going research in the field of biologic analytical sciences, 
new  assays  as  well  as  improved  analytical  equipment  will  facilitate  on-line 
monitoring of stem cell cultures with non-invasive methods.  
Table 1.3 In-process characterisation assays required for the development of a 
cell  expansion  protocol  for  hMSC  and  for  routine  analysis  of  an  established 
process. 
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Parameter 
Experimental - Characterisation of cell line  Routine - Process Analysis 
Assay  Description  Sample size  Assay  Sample 
size 
Oxidative 
Stress 
Dihydroehtidine  Stains peroxide mediated rxns 
CONFOCAL 
0.5 cm
2 slide   
p53  Detect presence of checkpoint 
p53 in the cell cycle (absent 
results in lack of control for 
cell division - tumorogenicity) 
WESTERN BLOT or RT-PCR 
~1 ml 
FLARE  Comet assay that measures 8-
oxoguanine damaged 
nucleotides (known mutation 
due to oxidative damage) 
CONFOCAL 
0.5 cm
2 slide 
Telomere 
length 
TRAP  Telomere repeat amplification 
protocol OD 
Depends on cell 
densities (min 
2.5x10
6 cells) 
TRAP  Depends on 
cell 
densities 
(min 2.5 
x10
6 cells) 
Cell 
characterisat
ion 
Histology  Stains cells and view through 
microscope 
0.5 cm
2 slide   
FACS  Stain surface markers 
characteristic of cell type with 
flourecent dyes 
2x10
6 cells per 
surface marker 
FACS  2x10
6 cells 
per surface 
marker 
CONFOCAL  Stain alpha actin, some surface 
markers. 
0.5 cm
2 slide  CONFOCAL  0.5 cm
2 
slide 
Stem cell 
functionality 
kit 
Differentiation into adipocytes, 
chondrocytes and osteocytes. 
Enough to 
inoculate new 
culture 
(depends on 
selected vessel) 
 
Cell 
Population 
Hemocytomet
er 
trypan blue exclusion  20 ul  Hemocytom
eter 
20 ul 
Guava cell 
counter 
viability, size distribution, cell 
cycle, apoptosis, other markers 
100 ul  Guava cell 
counter 
20 ul 
Cedex  viability, cell density     
Metabolic 
activity and 
process 
conditions 
Bioprofiler  Glucose, lactate, glutamine, 
glutamate, NH4, pO2, CO2, 
osmolality, Mg, Ca, Na, K 
30 ul  Bioprofiler  30 ul 
YSI  glucose/lactate  30 ul or 1 ml 
for turntable 
YSI  30 ul or 1 
ml for 
turntable 
glutamine/glutamate  30 ul or 1 ml 
for turntable 
 
Other sensors  O2 sensors  none  O2 sensors  none 
  pH sensors  none  pH sensors  none 
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1.4.2.2 Quantitative Indicators of Cell Growth Kinetics 
There  are  some  control  parameters  that  need  to  be  calculated  in  order  to 
characterise the process of cell expansion. These calculations are done routinely 
in the cell proliferation steps for the production of biological products in order to 
monitor the robustness of the process. Mathematical growth models derived from 
this data play a key role in developing a biological process, since they can be 
predictive tools for expansion potential and for the characterisation and measure 
of kinetic parameters of a stem cell population (Deasy et al., 2003). Such growth 
kinetic  parameters  that  characterise  the  growth  of  a  cell  population  are  cell 
growth  rate,  duration  of  the  lag  phase,  time  to  reach  stationary  phase,  and 
maximum cell density obtained at the stationary phase. 
1.4.2.3  Surface Markers as Indicators of Product Quality 
Routine characterisation is important for the expansion of stem cells, since they 
can differentiate spontaneously while maintaining the same morphology and cell 
growth characteristics. Surface marker expression can provide a good indication 
of the identity of the cell population as  well  as  the degree of differentiation. 
Considering the limited amount of stem cells obtained from a donor and the large 
amount of cells needed for flow cytometry analysis of cell markers, this is not a 
test  that  can  be  done  frequently  for  routine  processing.  However,  new 
technologies are being developed that require fewer cells (2-5x10
3 cells) to obtain 
an accurate measurement for surface markers, such as a high throughput flow 
cytometer  developed  by  Guava  Technologies.  Although  cell  surface  marker 
expression alone cannot be used to ensure the ability of a cell to behave as stem 
cell and exhibit all characteristics of such in vivo as well as in vitro, it provides a 
good estimate of the identity and quality of the cell population at a given time in 
the cell expansion process. Loss of expression of surface markers characteristics 
of a specific progenitor population can be interpreted as changes in the phenotype 
of the cell population, and possible decrease in differentiation potential.       Chapter One 
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1.5  Automation for the Cell Expansion Process of hMSC 
In spite of the initial capital investment and development cost to implement an 
automated process, there are several advantages over a manual process and some 
companies have already chosen to automate cell culture operations (Chapman, 
2003; Kempner et al., 2002). The advantages of automation are: 
  Better control over process parameters 
  Less variability between batches 
  Cost effectiveness through reduced staff, training and process operation time 
  Time  efficiency  since  more  manipulations  can  be  achieved  in  a  given 
timeframe 
The main reason why many processes are not automated is time to market. Most 
processes are a scale-up of the laboratory techniques used during the discovery 
phase of a new product. The extra time required to implement automation in a 
process may jeopardize the time lines dictated by market strategies and the ability 
to be „first to market‟ with a new product.  
The  best  way  to  overcome  the  challenge  of  reaching  the  market  first  whilst 
realising the benefits of an automated process that may be cost effective down the 
line, is to create a platform technology that could be transferable to different 
products.  Once  the  platform  technology  has  been  developed,  it  can  be 
implemented  earlier  at  the  research  and  development  stage  of  a  process.  The 
purpose of this project is to develop a platform technology for the cell expansion 
and differentiation of hMSC in microwell reactors that could be applied to any 
process for the use of stem cells in any regenerative medicine applications. 
1.6  Aims and Objectives of Thesis 
hMSC have the potential to differentiate into lineages of mesoderm origin, such 
as  osteogenic,  chondrogenic,  and  adipogenic  lineages,  presenting  a  promising 
potential for autologous cell and gene therapy (Prockop, 1997), and regenerative 
medicine applications (Jaiswal et al., 2000). Research in the last decades has been 
focused in the understanding of directed differentiation of these cells into desired 
lineages for the construction of tissue-engineered organs for implantation or for       Chapter One 
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cell therapy applications as shown in Section 1.1.3. However, one of the main 
challenges in designing a robust expansion protocol that would ensure provision 
of enough cells of the desired quality for clinical applications is the ability to 
account for the inherent variability of the cell source.  In order for autologous 
hMSC therapy to become available and to satisfy market needs, the variability of 
cell growth kinetics according to age, sex, and health of the bone marrow donor 
(Phinney et al., 1999) must be taken into consideration. Also, controlling physical 
parameters during the cell expansion process for hMSC and understanding the 
effect of these environmental factors on cell growth in an undifferentiated state is 
imperative when designing a robust process for the manufacture of biological 
material. 
To  ensure  production  of  sufficient  cells  to  satisfy  market  needs,  bioprocess 
conditions and equipment for the expansion of hMSC need to be investigated and 
adopted, ensuring optimum growth in an undifferentiated state. The use of an 
automated platform will potentially facilitate higher output capabilities, whilst 
reducing  variability  due  to  operator  manipulations  (Terstegge  et  al.,  2006, 
Joannides  et  al.,  2006,  Bernard  et  al.,  2004).  In  addition,  rigid  control  of 
determining parameters for growth will result in a robust cell expansion process 
for industrial applications in the emerging regenerative medicine sector. Study of 
the effect of physical conditions experienced by the cultures during automated 
manipulations will generate a set of Standard Operating Procedures (SOP) for an 
appropriate range of conditions,  aimed at  ensuring  cells  are maintained in  an 
undifferentiated and still multipotent state. 
The  aim  of  this  thesis  is  to  investigate  hMSC  growth  characteristics  under 
different processing conditions, and to define the optimal culture conditions for 
the effective clinical scale production in an automated platform of large numbers 
of hMSC. It is also the aim of this thesis to develop a mathematical model that 
could describe the kinetics of growth for cells from each donor with the intention 
of forward predicting the overall cell expansion process time for each individual 
patient       Chapter One 
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The specific objectives of this thesis are:  
  To characterise growth kinetics over sequential passages with the objective of 
establishing a baseline cell expansion process for future optimisation. Chapter 
3 evaluates different isolation techniques for the separation of hMSC from 
bone marrow, as well as the effect of cell banking on cell growth, and the 
effect of culture surfaces and sequential cultivation on hMSC growth kinetics. 
  To  evaluate  the  controlled  parameters  for  an  automated  hMSC  expansion 
process. Chapter 4 assess the impact of inoculation seeding densities, feeding 
strategy,  and  pH  and  temperature  excursions  in  hMSC  expanded  in  an 
automated platform. 
  To  establish  a  mathematical  model  for  hMSC  growth  kinetics.  Chapter  5 
demonstrates the accuracy of a mathematical model to forward predict the 
growth rate of cells from different donors over multiple passages as well as 
examines the surface marker expression of hMSC throughout the expansion 
process. 
In addition to these chapters, Chapter 2 details all materials and methods that 
were  used  throughout  the  work  and  Chapter  6  gives  a  summary  of  the  main 
observations and conclusions of the study as well as suggestions for future work.      Chapter Two 
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CHAPTER TWO 
Materials and Methods       Chapter Two 
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2  MATERIALS AND METHODS 
2.1  Isolation of hMSC from Bone Marrow Aspirates 
Two methods were used to isolate hMSC from frozen bone marrow samples, 
Ficoll-Paque density gradient centrifugation and direct isolation. 
2.1.1 Ficoll-Paque Density Gradient Centrifugation 
Human bone marrow aspirates were collected from the iliac crest of volunteer 
donors after informed consent and stored in 250 ml sterile bags, at -140 to -170˚C 
in liquid nitrogen after addition of DMSO and heparin (in quantities not provided 
by the source) to prevent cell membrane breakage and clotting when thawed. The 
frozen samples were provided by the Department of Haematology, University 
College London Hospital, ranging in volume from 74 ml to 120 ml per bag. This 
isolation technique was performed on five bone marrow samples from different 
patients. 
Frozen bone marrow samples were initially thawed at 37˚C and filtered through a 
40 m cell strainer (Falcon, Bibby Sterilin, Stone, UK) inside a class II biosafety 
cabinet  to  remove  bone  particles  and  aggregates  of  adipose  tissue. 
Mononucleated  cells  were  isolated  from  the  filtered  material  by  Ficoll-Paque 
density  gradient  centrifugation  (StemCell  Technologies,  Vancouver,  British 
Columbia, Canada). Ficoll-Paque solution is a mixture of Ficoll™ PM400 and 
sodium  diatrizoate  at  a  density  of  1.077  g/ml,  developed  for  purification  of 
mononuclear cells from anti-coagulant treated human peripheral blood (Minami 
et  al.,  1978;  Elequin  et  al.,  1977;  Arkin  et  al.,  1991;  Deguch  et  at.  1991). 
Differential migration after centrifugation of a blood sample deposited over an 
equal amount of Ficoll-Paque, results in the formation of layers of different cell 
types.  This method required initial dilution of the filtered sample with an equal 
amount of Dulbecco‟s phosphate buffered saline (DPBS, Sigma Chemical Co., 
St.  Louis,  Missouri,  USA).  This  solution  was  slowly  poured  over  an  equal 
volume of Ficoll-Paque in a 50 ml Falcon centrifuge tube to avoid any mixing 
between the two phases prior to centrifugation at 650g and 21˚C, for 30 minutes 
(Eppendorf 5810R AG, Hamburg, Germany). After centrifugation, several layers       Chapter Two 
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were visible along the centrifuge tube. From the bottom of the tube up there was a 
lower layer containing erythrocytes and granulocytes, a layer of Ficoll-Paque, an 
interface of mononuclear cells in the middle of the tube, and a top layer of plasma 
as shown in Figure 2.1.  
 
Figure 2.1 Schematic representation of Ficoll-Paque and bone marrow samples 
pre-  and  post-centrifugation.  Bone  marrow  sample  is  poured  over  an  equal 
volume of Ficoll-Paque and centrifuged. Different layers are formed after Ficoll-
Paque density gradient centrifugation to separate mononucleated cells from bone 
marrow as described in section 2.1.1. 
After centrifugation, the 50 ml falcon tube was taken into a class II biosafety 
cabinet. The plasma phase was carefully removed with a sterile pipette without 
disturbing the mononuclear cell interface, which was then collected for further 
processing. In order to remove any possible plasma and Ficoll-Paque solution 
aspirated  along  with  the  mononuclear  cells,  approximately  5  to  6  ml  of  the 
collected interface sample was mixed with 35 ml of DPBS in a 50 ml Falcon tube 
and  centrifuged  at  650  g  and  21˚C,  for  15  minutes.  The  resulting  pellet  was 
resuspended in hMSC culture medium, which consists of low-glucose DMEM 
(BioWhittaker,  Walkersville,  Maryland,  USA)  supplemented  with  10  %  (v/v) 
FBS (StemCell Technologies), 2 mM L-glutamine (BioWhittaker) and 100 U/ml 
penicillin and streptomycin (BioWhittaker). This medium formulation has been 
used in all experiments in this thesis for the cell expansion of hMSC, and will be 
referred to hereafter as culture medium. In order to minimise possible variability 
due to different lots of FBS as discussed in Section 1.3.2, only two lots of serum 
pre-selected for hMSC growth by the vendor (lot #05B14288 and lot #05B14286 
from StemCell Technologies) were used for all experiments in this thesis. Cell 
viability was assessed by Trypan Blue exclusion method as described in section 
Bone  marrow
     
Ficoll-Paque  Centrifugation 
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2.6.1, by which the permeable cytoplasmic membrane of dead cells is penetrated 
by Trypan (BioWhittaker) staining the whole cell dark blue in contrast with the 
unstained  life  cells.  Cell  density  was  determined  using  a  haemocytometer  as 
described in section 2.6.1. 
A second separation step was needed to extract hMSC from the suspension of 
mononuclear cells. This was achieved on the basis that hMSC are the only cells 
from  the  bone  marrow  extract  that  would  adhere  to  a  treated  culture  surface 
(Friedenstein et al., 1970; Friedenstein et al., 1976). Isolated mononuclear cells 
were seeded into T-25 or T-150 culture flasks (Corning Life Sciences, Corning, 
New  York,  USA)  at  inoculation  cell  densities  ranging  from  1x10
4  to  1x10
7 
cells/cm
2, in culture medium, and incubated at 37˚C in a humid 5% (v/v) CO2 
atmosphere. Non-adherent cells were removed from the culture three days after 
initial isolation by performing a medium exchange. Fourteen to twenty days later, 
with  medium  exchanges  every  three  to  four  days,  adherent  cells  showing 
mesenchymal stromal phenotype covered 80% of the surface of the culture flask 
and  were  removed  by  enzymatic  exposure  to  0.25%  trypsin  in  1  mM  EDTA 
solution (Sigma) for subsequent cell expansion (Section 2.4) or for the generation 
of a cell bank (Section 2.2). 
2.1.2 Direct Isolation 
Eighteen bone marrow sample bags from different patients were used to optimise 
and  perform  isolations  using  a  novel  Direct  isolation  technique  that  would 
facilitate  automation.  Sterile  bags  of  frozen  bone  marrow  aspirates  (source 
indicated in Section 2.1.1) were thawed at 37˚C and the content of the bag was 
mixed with culture medium to achieve the desired inoculation cell density prior to 
seeding. In order to optimise the procedure, bone marrow samples were diluted 
with culture medium in different volume ratios ranging from 1:0 to 1:4 bone 
marrow in medium, as well as at different cell density concentrations ranging 
from  1x10
4  to  1x10
6  cells/cm
2.  The  mixed  suspension  of  bone  marrow  with 
medium  was  then seeded into T-25 or T-150 Corning flasks,  with  a working 
volume ranging from 0.2 to 0.53 ml/cm
2. The medium was exchanged after 24 hr 
to  remove  the  cells  in  suspension,  and  from  then  on  it  was  exchanged  at  a       Chapter Two 
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frequency ranging from once every three days to daily until 80% confluency of 
hMSC was reached. The cells were then detached from the surface of the flask by 
exposure to 0.25% trypsin in 1 mM EDTA for subsequent cell expansion (section 
2.4) or for the generation of a cell bank (section 2.2). 
2.2  Cell Banking 
Cells were detached from the surface of the culture vessel (T-150, T-75, or T-25 
flasks) by exposure to 0.04 ml/cm
2 of 0.25% trypsin in 1 mM EDTA solution for 
no less than 5 minutes and no longer than 10 minutes at 37˚C, after removing the 
spent medium and washing the cell monolayer with DPBS. Trypsin activity was 
inhibited by addition of 0.04 to 0.08 ml/cm
2 of culture medium. The content of 
each flask seeded from a single bone marrow donor was pooled into a common 
sterile container (Nalgene Nunc International, Rochester, New York, USA) and 
mixed by slowly pipetting up and down a minimum of ten times with gentle 
swirling. Two independent 0.5 ml samples of this concentrated cell suspension 
were taken for cell density measurements (Section 2.6). The cell viability and 
density of the concentrated cell suspension were determined by the Trypan Blue 
exclusion (Section 2.6.1).  
A diluted cell suspension was then prepared to achieve 1x10
6 cells/ml in a final 
formulation of freezing medium. Freezing medium was prepared with 90% (v/v) 
culture  medium  and  10%  (v/v)  of  the  total  volume  of  DMSO  (Sigma).  The 
concentrated  cell  suspension  in  freezing  medium  was  dispensed  into  1.5  ml 
Nalgene internal thread cryovials (Nalgene Nunc International) with 1 ml of cell 
suspension  (or  1x10
6  cells)  per  vial,  placed  in  a  5100  Cryo  1˚C  Freezing 
Container widely known as „Mr. Frosty‟ (Nalgene Nunc International) and left in 
a -70˚C freezer for 24 to 48 hours. A „Mr. Frosty‟ is a polycarbonate container 
with a foam insert. After soaking the foam with 100% isopropyl alcohol, Mr. 
Frosty allows for control rate freezing of the cells at a cooling rate of 1˚C per min 
required for successful cell cryopreservation. After 24 to 48 hours in a  -70˚C 
freezer, the vials of hMSC were transferred into a liquid nitrogen freezer. 
For one of the banks created, the vials were placed inside a Nunc CryoFlex™ 
tubing  (Nalgene  Nunc  International),  a  heat  sealable  polyethylene  tubing       Chapter Two 
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designed  for  CryoTube  Vial  encasement  to  reduce  possible  hazards,  prior  to 
immersion  of  the  vials  in  a  liquid  nitrogen  freezer.  The  time  required  to 
encapsulate individual vials,  and the difficulty involved while removing them 
from the tubing did not justified the use of Nunc CryoFlex™ tubing for any other 
cell banks. 
A total of six cell banks were created, each from a different donor at passages 
ranging from passage zero (P0 is considered to be the first hMSC collected from 
T-flasks  seeded  directly  from  bone  marrow  samples  (Section  2.1.2)),  or 
mononucleated cells isolated from a Ficoll-Paque density gradient centrifugation, 
(Section 2.1.1)) to passage four (P4). The number of vials per cell bank created 
ranged from 5 to 34 vials. 
2.3  Culture Surfaces and Vessels 
Different  culture  vessels  and  surfaces  were  used  for  the  expansion  of 
undifferentiated  hMSC.  Culture  treated  surfaces  from  Corning  were  used  for 
static attachment cultures while ultra-low attachment plates from Corning were 
used for microcarrier suspension cultures of hMSC. Microcarrier cultures were 
performed  with  MicroHex  (Corning)  and  with  Cytodex  1,  and  Cytodex  3 
(Pharmacia, Uppsala, Sweden). 
2.3.1 T-flasks 
T-flasks used for the expansion of hMSC were standard tissue culture treated 
polystyrene  surfaces  by  Corning.  The  surfaces  are  modified  using  a  corona 
discharge  that  generates  highly  energetic  oxygen  ions  which  graft  onto  the 
surface  polystyrene  chains,  so  that  the  surface  becomes  hydrophilic  and 
negatively  charged  to  optimise  cell  attachment  (Hudis,  1974;  Amstein  and 
Hartman, 1975; Ramsey et. al., 1984).  T-flasks had vent caps with  a 0.2 µm 
membrane  sealed  into  the  cap,  allowing  sterile  gas  exchange  from  the  CO2 
controlled incubators to regulate the pH of the culture medium. Different culture 
surface sizes used were 25 (T-25), 75 (T-75) and 150 (T-150) cm
2.       Chapter Two 
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2.3.2 Microwell Plates 
Flat-bottom,  round-well  microwell  plates  from  Corning  with  identical  surface 
properties to T-flasks (section 2.3.1) were also used for cell expansion. Three 
different well size plates were used: 6, 12, and 24-well plates. Each well had a 
surface area of 9.5 cm
2/well in a 6-well plate, 3.8 cm
2/well in a 12-well plate, and 
1.9  cm
2/well  in  a  24-well  plate,  with  working  volumes  of  3,  2,  and  1  ml 
respectively unless indicated otherwise. 
2.3.3 Microcarriers and Microcarrier Cultures 
Three different microcarries were tested for cell expansion of hMSC. Ultra-low 
attachment coated polystyrene surface well plates by Corning were used for all 
microcarrier experiments to avoid cell attachment to the surface of the wells. This 
surface is a covalently bound hydrogel layer that is hydrophilic and neutrally 
charged.  Proteins  and  other  biomolecules  attach  to  a  surface  through  either 
hydrophobic or ionic interactions (Grinell, 1978), and so this hydrogel surface 
inhibits nonspecific immobilization via these forces, thus inhibiting subsequent 
cell attachment. Shake flasks, 125 ml, with a working volume of 20 ml, from 
Corning, were also used for larger cultures with 2D-microhex microcarriers. 
2.3.3.1  Cytodex 1 
Cytodex  1  (Pharmacia)  are  transparent  non-porous  microcarriers  made  of  a 
spherical matrix of cross-linked dextran with positively charged N,N,N-trimethyl-
2-hydroxy-aminopropyl groups for optimal cell growth. The charged groups are 
distributed throughout the microcarrier matrix. They have a density of 1.03 g/ml, 
average diameter of 180 m providing a surface culture area of 6000 cm
2/g dry 
weight,  a  ratio  of  microcarrier  per  gram  of  6.8x10
6.  The  microcarriers  were 
hydrated  and  swollen  in  Ca
2+,  Mg
2+  free  DPBS  and  pre-conditioned  for  a 
minimum of 3 hours at room temperature. The supernatant was decanted and the 
microcarriers were washed in fresh DPBS and sterilized in an autoclave. 
One gramme of microcarriers was recovered from the sterile solution, DPBS was 
removed and replaced with culture medium at 37˚C, at a concentration of 9.6 mg 
microcarriers/ml. Microcarrier cultures were set in 24-well ultra-low attachment       Chapter Two 
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plates,  at  cell  densities  of  5x10
3  and  1x10
4  cells/cm
2,  or  13  and  26 
cells/microcarrier respectively with a final microcarrier density of 3 g/L. All the 
cells and microcarriers were seeded with an initial working volume of 0.5 ml/well 
to aid cell attachment, and culture medium was added after 24 hours in culture up 
to a final working volume of 2 ml/well. The plates were incubated in a 37˚C 
humidified incubator with 5% (v/v) CO2 either in static conditions for the first 6 
hours  with  periodical  shaking  at  250  rpm  for  5  min  every  2  hours,  or  under 
continuous  agitation  of  250  rpm  on  an  orbital  shaker  (KS  130  control,  IKA) 
placed inside the incubator six hours after inoculation. 
2.3.3.2  Cytodex 3 
Cytodex 3 (Pharmacia) consists of a matrix of cross-liked dextran coated with a 
layer of denatured Type I collagen in an approximate amount of 60 g/cm
2 which 
results in maximum cell yields (Gebb et al., 1983). These microcarriers have a 
density of 1.04 g/ml, average diameter of 175 m providing a surface culture area 
of 4600 cm
2/g dry weight, a ration of microcarrier per gram of 4.0x10
6. The 
microcarriers were sterilized in the same manner as with Cytodex 1 microcarriers 
(section 2.3.3.1). 
One gramme of microcarriers was recovered from the sterile solution, DPBS was 
removed and replace with culture medium at 37˚C, at a concentration of 9.6 mg 
microcarriers/ml.  Microcarrier  cultures  were  performed  in  24-well  ultra-low 
attachment plates, at cell densities of 5x10
3 and 1x10
4 cells/cm2, or 10 and 20 
cells/microcarrier respectively with a final microcarrier density of 3 g/l. Cultures 
were performed as described in Section 2.3.3.1. 
2.3.3.3 2D-Microhex 
2D-Microhex  (Nalgene  Nunc  International)  are  solid  two  dimensional 
microcarriers made of polystyrene, non-porous and non-absorbing particles with 
the same properties as the cell culture plastic-ware produced by Nunc. They are 
gamma irradiated, and do not need conditioning prior to use. The microcarriers 
are flat flakes of hexagonal shape, with dimensions of 125 m in side length and 
25 m in thickness, a density of 1.05 g/cm
3 and cultivation area of 760 cm
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Microcarrier  cultures  with  2D-Microhex  were  inoculated  at  a  cell  density  of 
5x10
3 cell/cm
2 and a microcarrier density of 10 cm
2/ml in a 125 ml shake flask 
(Corning)  with  a  20  ml  working  volume.  The  shake  flask  was  placed  in  a 
humidified  incubator  at  37˚C,  with  5%  (v/v)  CO2  atmosphere  under  static 
conditions for one hour to allow for cells to attach to the microcarriers. The flask 
was then shaken manually for 2 minutes after one hour in static condition, and 
continually after three hours from inoculation at 100 rpm in a orbital shaker. 
Microcarrier experiments were carried out in 24-well ultra-low attachment plates, 
seeded at 1x10
2 and 5x10
3 cells/cm
2 and a microcarrier surface density of 5 and 
10 cm
2/ml. Initial working volumes ranged from 0.5 to 1.5 ml/well. After the 
cells were allowed sufficient time to attach to the surface of the microcarriers, 
additional culture medium was added to a final working volume of 1.5 ml/well. 
Plates were placed in an incubator, same conditions than above, in static culture 
conditions and shaken for 5 minutes at 250 rpm at inoculation and at different 
time  intervals  post  inoculation  ranging  from  once  every  one  to  ten  hours 
afterwards. Continuous shaking conditions were started three to 16 hours after 
inoculation  in  an  orbital  shaker  placed  inside  the  incubator  at  stirring  speed 
ranging from 200 to 280 rpm. 
2.4  Cell Expansion 
hMSC  thawed  from  a  frozen  vial  (Section  2.2)  or  a  previous  passage,  were 
seeded into a culture vessel from a diluted cell suspension prepared with culture 
medium and hMSC to a determined volumetric cell concentration (cells/ml) in 
order  to  achieve  a  desired  surface  inoculation  cell  density  (cell/cm
2).  When 
replicates were seeded in parallel, each vessel or well was inoculated from the 
same diluted cell suspension to reduce variation. Cell cultures seeded in T-flasks 
or microwell plates, were placed in a 5% (v/v) CO2 humidified incubator at 37˚C 
unless  otherwise  specified.  Complete  exchange  of  the  culture  medium  was 
performed at regular intervals, ranging from every 2 hours to every 3 days. 
Once the hMSC had covered approximately 80% of the culture surface (or had 
reached mid-exponential phase of growth), the cell monolayer was detached with 
an enzymatic treatment. First the spent medium was decanted from the flask or       Chapter Two 
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well, and replaced with an equal amount of DPBS without Ca
2+ and Mg
2+, to 
remove traces of serum. The buffer was removed by aspiration, and 0.04 ml/cm
2 
trypsin/EDTA was added to the cell monolayer to break cadherin mediated cell-
cell adhesion by cleavage of peptide bonds at lysine and arginine residues and to 
sequester divalent cations that interfere with trypsin activity (Olsen et al., 2004, 
Freshney, 1994). Trypsin activity was aided by placing the culture vessels in an 
incubator under the same conditions as the ones used for cell cultures, for no 
longer than 10 minutes to avoid any damage to the cells. As soon as the cells 
were  detached  from  the  surface,  which  was  determined  by  microscopic 
observation,  trypsin  activity  was  inhibited  by  addition  of  culture  medium,  in 
quantities from 0.04 to 0.08 ml/cm
2. To ensure optimal recovery of the hMSC 
from the culture surface, the cell suspension was pipetted up and down to wash 
cells from culture surface, prior to removal of the cell suspension from the culture 
vessel. Samples were taken from the concentrated cell suspension for cell density 
measurements, which was determined by Trypan Blue exclusion (Section 2.6.1) 
or by Guava analysis (Section 2.6.2). 
2.5  Replacement of FBS with Protein Hydrolysates from Culture Medium 
FBS was replaced by protein hydrolysates from the growth medium to test if this 
new media formulation without animal derived components could sustain hMSC 
growth.  Four  different  protein  hydrolysates  were  tested,  HyPep  4601,  HyPep 
1511, HyPep 1510, and Hy-Soy (all from Kerry Bio-Science, Tralee, Ireland). 
Culture medium was formulated with 1g/L glucose DMEM (BioWhittaker), 2mM 
L-glutamine  (BioWhittaker),  100  U/ml  penicillin  and  streptomycin 
(BioWhittaker)  and  4  g/L  (w/w)  protein  hydrolysate.  After  formulation,  the 
medium was filtered through a 0.2 m filter (Nalgene). hMSC diluted into each 
of the four animal-free  medium  formulations  were seeded into 24-well plates 
with 5x10
3 cells/cm
2. The cultures were kept for 13 days with medium exchanges 
every  three  days.  Wells  from  each  of  the  growth  medium  conditions  were 
harvested at different time point intervals to determine cell growth kinetics based 
upon viable cell counts (Section 2.6.).       Chapter Two 
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2.6  Quantification of Cell Viability and Cell Density 
Two different  assay techniques were used to  determine cell viability  and  cell 
density in hMSC cultures; Trypan Blue exclusion and Guava Viacount (Guava 
Technologies, Hayward, California, USA).  Trypan Blue exclusion is a widely 
used  method  for  enumerating  living  and  dead  cells  in  culture.  Guava 
Technologies have recently developed a new method to evaluate cell viability and 
density  based  on  DNA  fluorescent  stains  that  can  be  detected  with  a  Guava 
Easycyte flow cytometer (Guava Technologies). 
In general samples from parallel replicate experiments were used for cell density 
determination, but when this was not possible, replicate samples from the same 
condition were analysed with either of the these two techniques. 
2.6.1 Trypan Blue Exclusion and Haemocytometer for Cell Density and 
Viability Quantification 
Trypan Blue is a vital dye. The reactivity of Trypan Blue is based on the fact that 
the chromophore is negatively charged and does not interact with the cell unless 
the membrane is damaged. Therefore, all the cells which exclude the dye are 
viable and the ones with permeable membranes that take up the dye are dead and 
appear dark blue under a microscope. 
Cell suspensions of hMSC were mixed by gently pipetting up and down prior to 
sampling to ensure homogeneity of the suspension. Independent 0.2 to 0.5 ml 
samples were taken in 1.5 ml Eppendorf tubes. Trypan Blue was then added to 
each sample and a minimum of 3 minutes were allowed for the stain to penetrate 
the cells. Depending on the density of the cell suspension, the ratio in volume of 
cell suspension to dye used for haemocytometer measurements, ranged from 1:1 
to 1:40. The stained cell suspension was then loaded into a haemocytometer. A 
haemocytometer is a specialized microscope slide with a thick base containing a 
grid in a counting chamber, and uses a special cover glass which is thick enough 
to stay flat under the pull of surface tension from the solution in the chamber. The 
haemocytometer chamber is divided into two sides with a grid of 9 squares each 
and a loading volume of 10 l per side. The dye stained cell suspension was       Chapter Two 
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loaded into the haemocytometer by pipetting 10 l into each side of the chamber. 
Ten  squares  were  counted  per  haemocytometer  loaded,  and  cell  density  in 
cells/ml and percent viability were determined according to: 
counted squares of no.
10 factor dilution counted cells of no.
(cell/ml) ion concentrat Cell
4  
   (2.1) 
Cell concentration was expressed in surface cell density by the formula: 
) (cm   area   surface
(ml) suspension cell of volume (cell/ml) ion concentrat cell Viable
) (cell/cm density cell Viable
2
2 

    (2.2) 
Percentage viability was calculated according to: 
100 .
cells of number total
cells live of number
(%) Viability     (2.3) 
2.6.2 Guava for Cell Density and Viability Quantification 
Guava Viacount reagent was used in conjunction with a Guava EasyCyte 96-well 
flow-cytometer  (both  from  Guava  Technologies)  to  determine  hMSC 
concentration  and  viability.  Results  were  analysed  using  Guava's  ExpressPlus 
software (CytosoftPCA, by Guava Technologies). 
The Guava ViaCount assay consist of two DNA-binding dyes. One of the dyes is 
membrane permeable and stains all nucleated cells; fluorescent signal from the 
nuclear staining dye is detected by photomultiplier tube 2 (PM2). The other dye 
only penetrates cells with compromised membrane integrity (i.e. non-viable cells) 
and is detected by photomultiplier tube 1 (PM1). Forward light scatter (FSC) 
intensity is used to detect the size of a particle, and to distinguish between debris 
events with low FSC signal and cells with higher FSC signal. 
Viable cell concentration and viability were measured by staining 200 l of cell 
suspension with 3 l of ViaCount dye followed by a 15 minute incubation period 
at room temperature in the dark. Each sample was loaded into a 96-well plate, 
and inserted in the autosampler platform of the Guava instrument. Samples were       Chapter Two 
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mixed  for  6  seconds  prior  to  sampling  with  an  internal  rotating  mixer  and  a 
minimum of 2000 events were collected for each sample. 
2.6.3 Comparison of Haemocytometer and Guava Viable Cell Density 
Determination 
Cell  viability  and  cell  density  were  determined  using  either  Trypan  Blue 
exclusion  (Section  2.6.1)  or  the  Guava  method  (Section  2.6.2).  In  order  to 
evaluate the validity of the results obtained from either method and to enable a 
comparison of results from different experiments in this thesis, a comparison of 
viable cell counts from both assays was performed. 
A total of 18 samples of hMSC of different cell concentrations were subjected to 
both  assays  to  determine  viable  cell  density.  The  results  from  the 
haemocytometer cell counts were plotted against the results from Guava Viacount 
as shown in Figure 2.2. Comparison between both results shows that viable cell 
count determination between both methods follow a linear relationship and that in 
general there is a good agreement between the two methods. 
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Figure 2.2 Comparison of the two different methods used to determine viable 
cell density. Haemocytometer counts as described in Section 2.6.1 and Guava 
counts as described in Sections 2.6.2.       Chapter Two 
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2.6.4 Calculations Used for Cell Growth Characterisation 
Based on viable cell density and viability measurements (Section 2.6) at specific 
time points during cell proliferation within one passage, cell growth rates and 
doubling  times  were  calculated  to  enable  quantitative  comparison  of  culture 
performance and modelling of the cell expansion process. 
2.6.4.1  Cell Growth Rate and Doubling Time 
Cell growth rate is an intrinsic characteristic of hMSC for each donor and for 
each passage of the overall cell expansion process (Phinney et al., 1999; Bruder 
et  al.,  1997;  Mareschi  et  al.,  2006).  It  is  used  as  an  indicator  of  culture 
performance in response to different medium formulations and culture operating 
conditions. Solving a cell balance for a batch culture (Equation 2.4), yields the 
following equation to calculate cell growth rates (Equation 2.5): 
μX
dt
dX
   (2.4) 
where X is the cell density at time t, and  is the cell growth rate as described by: 
  0 f
0
f
t t
X
X ln



 


    (2.5) 
where Xf is the final cell density, X0 is the initial cell density, tf is the time at 
which the cell density reaches Xf and t0 is the initial time. For cell growth rate 
calculations, the time that the culture is in lag or stationary phases is not taken 
into consideration, and t0 and tf are considered as the points in the culture when 
the cells enter and exit the exponential growth phase respectively as determined 
from the linear region of a plot of ln(X/X0) against t. 
Doubling time (Td) is defined as the time taken for the cell population to double 
in number, or when X is equal to 2X0. By making this substitution in Equation 
2.4, and solving for t, the equation for calculating doubling time is obtained: 
 

2 ln
Td   (2.6)       Chapter Two 
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For a limited number of cultures in T-flasks without replicates, where only initial 
and final cell densities are know, approximate growth rates are calculated based 
on these two data points. It is important to understand that when growth rates or 
doubling times are calculated in this manner, it represents an estimate of the real 
value. Other factors such as lag phase time length and duration of exponential 
growth will not be known and it can result in slower calculated growth rates and 
doubling times depending on the time at which the final measurement is taken. 
2.6.4.2 Population Doubling Level 
Population Doubling Level (PDL) indicates the number of times that the cells 
have doubled (divided) over the cell expansion process, as expressed by Equation 
2.7.  Changes  in  PDL  can  be  calculated  by  solving  Equation  2.7  for  PDL 
(Equation 2.8). The overall PDL of the culture can be determined by adding each 
PDL if the history of the cells is known from P0 or from isolation. PDL is time 
independent, and it is a more accurate indicator of the age of the culture than a 
passage number.  
PDL    2 X X 0 f   (2.7) 
which can be rearranged to give: 
  2 ln
X
X ln
PDL
0
f 

 


    (2.8) 
2.6.4.3 Metabolic Rates 
Consumption rates for glucose and glutamine and production rates of lactate and 
glutamate  give  an  indication  of  the  culture  behavior.  These  rates  also  help 
understand possible rate limiting components for growth in the culture medium, 
or toxic accumulation of byproducts  that may inhibit growth. Metabolic rates 
were normalized on the basis of viable cell density, to give specific rates. 
Metabolic rates were calculated with a mass balance on the metabolite over the 
period of the culture or of the sampling range as expressed by Equation 2.9:       Chapter Two 
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X qA
dt
dCA     (2.9) 
where  CA  is  the  metabolite  concentration,  qA  is  cell  specific  metabolite 
production/consumption rate (in mass per viable cell per unit time), and X is the 
cell density per unit volume. 
2.7  Quantification of Metabolite Concentrations 
Metabolites from 1 ml filtered samples of the spent medium collected at different 
time points during the culture of hMSC were measured using a Bioprofile 400 
(Nova  Biomedical,  Waltham,  MA,  USA).  This  device  provided  readings  for 
glucose, lactate, glutamine, glutamate and ammonium. In addition to metabolites, 
the  Bioprofile  400  also  provided  values  for  pH,  sodium,  potassium,  and 
osmolality. 
2.8  Temperature On-Line Monitoring 
Temperature  variations  during  cell  expansion  of  hMSC  occur  during  medium 
exchanges or microscopic observations, when the cultures are taken out of the 
incubator  into  a  biosafety  cabinet  or  placed  under  the  microscope.  The  two 
possible  temperature  step  changes  that  the  cultures  are  exposed  to  are:  (i)  a 
downward step change from 37˚C to room temperature and (ii) an upward step 
change from room temperature to 37˚C in a humidified incubator with air blowers 
that pump a controlled 5% (v/v) CO2 atmosphere. Temperature changes in the 
culture medium due to these step change temperature variations were measured in 
12-well plates.  
All  wells  in a 12-well plate were filled with  culture medium  with  a working 
volume of 2 ml per well, the same volume used for the culture of hMSC. Two 
glass fibre insulated type-T thermocouples (RS Components, Corby, UK) were 
immersed in the liquid of two wells in different locations in the plate (one at the 
corner well and another one in a central well), and another two thermocouples 
were placed 10 to 25cm above the plate to record the ambient temperature. The 
thermocouples  were  connected  to  a  USB-based  eight  channel  temperature       Chapter Two 
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measurement  module  (USB-TC,  Measurement  Computing,  Norton,  Maryland, 
USA) that converted the signal from analog to digital and recorded the data into a 
computer. The USB-TC measurement module was allowed to equilibrate for a 
minimum  of  30  minutes  before  calibration  as  per  the  manufacturer 
recommendations,  and  calibrated  using  Instacal  calibration  software 
(Measurement  Computing).  The  data  was  processed  using  TracerDAQ  2.0 
(Measurement Computing). 
A number of different operating scenarios were reproduced, and the subsequent 
temperature  changes  in  the  liquid  of  the  wells  as  well  as  in  the  surrounding 
environment were measured.  
1.  Maximum temperature change from 37˚C to room temperature. The plate 
was equilibrated in the incubator until all temperature sensors recorded 37˚C. 
Then, the plate was removed from the incubator and left on the laboratory 
bench  until  the  temperature  of  the  liquid  in  the  wells  reached  room 
temperature. 
2.  Maximum temperature change from room temperature to 37˚C. The plate 
was equilibrated on the bench top at room temperature to ensure that the 
liquid temperature was reading the same temperature as the sensors recording 
room  temperature.  Then  it  was  placed  in  the  incubator  at  37˚C  until  the 
temperature sensors in the liquid of the wells reached 37˚C. 
3.  Fifteen minute step change from 37˚C towards room temperature. Fifteen 
minutes  was  determined  to  be  the  maximum  time  it  takes  for  a  trained 
operator to manually remove a 24-well plate from the incubator, perform a 
medium exchange in all wells of the plate, and place the plate back into the 
incubator. For this measurement, a pre-equilibrated plate was removed from 
the incubator and placed inside a biosafety cabinet removing the lid, to take 
into consideration the heat transfer effect of the blowers inside the laminar 
hood. After 15 minutes, the lid was placed back onto the 12-well plate, and 
the plate was placed back into the incubator. 
4.  Step change from room temperature to 37˚C with shaking. To accelerate heat 
transfer into the liquid of the wells orbital shaking of the plates was tested at 
shaking frequencies of 150 and 250 rpm.       Chapter Two 
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2.9  pH Monitoring 
The culture medium contains phenol red as a pH indicator, and is buffered to 
maintain a pH of 7.4. The pH of the culture medium changes during the cell 
expansion  process  and  during  manual  manipulations  with  exposure  to 
atmospheric CO2 levels and it is dependent on temperature.  
2.9.1 pH On-Line Monitoring 
Changes  in  the  pH  of  microwell  cultures  due  to  environmental  variations 
(temperature and gas composition) were detected by pH-sensitive optical mini-
sensors in conjunction with a pH-4 mini - Four Channel pH meter for fibre-optic 
pH mini-sensors (both from PreSens GmbH, Regensburg, Germany), based on 
pH sensitive, fluorescent dyes.  
The pH-4 mini is a PC-controlled four channel pH meter device based on the 
DLR  (dual  luminophore  reference)  method.  This  referencing  method  uses  the 
measurement of average decay times. The sensor (Figure 2.3) consists of a pH 
indicator with short decay time and an inert reference dye with long decay time. 
The average decay time is a measure of the ratio of the intensities of the two dyes 
and  therefore  for  pH.  This  method  allows  therefore  referenced  measurements 
with the use of a single light source and detector and a single filter combination. 
The device is controlled through HView software, which also saves and displays 
the data collected.        Chapter Two 
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Figure  2.3  Schematic  diagram  of  the  pH  sensor  for  the  pH-4  mini.  (Image 
sourced from www.presens.de).  
The sensor foil on the tip sterilized by gamma irradiation are planar pH sensor 
spots  made  of  polymer  optical  fibers  (POF)  containing  immobilized  indicator 
dyes.  They  can  be  detected  in  a  non-invasive  and  non-destructive  way  from 
outside the wall of a transparent well, with a resolution of 0.005 in units of pH. 
These 2 mm in diameter circular spots were secured with silicon glue inside the 
wells of a 12-well plate in the centre of the well. The well plate was secured onto 
a  raised  platform  with  perforated  holes  to  allow  placement  of  the  probe 
underneath the wellplate.. The fiber optic probe was connected to the spots from 
the outside of the well through the bottom of the platform. The optical sensors do 
not  leach  into  the  culture  medium,  but  they  are  subject  to  photobleaching. 
Bleaching is proportional to the light dose with a decay rate of 0.01 pH for every 
1000 measuring points, therefore it can be minimised by the decrease of LED 
current or larger measurement intervals.  
A  six  point  calibration  of  the  sensor  spots  was  performed  before  all 
measurements. The calibration has a sigmoid shape described by the Boltzman 
curve, Equation. 2.10:        Chapter Two 
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Where min and max are minimum and maximum phase numbers, pH is the pH-
value  of  the  buffer  solution,  pH0  is  the  measured  pH  value,  and  dpH  is  the 
differential of the pH values. 
Six pH calibration buffers (4.0, 5.0, 6.0, 7.0, 8.0, and 9.0) were used to obtain all 
the  coefficients  of  the  curve  (Figure  2.4).  PreSens  provide  a  calibration 
programme DLR470.xls, in which by entering the phase values obtained from the 
measurement with  each  buffer solution  at  room  temperature, values  for   min, 
 max, pH0, and dpH were obtained (Table 2.1). These values were entered in the 
set-up menu of HView software, which records and displays pH measurements. 
Table 2.1 Example of calibration results from PreSens pH optical fibre sensor 
spots. Measurements performed as described in Section 2.9.1. 
Calibration and Predicted 
Values 
Calibration Results 
Buffer Soln 
pH 
Measured 
Phase 
4  52.9800   min  54.917 
5  51.7700   max  18.663 
6  45.7500  dpH  0.87 
7  33.8100  pH0  6.87 
8  28.1900   
9  20.7600       Chapter Two 
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Figure 2.4 Example of a calibration curve for PreSens pH optical fiber sensor 
spots.  Calibrations  measurements  performed  as  described  in  section  2.9. 
Calibration curve fitted according to Equation 2.10. 
Experimental step up and environmental exposures to different temperature and 
CO2  conditions  were  identical  to  the  ones  detailed  in  Section  2.7.  All  values 
obtained for pH were corrected for temperature with the measurements obtained 
from  on-line  temperature  measurements  collected  in  that  section,  following 
Equations 2.11 to 2.14. 
Tcal) (T 0.05526 min(Tcal) min(T)        (2.11) 
Tcal) (T 0.04402 max(Tcal) max(T)        (2.12) 
Tcal) (T 0.01744 (Tcal) pH (T) pH 0 0       (2.13) 
Tcal) (T 0.00258 pH(Tcal) d pH(T) d       (2.14) 
where   min(Tcal),   max(Tcal),  pH0(Tcal),  and  dpH(Tcal)  were  the  values 
obtained  during  calibration  at  a  set  temperature  as  shown  in  table  2.1,  and 
 min(T),  max(T), pH0(T), and dpH(T) were calculated for each measurement       Chapter Two 
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taken at the temperature recorded at the same time. Both parameters, temperature 
and pH, were measured at identical time points in intervals of 15 seconds. 
2.9.2 pH Off-Line Monitoring 
A  pH  meter  equipped  with  a  temperature  probe  for  temperature  correction 
(SevenEasy pH, Mettler Toledo, Columbus, OH, USA) was used to measure pH 
off-line. A two point calibration at 4.01 and 7.01 pH was performed prior to each 
measurement. Measurements of media samples equilibrated inside the incubator 
at 37˚C and preset CO2 concentrations of 0, 2, and 5% were taken within one 
minute of removal from these controlled conditions. 
2.10  Cell Surface Marker Characterisation 
Cell  surface  marker  expression  for  CD90,  CD105  (SH2)  and  CD166  was 
determined at different stages of growth. Mouse anti-human all surface marker 
antibodies  were  monoclonal  mouse  anti  human  FITC  conjugated  from  AbD 
Serotec (Kidlington, UK). Mouse IgG1 FITC conjugated, also from AbD Serotec, 
was used as a negative control. Unstained cell suspensions stained with Viacount 
Reagent were also tested in parallel. 
Cultures of hMSC were harvested during the mid exponential phase of culture as 
described  in  Section  2.4.  The  cells  were  trypsinized  from  the  tissue  culture 
surface, and samples were taken to determine cell density (Section 2.6). The rest 
of the cell suspension was centrifuged at 400 g for 5 minutes, and the supernatant 
removed. The cell pellet was washed twice with buffer (PBS containing 2 mM 
EDTA and 0.5% (w/v) BSA, pH 7.2) using centrifugation at 400 g for 5 minutes, 
to remove traces of media. Aliquots of 5x10
5 to 5x10
6 cells in 100 l of buffer 
were incubated with 10 l of the corresponding conjugated monoclonal antibody 
at 4˚C in the dark for 30 minutes. After incubation, samples were washed twice 
with  buffer,  and  the  cell  pellets  were  resuspended  in  buffer  to  a  500  cell/l 
suspension. 
Surface marker expression was  determined by  flow cytometry using a  Guava 
Easycyte 96 as described in Section 2.6.2. For each sample, 200 l were loaded       Chapter Two 
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into a well from a 96-well plate, and 3 l of Viacount reagent was added to stain 
for nuclei. The plate was incubated in the dark for 10 minutes, and measurements 
acquiring 5000 events were performed. hMSC were gated in a plot of forward 
side scatter (FSC) versus PM3 (green fluorescence to detect FITC conjugated 
antibodies). 
2.11  Cell Size Measurements 
Cell  size  for  hMSC  at  passage  1  (P1)  and  5  (P5)  was  determined  using  two 
different devices, Zetasizer 3000 (Malvern Instruments Ltd, Malvern, UK) and 
Cedex.HiRes (Innovatis AG, Bielefeld, Germany). 
2.11.1  Mastersizer 
Cell  suspensions  harvested  from  hMSC  cultures  were  sized  by  dynamic  light 
scattering using a Zetasizer 3000 (Malvern Instruments Ltd). The principle of the 
measurement is based on the intensity of the scattered light of a laser when going 
through a sample of particles diluted in liquid (www.malvern.com). The intensity 
of the scattered light fluctuates at a rate that is dependent upon the size of the 
particles. Analysis of these intensity fluctuations can then be correlated to the 
average diameter of the particle. 
The  hMSC  suspension  samples  were  diluted  in  a  1:10  ratio  with  PBS  and 
analyzed in duplicate. All measurements were taken from a reservoir at 25˚C, 
with a counting time of 60 s each, a low rotation speed of 400 rpm in the sample 
chamber  to  minimise  cell  damage,  and  were  run  at  a  90˚  fixed  angle.  The 
measurements were analysed using the software supplied by the manufacturer. 
2.11.2  Cedex Imaging 
Cedex HiRes is an automated cell culture analyzer that uses the Trypan Blue 
exclusion method in conjunction with digital image recognition to determine cell 
density, viability, diameter and aggregate rate of the cell suspension. It uses a 
liquid handling system to load the cell suspension, and to stain it with Trypan 
Blue. The stained cell suspension is scanned and 300 images are analyzed per 
sample. Samples of harvested cell suspension from P1 and P5 were loaded into a       Chapter Two 
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Cedex HiRes to measure average cell size and size distribution in the population. 
Each sample was of a minimum of 300 l in volume. 
2.12  Automation of Cell Expansion Process 
A  Tecan  automated  platform  with  liquid  handling  system  was  used  for  the 
expansion of hMSC throughout one passage (Figures 2.5 and 2.6). 
 
Figure 2.5 Tecan Automated Platform for the expansion of hMSC. The robotic 
arm on the right-hand-side transports the well-plates from the incubator to the 
platform.  The  liquid-handling  arm  on  the  left-hand-side  can  perform  medium 
exchanges as well as trypsinisation operations by aspirating spent medium and 
dispensing new media or cell suspensions into the wells or well-plates. 
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Figure 2.6 Automated system for the aseptic cell expansion culture of hMSC. 
The robotic platform that manipulates well-plate cultures is enclosed within a 
temperature and gas controlled biosafety cabinet. The system is equipped with a 
robotic incubator and a centrifuge, both of them with aseptic connections into the 
robotic platform. 
2.13  Non-linear Regression Analysis  
Growth curves of hMSC were characterised by a four-coefficient generalisation 
of the Gompertz equation as described later in Section 5.2. The experimental data 
were  fitted  using  a  non-linear  regression  algorithm  provided  with  SigmaPlot 
(SigmaPlot  for  Windows,  version  9.0).  Values  for  the  coefficients,  standard 
errors, and correlation coefficients (r
2) for each fitted curve were generated by 
SigmaPlot.       Chapter Three 
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3  HMSC ISOLATION AND CELL GROWTH CHARACTERISATION 
3.1  Introduction and Aims 
As  described  in  Section  1.1.2.1  hMSC  are  anchorage  dependent,  requiring  a 
surface to adhere to for both survival and proliferation (Silva et al., 2003, Colter 
et al., 2000). They are also contact inhibited, meaning they only grow until a 
monolayer is formed and all cells are in contact with each other. At this point 
they will stop proliferating and apoptosis or senesce will be induced (Hayflick, 
1965;  DiGirolamo  et  al.,  1999;  Sekiya  et  al.,  2001).  From  a  biochemical 
engineering  perspective,  these  characteristics  make  the  cell  expansion  process 
more  challenging  than  for  suspension  cultures,  since  large  surface  areas  are 
needed to scale up the process (Barrilleaux et al., 2006). In vitro expansion of 
hMSC  allows  cell  proliferation  in  an  undifferentiated  state  while  exhibiting 
characteristics  typical  of  the  Hayflick  model  of  cellular  senescence,  having  a 
limited lifespan which depends on the source of the cells, and it does not go 
beyond 38 population doublings while maintaining multipotency (Bruder et al., 
1997).  
In addition, various parameters intrinsic to the source of the cells also affect the 
proliferation potential of hMSC, and the quality of the cells at the end of the 
expansion process. Due to the variability of cell growth kinetics according to age, 
sex, and health of the bone marrow donor (D'Ippolito et al., 1999; Phinney et al., 
1999), it is challenging to design a robust expansion protocol that would ensure 
provision  of  enough  cells  of  the  desired  quality  for  clinical  applications  and 
which is able to account for the inherent variability of the cell source.  
The aim of this chapter is to quantitatively study the characteristics of growth and 
differentiation of hMSC in relation to the isolation technique used to separate 
them  from  bone  marrow.  The  specific  objectives  will  be  to  characterise  the 
influence of the culture vessel employed for the cell expansion process, the nature 
of the surface employed for attachment, and the extent to which cells can be 
expanded while retaining crucial stem cell like properties. Cell growth kinetics 
will  also  be  modeled  in  order  to  enable  a  quantitative  comparison  of  culture 
conditions  and  to  provide  a  basis  for  a  more  detailed  model  of  a  multi-step,       Chapter Three 
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automated cell expansion process as described later in Chapter 5. These studies 
thus serve to characterise the baseline profiles of hMSC growth under standard 
culture conditions, from which it will be possible to assess the success or failure 
of future optimisation experiments. The specific objectives of the work are: 
  To examine different isolation techniques for the separation of hMSC from 
bone marrow and to assess the impact of such techniques in growth kinetics, 
as well as to evaluate the effect of cell banking on cell growth. 
  To examine different culture surfaces for the cell expansion of hMSC 
  To characterise growth kinetics over sequential passages with the objective of 
establishing  a  baseline  cell  expansion  process  for  future  optimisation  in 
subsequent Chapters. 
3.2  hMSC Isolation from Bone Marrow and Cell Banking 
The first step toward the selection and characterisation of hMSC was to isolate 
the cells from bone marrow samples, and to create a bank of cells from different 
donors for subsequent experiments. Frozen bone marrow samples, acquired as 
described in Section 2.1, were used for all isolations. They contained a mixture of 
bone marrow fluid, blood, adipose tissue, and small pieces of bone in some cases. 
Creating a cell bank from a given source at a specific passage allows not just for 
the  availability  of  cells  for  experimentation  at  a  later  time,  but  also  for 
consistency of results within a given source of cells from the same origin and at 
the same stage of growth by removing any intrinsic variability that is observed in 
cells obtained from different donors and cells at different population doublings 
(Section 3.2.2).  
A  relatively  limited  number  of  techniques  have  previously  been  used  for  the 
isolation of hMSC from bone marrow extracts, such as Ficoll density gradient 
centrifugation,  Direct  isolation,  fluorescence-activated  cell  sorting,  and 
Immunomagnetic selection as indicated in Section 1.2.1. The most commonly 
used technique is  Ficoll isolation, which uses a polysaccharide and sodium 
diatrizoate  solution  for  density  gradient  centrifugation  of  mononucleated  cells 
from bone marrow. This method is not highly selective, initially recovering all       Chapter Three 
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mononucleated  cells  from  bone  marrow.  However,  the  hMSC  isolation  is 
completed during the first passage on the basis that the hMSC are the only cells 
that attach to a surface-treated plastic culture vessel. Direct isolation, by seeding 
bone marrow alone or diluted with culture medium into a culture vessel, also 
achieves acceptable recovery levels of hMSC present in the original biopsy, while 
minimizing the stress exerted to cells during the sequential centrifugation steps 
required for a density gradient isolation. Selection of hMSC by Direct isolation is 
of special interest for this project since it allows potential implementation of the 
isolation  step  in  an  automated  platform.  From  each  of  these  two  methods, 
Ficoll and Direct isolation, it was  able to  recover hMSC and to create cell 
banks  for  subsequent  usage.  Both  methods  were  compared  to  establish 
differences in cell recovery and subsequent growth. 
The  effect  of  controlled  freeze/thaw  during  cell  banking  and  subsequent 
resuscitation of the cells was also assessed (Section 3.2.2). These are important 
control experiments that enable comparison of growth kinetics of hMSC that had 
been frozen with DMSO versus those that had not undergone such treatment. 
Such studies are also necessary with regard to the validation of this step in what 
is envisaged to be a cGMP compliant cell expansion process. 
3.2.1 Ficoll Isolation versus Direct Isolation 
Eighteen frozen bone marrow bags from different donors (stored as described in 
Section 2.1.) were used for these studies to compare isolation techniques and to 
recover hMSC for subsequent experimentation. The bags contained bone marrow 
samples in addition to heparin and DMSO to prevent clotting and cell membrane 
breakage when thawed as indicated in Section 2.1. They had been stored in liquid 
nitrogen for various length of time ranging from four to ten years. The volume of 
each bag varied between 120 and 74 ml. 
All  eighteen  bone  marrow  bags  were  subjected  to  Direct  isolation  as  per  the 
protocol indicated in Section 2.1.2, and of those, five were also processed by 
Ficoll density gradient isolation as per the protocol indicated in Section 2.1.1. 
Eight of the eighteen bags failed to undergo isolation after plated in T-flasks due       Chapter Three 
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to  gel  formation  within  thirty  minutes  to  three  hours  after  seeding  or  due  to 
contamination.  The  cause  of  a  gel  formation  was  not  further  investigated, 
although there is a possibility that either the amount of heparin added following 
the initial donor biopsy was not sufficient to prevent clotting in those samples, or 
that the samples had been stored in liquid nitrogen for too long. No association 
with a specific isolation technique was identified as the source of clotting. 
The initial number of viable cells present in the bone marrow bags tested, ranged 
from 7.5x10
6 to 2.9x10
6 cells/ml with an average of 4.9x10
6 cells/ml (n=4). These 
numbers  account  for  a  mixed  population  of  cells  prior  to  isolation.  The 
percentage of hMSC from this initial diverse cell population could vary and it 
was unknown for each specific sample, but it has been reported to be in the range 
around 1 in 1x10
7 to 10
8 cells (Reyes et al., 2001; Silva et al., 2003). The initial 
viable  cell  densities  were  therefore  not  indicative  of  the  possible  success  of 
hMSC isolation. This could only be assessed after a number of days in culture 
following the plating of the cells in T-flasks. 
The effect of isolation conditions on hMSC recovery and growth kinetics was 
studied  by  subjecting  cells  from  a  common  bone  marrow  sample  to  different 
isolation techniques. Ficoll isolations were performed as described in Section 
2.1.1, in which mononucleated cells are recovered from an interface formed after 
centrifugation of PBS and bone marrow over a layer of Ficoll. This technique 
exposes the cells to a minimum or two centrifugation steps prior to seeding into a 
tissue  flask.  Direct  isolations  were  performed  by  seeding  unprocessed  bone 
marrow with different ratios of bone marrow to culture media into T-150 culture 
vessels. The effect of centrifugation on cell recovery was studied by centrifuging 
an aliquot of bone marrow diluted with PBS (1:1 v/v), removing the supernatant, 
re-suspending the pellet into media and seeding into a culture vessel. 
For this comparison of isolation techniques four aliquots were prepared from the 
thawed content of a bone marrow bag. One aliquot was used to seed a T-150 flask 
with 10 ml of bone marrow and 20 ml of culture media (ratio of 1:3 v/v bone 
marrow to culture media). A second aliquot was used to seed 25 ml of bone 
marrow into a T-150 flask without any physical separation or media additions       Chapter Three 
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(1:0 v/v bone marrow to culture media). A third 10 ml aliquot was mixed with 10 
ml  of  PBS  and  centrifuged  at  650  g,  21˚C  for  15  minutes  to  mimic  the 
centrifugation conditions during the washing step of the mononucleated fraction 
of  cells  recovered  from  the  interface  of  a  Ficoll  separation.  The  remaining 
pellet of cells was re-suspended in 30 ml of media and seeded into a T-150 flask. 
The fourth 10 ml aliquot was subjected to a Ficoll separation and seeded with 
30 ml of culture media into a T-150 flask. The flasks were monitored by daily 
microscopic observations, and the media was  exchanged on day 1, and every 
three to four days from then on until harvest. 
Microscopic observations on day one revealed a more uniform cell population in 
the flask seeded with mononucleated cells recovered from Ficoll isolation, than 
for any of the other conditions. However, after the first two medium exchanges 
on days one through four, this method appeared to yield cells with a similar cell 
morphology and percentage cell surface coverage to those found with the direct 
seeding  with  unprocessed  bone  marrow  and  culture  media.  After  ten  days  in 
culture, Direct  isolation with  unprocessed bone marrow visually had a higher 
confluency of hMSC cells than any other condition. All flasks were harvested 
after 19 days in culture, at which point the cells isolated with Ficoll and Direct 
inoculation  of  unprocessed  bone  marrow  with  culture  media  had  reached 
confluency. At the time of harvest the other two conditions, straight inoculation 
of bone marrow without media addition and centrifuged sample with PBS, did 
not exhibit any cells with hMSC morphology. This result indicates that culture 
media  addition  after  thawing  is  essential  for  the  survival  of  hMSC  in  vitro 
cultures,  and  that  centrifugation  can  be  detrimental  to  hMSC  isolation  and 
growth. 
The  cells  from  the  two  T-150  flasks  containing  hMSC  were  harvested  after 
reaching confluency and seeded into T-150 flasks at an inoculation cell density of 
5x10
3 cell/cm
2 according to the cell expansion procedure indicated in Section 2.4. 
The  medium  was  exchanged  every  three  to  four  days,  and  the  cells  were 
recovered after seven days in culture. Cell density and viability were determined, 
indicating a 34% increase in hMSC growth and survival from the flask seeded 
with cells recovered by Direct isolation (1.53x10
4 viable cells/cm
2) than from the       Chapter Three 
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flask  seeded  with  cells  recovered  by  Ficoll  isolation  (1.00x10
4  viable 
cells/cm
2). This effect could be an indication of accumulated stress damage to the 
cells after undergoing density gradient centrifugation, resulting in a decrease in 
cell growth rates for the first passage after isolation. 
Variations of this experiment during the course of the project (data not shown) 
yielded the same trend as assessed by microscopic observation within four to 
seven days after initial seeding of cells recovered after isolation. Those cells that 
had  undergone  Ficoll  isolation  took  longer  to  reach  confluency  in  the  first 
passage than the ones seeded directly from bone marrow and supplemented with 
formulated  culture  media  in  ratios  of  1:3  or  1:4  v/v  bone  marrow  to  culture 
media. Any other dilution ratio of bone marrow to media tested proved to be 
unsuccessful for the isolation of hMSC. The overall number of cells recovered 
from each isolation procedure depended on the initial volume of the bone marrow 
sample,  the  initial  number  of  cells/ml  on  the  sample,  or  the  donor,  and 
consequently these values were not used to compare performance of the isolation 
for any cell source when coming from a different donor. 
3.2.2 Cell Banking and the Effect of Freeze/Thaw on Isolated hMSC 
Six cell banks were generated following the cell banking procedure indicated in 
Section 2.2. Each bank was generated from a different donor after a Ficoll or a 
Direct isolation, at passage numbers ranging from P0 (first recovered cells from 
initial seed into a culture vessel after Ficoll or Direct isolation) to P4 (cells 
expanded for four passages as per protocol in Section 2.4). Each bank generated 
provided  from  5  to  34  one-millilitre  vials  containing  1x10
6  cells/ml  for 
subsequent  experimentation.  The  number  of  vials  created  depended  on  the 
number of cells recovered from isolation as well as the volume of cell suspension 
removed at a given passage for subsequent experimentation, and therefore was 
not indicative of the yield of hMSC obtained from a specific donor. All banks 
created  successfully  provided  a  source  of  viable  hMSC  for  further 
experimentation.       Chapter Three 
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To understand if cell banking could cause any detrimental effect on cell growth 
kinetics  when  compared  to  cells  that  had  not  undergone  a  freeze/thaw  step, 
hMSC that had reached P4 from subsequent passages after Ficoll isolation were 
banked, and the rest were carried forward for one more passage. From P4, nine 
vials were prepared and frozen with DMSO as described in Section 2.2. The rest 
of the cell suspension was used for a subsequent cell expansion in six-well plates, 
inoculated  with  5x10
3  cells/cm
2.  The  cells  that  were  not  frozen  had  reached 
confluency after five days in culture, to a final cell density of 2.37x10
4 cells/cm
2. 
By comparison, one vial from this cell bank created from the same cell source 
was thawed, and the content of the vial was seeded in T-150 flasks with an equal 
initial cell density of 5x10
3 cells/cm
2. It took 13 days for this culture to reach 
confluency instead of the 5 days required for the same cells when they had not 
undergone a freeze/thaw treatment. Also, the final cell density reached was lower 
for the cells expanded from the cell bank, reaching 1.30x10
4 cells/cm
2 – a 50% 
reduction from the maximum cell density achieved with the cells obtained from 
cells  that  had  not  been  frozen.  The  cell  growth  rate  (calculated  according  to 
Equation 2.5) for this particular passage for cells that were not frozen was 0.31 
day
-1 in comparison to 0.07 day
-1 for those cells coming out of a frozen vial. This 
represents a significant reduction of growth kinetics and provides insight into the 
operation of a hospital-based autologous cell expansion process. Not enough data 
was collected as to address any differences in the duration of the lag phase for 
each of these two conditions, therefore the reduction in the growth rate observed 
for the cell population recovered after thaw could be in part attributed to a longer 
lag phase. The difference in the apparent growth rate calculated with the final cell 
density at harvest is large enough as to indicate that also the rate of growth could 
have been hindered by the thawing process, and that an adaptation to the culture 
environment during a first passage of growth can be one of the reasons for the 
lower growth rate for the cells that had undergone freezing conditions.  These 
results are summarised in Table 3.1.       Chapter Three 
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Table 3.1. Effect of cell banking on hMSC growth characteristics for cultures 
expanded  up  until  P4.  hMSC  isolated  as  described  in  Section  2.1.1  and  then 
expanded as described in Section 2.4. Cell Bank indicates cells thawed from a 
frozen vial prior to seeding at P4, and Cell Train indicates cells that have been 
sequentially  passaged  without  undergoing  a  freeze/thaw  procedure  prior  to 
seeding at P4. 
Cell Source at 
P4  
Time to Reach 
Confluency (days) 
Maximum Viable Cell 
Density (cell/cm
2) 
Growth Rate (day
-1) 
Cell Bank  13  1.30x10
4  0.07 
Cell Train  5  2.37x10
4  0.31 
 
Both  cultures  expanded  consisted  of  the  same  cell  source  at  the  same  cell 
passage, same inoculation cell density, and medium exchanges performed every 
three  to  four  days.  Any  effect  on  cell  growth  that  could  be  attributed  to  the 
different dimensions of the culture vessels (6 well-plates versus T-150 flasks) 
was addressed, showing no impact in cell growth as detailed later in Section 3.3. 
The only difference between both cell cultures was a cell freezing step, that was 
shown to have a detrimental effect on cell growth for the first passage directly 
following vial thawing. Both growth kinetics, as well as maximum viable cell 
density achieved after seeding pre-frozen hMSC showed lower values than in 
those cells that had not undergone such treatment. 
3.3  The Effect of Culture Surface Dimensions on hMSC growth 
Characterisation  of  the  cell  expansion  processes  of  hMSC  can  be  carried  out 
using different culture surfaces depending on the purpose of the experiment, the 
routine protocols of the laboratory, or the number of cells available at the time. 
As an example, to  generate cell growth curves,  it is  necessary to  collect  cell 
density values at different time points during a passage. In order to obtain these 
time point cell densities, cells must be removed from the surface of a sacrificial 
vessel every day or every other day to determine the kinetics of growth. This 
protocol involves an initially large number of culture vessels to be sacrificed over 
the course of the passage, and consequently a large number of hMSC. For this 
reason, cell growth kinetic studies are more conveniently executed in well plates       Chapter Three 
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than in T-flasks when cell numbers are a constraint, since the cell requirement to 
seed a smaller surface area on each well is minimum compared to the number of 
cells  it  would  take  to  seed  enough  T-flasks  to  get  the  required  data  points 
throughout the time of the passage. In other cases, when a large number of cells 
are needed to perform a series of assays at a specific time point, or when the only 
purpose of a particular passage is to expand the cells for subsequent passages or 
to  create  a  cell  bank,  T-flasks  that  provide  a  larger  culture  surface  are  more 
convenient. 
In either case, even if all surfaces used are from the same manufacturer with the 
same surface treatment, there may be differences in cell growth from T-flasks to 
wells due to the difference in geometries and dimensions (Lundholt et al., 2003). 
In wells, the percentage of working volume in contact with the wall of the vessel 
is larger. Next to the wall there is a gradient of gas transfer from the head space 
due to the boundary formed by the plastic wall, and microscopic observations 
reveal that the cells tend to proliferate away from this location towards the centre 
of the well. For the results obtained from different cell expansion protocols to be 
comparable, it is important to first of all verify that the patterns of growth of 
hMSC in all vessels used are not affected by the dimensions or the geometry of 
the culture flasks or well plates. 
To  study  cell  growth  kinetics  for  hMSC  expanded  in  well-plates  of  different 
dimensions, a pool of cells from the same donor at the same stage of growth was 
seeded into 6, 12, and 24 well plates from Corning. Growth curves for each well 
plate were determined by sacrificing one well from each plate at different time 
points throughout the passage as described in Section 2.6.4.  
The  hMSC  growth  curves  obtained  from  each  of  the  three  well  plates  tested 
(Figure  3.1),  showed  no  significant  difference  in  cell  growth  characteristics 
amongst any of the surface sizes. Similar growth rates ranging from 0.17 to 0.19 
days
-1 were observed for all conditions as indicated in the leyend in Figure 3.1. 
Growth  rates  were  calculated  as  per  equation  2.5  detailed  in  Section  2.6.4.1. 
These results prove that hMSC spread evenly over the surface of the well and 
grow  at  similar  rates,  regardless  of  the  surface  area  of  the  culture  vessel.       Chapter Three 
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Consequently, any of these three well plates will be acceptable to use as culture 
vessels  to  perform  characterisation  studies  for  the  engineering  parameters 
influencing hMSC cell expansion during an automated cell expansion process. 
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Figure 3.1 Comparison of hMSC growth kinetics in different well-plates over 
one passage. The effect of well size on hMSC cell growth kinetics in  6, 12, and 
24 well Corning plates cultured for 22 days under identical set of conditions is 
shown. Error bars represent one standard deviation about the mean (n=3). hMSC 
isolated as described in Section 2.1.2 and then expanded as described in Section 
2.4 from an initial cell density of 5x10
3 cells/cm
2. 
To study if there was any variation in cell growth characteristics when expanded 
in well-plates versus T-flasks, one pool of cells from the same donor immediately 
after isolation (P0) was seeded into T-flasks of different dimensions (T-25, T-75, 
and T-150) and 24 well plates all at an identical inoculation cell density of 5x10
3 
cell/cm
2. This cell train was expanded for five passages, during which cell growth 
curves were determined in either 24 well plates or T-flasks. Individual wells or T-
flasks were sacrificed at different time points during each passage for surface 
marker  analysis.  Larger  surface  T-flasks  of  150  cm
2  (T-150)  were  sacrificed 
during the first days of culture, smaller T-flasks of 75 cm
2 in surface (T-75) were 
used for time points during the mid-exponential phase of growth, and smaller T-
flasks of 25 cm
2 in surface (T-25) were sacrificed for later time points within a       Chapter Three 
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given passage. The medium was exchanged at the same time for all wells and T-
flasks,  and  they  were  all  cultured  under  the  same  conditions  in  a  humidified 
incubator at 37
oC, with 5% v/v CO2. 
Comparison  of  hMSC  growth  in  24  well-plates  and  T-flasks  of  different 
dimensions is shown in Figure 3.2. Since two to four T-flasks were sacrificed 
during each passage of growth along with individual wells from 24 well-plates, a 
compilation of all the time points recorded along the five passages have been 
plotted against each other for those time points when a well and a T-flask were 
sacrificed at the same time. The data shows that cell densities are very similar in 
both wells and in T-flasks at any given time point. The linear fit of all the data 
shows a value for r
2 or 0.89 which is a reasonable fit considering the data is taken 
from over 5 cell passages. For some points, cell densities in T-flasks are slightly 
different than for well-plates, especially for those measuring higher cell densities 
or those at later stages of growth within a given passage. These discrepancies in 
cell densities, may be due to the different culture conditions that the cells have 
been exposed to during the passage. Although well-plates and T-flasks were kept 
in  the  same  incubator  at  the  same  conditions,  and  medium  exchanges  were 
performed at the same time intervals, only the well-plates were exposed daily to 
environmental  conditions  for  periods  of  30  min  approximately.  This  daily 
environmental  exposure  due  to  the  harvest  of  individual  wells  from  a  plate, 
resulted in step changes in temperature from 37˚C to room temperature and gas 
compositions from 5% to 0.038% v/v CO2 when the well plates were placed in 
the biosafety cabinet for manual operations. These changes can have an impact 
on  cell  growth,  as  shown  later  in  Chapter  4.  In  contrast,  T-flasks  were  only 
removed from the incubator only during medium exchanges every three to four 
days,  up  to  the  point  of  harvest  providing  them  with  more  stable  culture 
conditions over the period of incubation.       Chapter Three 
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Figure  3.2 Comparison  of hMSC growth  in  24  well-plates and T-flasks. The 
effect of well size on hMSC cell growth on 24 Corning well plates and T-25, T-
75,  and  T-150  Corning  flasks  at  different  time  points  over  sequential  cell 
expansion for five passages. hMSC isolated as described in Section 2.1.2 and 
then expanded as described in Section 2.4 from an initial cell density of 5x10
3 
cells/cm
2. 
For all culture vessels tested, well-plates and T-flasks, hMSC essentially behaved 
in the same manner when exposed to the same environmental conditions during 
cell expansion. Consequently, all the results obtained for experiments performed 
on  either  T-flasks  or  well-plates  can  be  interpreted  without  taking  into 
consideration the culture vessel as a variable that could affect growth kinetics. 
3.4  Effect of Well Location On hMSC Growth 
Assuming  the  same  working  volume,  medium  formulation,  feeding  strategy, 
inoculation cell density and culture conditions, each well in a micro-well plate is 
considered  to  be  an  exact  replicate  of  all  the  others.  However,  from  an 
engineering  perspective,  there  may  be  some  significant  and  uncontrolled 
parameters  that  are  intrinsically  different  from  well  to  well  according  to  the 
location  of  the  well  in  the  plate.  Temperature  gradients,  and  gas  transfer  is 
slightly different in the wells located at the edge and corners of the plate than the       Chapter Three 
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ones at the centre due to the geometry of the plate (Burt et al.,1979; Oliver et al., 
1981). It was also of interest to understand the well to well variability due to 
manual pipetting of the inoculum or any other operator routines in order to assess 
potential benefits of subsequent process automation. 
It was therefore necessary to observe the differences if any, in growth kinetics of 
hMSC seeded in different well locations of the plate to understand if replicate 
wells used within one plate and would yield equivalent cell densities. Replicate 
wells  seeded in  different  well-plates  were also  compared in  order to  evaluate 
possible  operation  errors  due  to  sequential  seeding  from  a  common  cell 
suspension. 
To study the effect of well location and serial inoculation on replicate plates on 
hMSC growth, three 24 well-plates were seeded from a common pool of hMSC at 
P6. Eight wells were seeded on each plate with 5x10
3 cell/cm
2 and two different 
wells from each plate were harvested per time point to evaluate cell densities on 
each well. During the time course of 23 days, a cell growth curve was generated 
from each of the three well-plates, and the individual data points were compared 
to understand if well location or seeding errors caused any discrepancy on the 
overall curve. 
Figure 3.3 shows the growth curve generated from the three different well-plates. 
The individual data points originate from two wells at each time point. Wells 
harvested from each of the 24 well-plates are indicated in different colour and 
shape as indicated in the legend. For samples taken at a given time, two wells 
from the same plate were harvested, to compare the well to well variability. For 
each  time  point,  one  well  was  harvested  from  a  corner  or  edge  location  and 
another one from a centre location from the same plate. A different plate was 
sampled every day to observe plate to plate variability, which could be accounted 
for  by  the  lack  of  accuracy  during  serial  inoculation.  Even  though  the  cell 
suspension was mixed and considered homogeneous, it was of interest to observe 
if serial pipetting during inoculation of several plates was a cause of variability 
between wells.       Chapter Three 
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Figure 3.3 Well-to-well and plate-to-plate variability. Comparison of cell growth 
kinetics on different  wells  within plates  and in different  plates  from identical 
geometries. Error bars represent one standard deviation about the mean (n=3). 
hMSC isolated as described in Section 2.1.2 and then expanded as described in 
Section 2.4 from an initial cell density 5x10
3 cells/cm
2. 
The results show that all time points collected fell within the cell growth curve 
generated for this particular cell population, regardless of the plate or the well 
from which a time point was generated. The difference in cell density observed in 
some points harvested from two wells in the same plate at the same time is no 
larger than the standard deviation due to the intrinsic error in haemocytometer 
counting  technique  (Section  2.6.1).  The  shape  of  the  growth  curve  was  not 
affected  by  well-plate  variability  either,  and  therefore  no  difference  in  cell 
behaviour was encountered between cells growing in replicate plates. 
3.5  hMSC Growth Using Microcarriers 
Microcarrier  culture  systems  have  been  designed  to  increase  the  yield  of 
anchorage-dependent  cells,  as  they  increase  the  culture  surface  available  for 
growth while minimizing the volume of culture medium required per surface unit 
(Crespi et al., 1981; Pharmacia Fine Chemicals, 1979). The cells can then grow       Chapter Three 
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attached  to  the  surface  of  microcarries  while  these  are  placed  in  stirred-tank 
bioreactors  under  controlled  environmental  conditions.  Control  of  culture 
parameters such as pH, temperature, and gas tension is much easier to achieve in 
microcarrier cultures expanded in bioreactors versus static cultures (van Hemert 
et al., 1969). Another advantage of stirred tank cultures is temperature and media 
homogeneity throughout the vessel, eliminating diffusion limitations of nutrients 
and  gasses  to  the  cell  membrane.  When  it  comes  to  process  optimisation, 
different feeding strategies such as semi-batch or perfusion cultures, can be easily 
implemented in stirred tanks to improve growth kinetics. Such an approach would 
be very labour intensive and hard to execute in static cultures, unless aided with 
automated liquid handling systems. Bioreactor cultures are also attractive because 
of the reduction in the number of open manipulations which consequently lowers 
the risk of contaminations due to exposure to open systems during sequential 
passaging (Crespi et al., 1981). For all these reasons, hMSC ability to attach and 
grow  in  microcarriers  was  studied  as  a  viable  option  for  the  cell  expansion 
process. A wide range of commercially available microcarriers has already been 
used for the production of biological products using mammalian cells, but their 
use in tissue engineering has been explored to a limited extent. A small selection 
of commercially available microcarriers was chosen to explore their performance 
with hMSC cultures. 
Three different types of microcarriers were used to expand hMSC: 2D Microhex, 
Cytodex  1  and  Cytodex  3,  whose  characteristics  are  listed  in  Section  2.3.3. 
Cytodex microcarrier systems were selected for these studies for their reported 
ability to support growth in fibroblasts and/or mesenchymal stromal cells, and 2D 
Microhex for their surface material which is the same used to produce Nunc T-
flasks.  Different  parameters  were  studied  in  order  to  aid  cell  attachment  and 
expansion of hMSC on each type of microcarrier system, such as inoculation cell 
density, microcarrier density, working volume, stirring speed, and culture vessel 
geometry. 
The ability of hMSC to attach and proliferate in 2D Microhex were studied in 125 
ml shake flasks and 24 well ultra-low attachment plates. Microhex carriers are 
hexagonal polystyrene two-dimensional flakes of low density that can be kept in       Chapter Three 
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suspension. They have been proven to support attachment and proliferation of 
CHO-K1 and VERO cells (Kenda-Ropson et al., 2002; Lenglois et al., 2004). 
Following the manufacturer‟s directions, the gamma-irradiated Microhex flakes 
were  aseptically  seeded  into  24  well-plates  and  125  ml  shake  flasks  at  cell 
densities  of  5  and  10  cm
2/ml  taking  the  surface  density  provided  by  the 
microcarriers as 760 cm
2/g. Cell densities of 1x10
2 and 5x10
3 cells/cm
2 were 
tested  for  cultures  seeded  in  24  well-plates,  and  5x10
3  cells/cm
2  for  cultures 
seeded in shake flasks. The working volume for 125 shake flask was 20 ml/flask. 
For 24 well-plates initial working volumes of 1 ml and 0.5 ml per well were 
tested to aid initial attachment. The working volume was increased to 1.5 ml after 
microscopic observation confirmed cells were attached to the microcarrier surface 
within the first 8 hours. The cultures were placed in a shaker in a humidified 
incubator under static conditions for the first three hours, with periods of 5 min 
agitation every hour or two hours. After the first three to sixteen hours in culture 
the stirring speed was kept at 200 rpm for shake flasks and 240, 250, and 280 rpm 
for 24 well-plates.  
Samples  of  0.5  ml  each  were  removed  aseptically  and  placed  on  a  slide  for 
microscopic observation at different time points. This revealed that the lowest 
inoculation cell density of 1x10
2 cell/cm
2 failed to encourage cell attachment onto 
the microcarriers, and so consequently no further analysis was conducted. Higher 
cell  densities  of  5x10
3  cell/cm
2  did  show  some  visible  attachment  to 
microcarriers. The optimum attachment judged by the highest number of carriers 
with cells attached to them per sample was observed in 24 well-plate cultures 
when  the  initial  working  volume  was  minimised  to  0.5  ml,  the  cell  density 
adjusted to 5x10
3 cells/cm
2 with a surface to volume density of 5 cm
2/ml, and 2 
hr intervals of static conditions during the first 8 hr before incubating the plates at 
250  rpm  for  the  remaining  of  the  culture.  Although  a  higher  number  of 
microcarriers showed hMSC attached to them for this condition, the attachment 
primarily  occurred  on  the  edges  of  the  hexagonal  flakes  and  no  expansion 
towards the flat surface was observed. After the first four days in culture no cell 
proliferation was observed, and a half-volume medium exchange was performed 
to encourage cell growth. The cultures were terminated after five to ten days in 
culture, showing a reduction on the number of cells attached to microcarriers and       Chapter Three 
99 
no proliferation. The supernatant was centrifuged and analysed for viable cell 
density  but  the  number  of  cells  was  too  low  to  consider  statistically 
representative. Due to the low percentage of cells attached to microcarriers after 
cultivation,  no further quantification analysis could  be done to  determine cell 
densities.  Attachment  and  proliferation  of  cells  can  be  further  enhanced  with 
coatings such as collagen or fibronectin, and such an alternative could be pursued 
in the future. Other materials such as poly (lactic-co-glycolic acid) (PLGA), poly-
(L)-lactic acid (PLLA) and hydroxyapatite are also promising candidates for the 
production of microcarriers as reviewed by Malda et al., 2006 and could yield 
better results in the future. However, there are already commercially available 
microcarriers that have shown better results than 2D Microhex for cells of similar 
characteristics than hMSC such as porcine MSC or fibroblast. From these studies 
with  2D  Microhex,  no  hMSC  proliferation  was  observed  under  the  set  of 
conditions studied and consequently other microcarrier systems were tested. 
Cytodex 1 and Cytodex 3 microcarriers are transparent spherical beads composed 
of a dextran matrix and developed for high yield culture of anchorage-dependent 
cells (Pharmacia, 1989). Cell attachment and proliferation of porcine MSC has 
recently proven successful on Cytodex 1 over the course of 28 days (Frauenschuh 
et al., 2007), and so they are a viable and attractive alternative to static monolayer 
surfaces. 
Both Cytodex 1 and Cytodex 3 microcarriers were tested for the attachment and 
proliferation  of  hMSC.  The  physical  and  chemical  characteristics  of  these 
microcarriers as well as preparation and manipulation techniques are detailed in 
Section 2.3.3.1 and Section 2.3.3.2 respectively. These microcarrier experiments 
were  carried  out  in  24  well  ultra-low  attachment  plates,  seeded  at  5x10
3  and 
1x10
4  cells/cm
2  with  microcarrier  surface  density  of  10  cm
2/ml  in  working 
volumes ranging from 0.5 to 2 ml/well. The initial volume of media added per 
well was 0.5 ml with the purpose of increasing the probability of contact and 
attachment between cells and beads. The working volume was increased to 1 ml 
on day 1, 1.5 ml on day 2 and 2 ml on day 2. Plates were placed on a shaker in a 
humidified  incubator  at  37C  in  static  conditions  and  agitated  at  250  rpm  at 
inoculation, and every two hours post inoculation for a period of 5 minutes each       Chapter Three 
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during the first 3 to 16 hours in culture. Continuous shaking was resumed at 250 
rpm to avoid microcarrier aggregation due to cell attachment to more than one 
sphere. After 16 hours on an orbital shaker, static conditions were resummed, and 
intermittent 5 minute agitation of the cultures every two hours were carried out 
for a period of 8 hours afterwards to allow for further attachment of the cells. 
Daily microscopic observations monitored cell attachment and growth of hMSC 
on both types of microcarriers. On days 1, 6, 11, and 21, one well per condition 
was  sacrificed  and  stained  with  neutral  red  and  photographs  with  a  10X 
magnification were taken to monitor hMSC attachment onto the microcarriers.  
As shown in Figure 3.4 hMSC could attach to both types of microcarriers within 
one day in culture. All pictures shown correspond to Cytodex 1 and Cytodex 3 
seeded at 1x10
4 cells/cm
2, showing the most optimum condition tested for both 
types of microcarriers. Results show that a higher percentage of microcarriers 
with hMSC attached to them was observed with Cytodex 3 than with Cytodex 1 
on day 1. No further hMSC proliferation was observed after day 1 on Cytodex 1 
microcarriers, with few cells left on some beads by day 21. The morphology of 
the cells still attached at that time had changed as well from flattened to round 
shape. 
Cytodex 3 microcarries have thus been shown to encourage cell attachment of 
hMSC  on  day  1,  and  proliferation  was  observed  during  subsequent  days  in 
culture. Cell attachment was not uniformly distributed among carriers, exhibiting 
some beads with a high surface coverage and others with no cells attached to 
them. From those microcarriers with high hMSC coverage, most of them formed 
aggregates of three to seven beads interconnected by cells that add attached to 
two or more microcarriers. Still with a high availability of free culture surface 
provided by empty microcarriers, hMSC failed to attach and expand on those 
passed day 6. By day 21, hMSC had proliferated onto the culture surface of the 
ultra-low attachment well whilst empty microcarriers still remained in the culture 
medium.       Chapter Three 
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Figure 3.4.  hMSC seeded onto Cytodex 1 (A, B, C, D) and Cytodex 3 (E, F, G, 
H) on days 1 (A, E), 6 (B, F), 11 (C, G), and 21 (D, H). hMSC isolated as 
described in Section 2.1.2 and then expanded on microcarriers as described in 
Section 2.4 from an initial cell density of 1x10
4 cells/cm
2.  
A 
B 
C 
D 
G 
H 
E 
F       Chapter Three 
102 
After  a  series  of  optimisation  experiments  in  which  inoculation  cell  density, 
microcarrier density, working volume, and agitation scheme were investigated 
(data not shown), the culture of hMSC on Cytodex 1 and Cytodex 3 did not show 
improved results over static monolayer cultures. Cytodex 3 microcarriers seeded 
with 1x10
4 cells/cm
2 showed the best results in terms of initial cell attachment 
and  proliferation,  although  they  did  not  provide  a  uniform  culture  across  all 
microcarriers. These findings are consistent with results obtained by Frauenschuh 
et al (2007) by which they achieved acceptable adherence of porcine MSC on 
Cytodex carriers when seeded at 1x10
4 cells/cm
2 but low proliferation rates after 
28  days  in  culture.  So  far,  no  many  results  on  the  expansion  of  hMSC  on 
microcarriers have been published (Schop et al., 2008). The results presented in 
this  chapter  were  satisfactory  enough  to  believe  that  further  optimisation 
experiments could result in a more uniform culture with faster proliferation rates 
but this was beyond the scope of this thesis. 
3.6  Sequential Passaging of hMSC 
The growth kinetics of hMSC are intrinsic to the source of the cells, and the 
overall growth rate depends on the donor from which the cells have been isolated 
(D'Ippolito et al., 1999; Phinney et al., 1999). Also, the doubling time or growth 
rate of hMSC is not constant over the cell expansion process (Kang et al, 2004). 
Several parameters can be optimised to speed up the rate of growth of hMSC, 
however it has been proven that under a constant set of conditions, the rate of 
growth decreases with increasing passage number, or with increasing population 
doubling level (Bruder et at., 1997). This effect has been attributed in part to the 
shortening of the telomeres and the lack of telomerase activity in hMSC (Banfi et 
al, 2002). For this reason, hMSC can only be expanded in vitro up to a limited 
number of passages, after which they senesce. 
From  a  bioprocess  standpoint,  it  is  important  to  determine  the  proliferation 
potential  of  hMSC  at  every  stage  of  the  cell  expansion  process  in  order  to 
schedule  medium  exchanges  and  harvest  times,  as  well  as  to  determine  the 
quality  of  the  cells  harvested  from  every  passage.  To  study  the  effect  of 
sequential passages on cell growth and differentiation potential, two bags of bone       Chapter Three 
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marrow from different donors were thawed, hMSC were isolated from each one 
of  them  through  Direct  isolation  (Section  2.1.2)  ,  and  the  isolated  cells  were 
expanded through five passages, P0 right after isolation to P4. For each passage 
two to three 24 well plates were seeded in conjunction with one T-150 flask. The 
well plates were used to generate cell growth curves by sacrificing one well per 
time  point,  and  the  T-150  flask  was  used  to  inoculate  the  next  passage.  All 
passages were inoculated with cells recovered from mid-exponential phase, since 
inoculation from cells recovered from stationary exhibit lower growth rates than 
those  inoculated  from  cells  collected  during  the  mid-exponential  phase. 
(Appendix III). 
For each donor the data was plotted and fitted to a Gompertz four-parameter 
sigmoidal  curve  as  shown  in  Equation  3.1  (Melero-Martin,  2004).  From  the 
parameters obtained by the modified Gompertz model derived as per Section 5.3, 
maximum cell densities and growth rates were calculated according to Equations 
3.2 and 3.3. Growth rate calculations based only on empirical data require two 
time points to be chosen as initial and final cell densities that will coincide with 
the start and end of the exponential growth phase. The selection of these two 
points is difficult depending on the time intervals of the data recorded and on the 
shape of the curve, and it may result in less than accurate results as shown in 
Section 5.2. The mathematical method used, based on the accurate representation 
of the growth curve by a sigmoidal equation, was chosen to calculate growth rates 
in a more objective manner. As explained in detail in Section 5.3 this modified 
Gompertz model closely represent growth kinetics for sequential passages when 
enough  data  from  an  initial  passage  is  collected,  and  it  is  useful  to  describe 
growth kinetics for later passages specially in cases when not many data points 
are available to fully characterise growth. Details about each parameter in the 
model are discussed further in Chapter 5. 
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 
b e
X X


0 max / ln
   (3.3) 
Where X is cell density, X0 is inoculation cell density, a is the increase in cell 
density all in cells/cm
2, t is time, t0 is related to the duration of the lag phase, b is 
related to duration of the exponential phase (as indicated in Section 5.2), Xmax is 
maximum cell density at stationary phase,  is the growth rate and e is constant 
2.71828. 
Growth curves obtained for the hMSC from donor A are shown in Figures 3.5 to 
3.10 (and also shown in Figure 5.15 and 5.16) and the ones obtained from donor 
B  are  shown  in  Figures  3.11  to  3.16.  Figures  3.5  and  3.11  compare  the  raw 
growth kinetic data from passages P0 to P4 for donor A and donor B respectively. 
From these two graphs the decrease in growth rates and maximum cell density 
achieved with increasing passage number is clear.  
Quantitative  values  of  the  kinetic  parameters  obtained  from  the  modified 
Gompertz model developed in Section 5.3 for each donor and each passage are 
shown in Table 3.2. Figures 3.6 to 3.10 (donor A) and 3.12 to 3.16 (Donor B) 
show there is a good fit of the model with the raw cell viability data for each 
passage with r
2 values ranging from 0.92 to 0.99.       Chapter Three 
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Figure 3.5 hMSC growth curves from donor A for passages P0 (solid circles), P1 
(open circles), P2 (inverted solid triangles), P3 (empty triangles), and P4 (solid 
square).  hMSC  isolated  as  described  in  Section  2.1.2  and  then  expanded  as 
described in Section 2.4 from an initial cell density of 5x10
3 cells/cm
2. 
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Figure  3.6  hMSC  growth  curve  from  donor  A  for  passage  P0.  Experimental 
conditions as described in Figure 3.5. Solid line fitted according to Equation 3.1. 
(R
2 = 0.99).       Chapter Three 
106 
P1
Time (hours)
0 100 200 300 400 500
Xv
 (cell/c
m
2
)
0
10000
20000
30000
40000
50000
60000
 
Figure  3.7  hMSC  growth  curve  from  donor  A  for  passage  P1.  Experimental 
conditions as described in Figure 3.5. Solid line fitted according to Equation 3.1. 
(R
2 = 0.99). 
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Figure  3.8  hMSC  growth  curve  from  donor  A  for  passage  P2.  Experimental 
conditions as described in Figure 3.5. Solid line fitted according to Equation 3.1. 
(R
2 = 0.99).       Chapter Three 
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Figure  3.9  hMSC  growth  curve  from  donor  A  for  passage  P3.  Experimental 
conditions as described in Figure 3.5. Solid line fitted according to Equation 3.1. 
(R
2 = 0.99). 
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Figure 3.10 hMSC growth curve from donor A for passage P4. Experimental 
conditions as described in Figure 3.5. Solid line fitted according to Equation 3.1.       Chapter Three 
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Figure 3.11 hMSC growth curves from donor B for passages P0 (solid circles), 
P1 (open circles), P2 (inverted solid triangles), P3 (open triangles), and P4 (filled 
square).  hMSC  isolated  as  described  in  Section  2.1.2  and  then  expanded  as 
described in Section 2.4 from an initial cell density of 5x10
3 cells/cm
2. 
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Figure 3.12. hMSC growth curve from donor B for passage P0. Experimental 
conditions as described in Figure 3.11. Solid line fitted according to Equation 3.1. 
(R
2 = 0.98).       Chapter Three 
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Figure 3.13. hMSC growth curve from donor B for passage P1. Experimental 
conditions as described in Figure 3.5. Solid line fitted according to Equation 3.1. 
(R
2 = 0.92). 
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Figure 3.14. hMSC growth curve from donor B for passage P2. Experimental 
conditions as described in Figure 3.5. Solid line fitted according to Equation 3.1. 
(R
2 = 0.99).       Chapter Three 
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Figure 3.15. hMSC growth curve from donor B for passage P3. Experimental 
conditions as described in Figure 3.5. Solid line fitted according to Equation 3.1. 
(R
2 = 0.99). 
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Figure 3.16. hMSC growth curve from donor B for passage P4. Experimental 
conditions as described in Figure 3.5. Solid line fitted according to Equation 3.1.       Chapter Three 
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Table  3.2  Growth  parameters  and  maximum  cell  densities  for  consecutive 
passages from P0 to P4 for hMSC isolated from two different donors, labelled as 
donor  A  and  donor  B.  Kinetic  parameter  values  obtained  from  fitting  the 
modified four-parameter Gompertz model (Equations 3.1, and 5.5 to 5.8) to each 
set of data as illustrated in Figures 3.6 to 3.10 and 3.11 to 3.16. Growth rates () 
calculated  from  Gompertz  parameters  and  apparent  growth  rates  (app)  were 
calculated from empirical data for comparison purposes. 
Donor  
A  X0  Xmax  a  t0  b  μ (hr
-1)  μapp (hr
-1) 
P0  4.25x10
3  4.69x10
4  4.27 x10
4  102  59  1.50x10
-2  1.29 x10
-2 
P1  4.25x10
3  4.22 x10
4  3.80 x10
4  112  59  1.43 x10
-2  1.23 x10
-2 
P2  4.25x10
3  3.75 x10
4  3.33 x10
4  122  59  1.36 x10
-2  1.04 x10
-2 
P3  4.25x10
3  3.28 x10
4  2.86 x10
4  132  59  1.27 x10
-2  1.05 x10
-2 
P4  4.25x10
3  2.81 x10
4  2.39 x10
4  142  59  1.18 x10
-2  0.66x10
-2 
Donor  
B  X0  Xmax  a  t0  b  μ (hr
-1)  μapp (hr
-1) 
P0  4.25x10
3  4.13 x10
4  3.71 x10
4  88  50  1.66 x10
-2  1.34 x10
-2 
P1  4.25x10
3  3.72 x10
4  3.29 x10
4  98  50  1.58 x10
-2  1.28 x10
-2 
P2  4.25x10
3  3.30 x10
4  2.88 x10
4  108  50  1.49 x10
-2  9.00x10
-3 
P3  4.25x10
3  2.89 x10
4  2.47 x10
4  118  50  1.40 x10
-2  1.15 x10
-2 
P4  4.25x10
3  2.48 x10
4  2.05 x10
4  128  50  1.28 x10
-2  0.67x10
-2 
 
 
For both  donors  two major trends  were observed over sequential  passages  of 
hMSC after isolation. The growth rate and the number of cells obtained at the end 
of  each  passage  decrease  with  increasing  passage  number.  Growth  rates  and 
maximum  cell  densities  were  also  different  from  each  donor  studied.  These 
differences are likely to be very important when determining the overall time 
required for a complete cell expansion process from isolation to delivery of cells 
to the clinic for patient therapy. The same trend was observed by Bruder et al. 
1997,  for  twice  weekly  fed  hMSC  yielding  a  viable  cell  density  of  3.12x10
4 
cells/cm
2  at  P1  and  only  1.35x10
4  cells/cm
2  at  P4.  Both  quantities  compared 
closely  to  the  values  obtained  and  shown  in  Table  3.2.  for  hMSC.  Apparent 
growth  rates  (app)  correlate  closely  with  the  values  for  growth  rates  () 
calculated  from  the  coefficients  obtained  from  the  modified  Gompertz  model 
developed in Chapter 5, section 5.3. The model uses the parameters obtained 
from the initial passage (P0) for which numerous data points are collected, to 
generate the parameters to be used for subsequent passages.       Chapter Three 
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The data and results obtained show that such modifications to the model result in 
comparable results to the empirical data collected for all four passages. Also, 
some indication of the duration of the lag phase and the maximum cell density 
obtained at the stationary phase can be assessed with this model when not many 
time points  are available for  analysis. From the two donors  studied, both  the 
empirical data as well as the mathematical model agree with the trend indicating 
a decrease in  maximum cell density with  increasing passage number.  Also,  a 
trend indicating a decrease in growth rates as the passage number increases is 
confirmed. The degree up to which an increase in lag phase is contributing to this 
decrease in growth rates cannot be fully assessed for each passage, especially for 
later passages where not many points are present in the growth curves. Given the 
selection of parameters for the model, for which the parameter b and X0 are fixed 
throughout the course of the cell expansion process for a given patient (Equations 
5.7 and 5.8), the calculation of the duration of the lag phase could not be as 
accurate as the one calculated from empirical data if such data was available for 
all consecutive passages. For the later passages from donors A and B not enough 
data was available as to determine the duration of the lag phase. Future studies 
characterising this possible trend should be addressed. Shortening the sampling 
time  intervals  during  sequential  passages,  as  well  as  performing  cell  cycle 
analysis  to  determine  the  percentage  of  the  population  at  different  stages  of 
division (G0, G1, S, or G2) will further enhance the understanding of hMSC 
expansion process as well as the possible extended capabilities of the modified 
Gompertz model developed in this thesis. 
Other contributing factors to the difference in growth kinetics over time could be 
attributed to  the possibility of a heterogeneous  population  isolated from  bone 
marrow  as  discussed  in  Section  1.1.5.  In  the  case  of  the  existence  of  other 
population of cells other than hMSC with lower survival ability in culture, the 
decrease  in  growth  rates  and  in  maximum  cell  densities  could  be  due  to  the 
disappearance  of  other  populations  from  the  culture  over  the  cell  expansion 
process. However, given the high viability of all samples tested, this explanation 
would not be able to account for the large decrease in cell recovery for later 
passages.       Chapter Three 
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The implications of these growth rate variations over sequential passages, as well 
as the variability of growth characteristics from different donors are reflected in 
Table 3.3. The total cells recovered from each passage as well as the time that it 
takes for the cells to reach stationary phase was calculated assuming: (i) an initial 
number of cells of 7.5x10
5 cells was available to inoculate one T-150 flask at P0 
(ii) subsequent passages were performed with a split ratio of 1:2. Because cells 
are  harvested  and  passaged  during  the  mid-exponential  phase  of  growth,  the 
lower split ratio accounts for the lower cell density obtained when passaging the 
cultures before they reach stationary phase. The time employed by each passage 
was calculated from Equation 3.4, using the growth rates shown on Table 3.2. 
Table 3.3 Total number of cells recovered from hMSC cell expansion process 
from two different donors between passage P0 to P4, and the time taken for each 
passage to reach stationary phase. Cumulative numbers in bold, indicate the final 
overall process time and the total amount of cells recovered from the process. 
  Donor A  Donor B 
  Time (hr)  Xtot (cells)  Time (hr)  Xtot (cells) 
P0  150  7.04x10
6  127  6.20 x10
6 
P1  149  1.27x10
7  127  1.12 x10
7 
P2  148  2.25 x10
7  126  1.98 x10
7 
P3  148  3.94 x10
7  126  3.47 x10
7 
P4  147  6.75 x10
7  125  5.95 x10
7 
Total  31 days  6.75 x10
7  26 days  5.95 x10
7 
 
The time required for the cells to reach final viable cell density for each passage 
was calculated by: 
 

0 max ln X X
t

    (3.4) 
Where, Xmax is the number of viable cells reaching stationary phase, X0 is the 
number of viable cells inoculated in the flask and  is the growth rate (h
-1). 
For  patient  specific  regenerative  medicine  applications  where  the  timing  and 
number  of  cells  are  critical  for  the  success  of  the  therapy,  differences  in 
processing time must be taken into consideration. The cell expansion process       Chapter Three 
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would take 31 days for donor A and 26 days for donor B, which involves five 
more days of scheduled operations and a higher cost for the process.  
3.7  Summary 
Characterisation of the growth kinetics for hMSC has been performed for the 
standard  culture  conditions  in  T-flasks  and  also  for  well-plates  and  on 
microcarriers.  Under  constant  operating  parameters  of  temperature,  aeration, 
humidity,  culture  medium,  and  incubation  time,  growth  characteristics  were 
shown to be similar for static cultures regardless of the geometry of the culture 
vessel  (Figures  3.1  and  3.2).  Microcarrier  cultures  were  also  tested  as  an 
attractive  alternative  to  increase  the  yield  of  growth  with  reduced  medium 
requirements and aseptic manipulations. From the three types of microcarriers 
tested,  MicroHex,  Cytodex  1,  and  Cytodex  3,  only  one  of  them,  Cytodex  3 
supported cell attachment and proliferation (Section 3.5). However, results for the 
conditions tested did not show any improvement of hMSC growth over static 
cultures and so microcarrier cultures were not investigated further. 
Two  different  isolation  techniques,  density  gradient  centrifugation  and  Direct 
isolation, were implemented and compared (Section 3.2.1). Both techniques were 
successful  for  hMSC  recovery,  and  cell  banks  were  created  from  the  cells 
obtained  from  each  one  of  these  isolation  techniques.  A  comparison  of  the 
performance of the cells recovered from each different method concluded that 
Direct  isolation  exhibited  higher  recovery  yields  than  density  gradient 
centrifugations, with a 34% increase in cell recovery. Direct isolation is also a 
faster method with less centrifugation steps involved, which present itself as an 
advantage from an operations and automation point of view. 
The effect of freeze/thaw was studied on cells that had undergone preparation 
steps to create a cell bank versus cells that were sequentially passaged without a 
freezing step. Cell banking is an important process that allows storage of a cell 
source for subsequent experimentation or future usage such as transport of cells 
to cGMP manufacturing facility, or to retain the cells during a halt in the cell 
expansion  process.  The  effect  of  such  procedure  on  cell  growth  were 
demonstrated  to  exhibit  some  detrimental  effect  on  cell  growth  rate  and       Chapter Three 
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maximum cell density reached at the end of the first passage (Section 3.2.2). This 
effect may not be cumulative, however it has a negative impact on cells seeded 
right after thaw. 
Finally,  a  study  on  the  characterisation  of  hMSC  over  sequential  passages 
confirmed a decrease in growth rates and maximum viable cell densities obtained 
as the passage number increases (Table 3.2). Quantitative analysis of the cell 
expansion process was aided by using a mathematical Gompertz model (Section 
3.6) that accurately represents the growth kinetics of hMSC as further examined 
in  Chapter  5.  Results  were  confirmed  by  experimenting  with  two  different 
sources of cells from two donors. The implications of the decrease in growth rate 
and cell recovery as the cell expansion progresses were assessed for the overall 
completion of the process (Table 3.3). 
Having  established  hMSC  culture  conditions  and  a  method  to  quantify  cell 
growth  kinetics,  optimal  culture  conditions  for  the  effective  clinical  scale 
production in an automated platform of vast numbers of hMSC will be evaluated 
in Chapter 4.        Chapter Four 
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4  OPTIMISATION OF CONTROLLED PARAMETERS FOR AN 
AUTOMATED HMSC EXPANSION PROCESS 
4.1  Introduction and Aims 
Previous research in the field of adult stem cells has tended to concentrate on 
understanding  and  controlling  the  differentiation  potential  of  hMSC  aided  by 
chemical additives in the culture media. The main focus of recent studies have 
been that of finding therapeutic applications for these cells and their potential in 
tissue engineering applications. Much of this work was described in Section 1.1. 
To date, however, comparably little effort has been directed toward controlling 
physical  parameters  during  the  cell  expansion  process  for  hMSC  and 
understanding  the  effect  of  these  environmental  factors  on  cell  growth  in  an 
undifferentiated  state.  Recently,  a  number  of  groups  have  discovered  the 
sensitivity of hMSC to some of the engineering parameters to which they are 
exposed  in  culture,  such  as  oxygen  (Moussavi-Harami,  2004),  medium 
composition (Sotiropoulou, 2005), and inoculation cell density (Sekiya, 2002). 
This  has  directed  attention  to  the  importance  of  controlled  environmental 
conditions during proliferation and differentiation of hMSC. 
To  ensure  production  of  sufficient  cells  to  satisfy  market  needs,  bioprocess 
conditions and equipment for the expansion of hMSC need to be investigated and 
adopted, ensuring optimum growth in an undifferentiated state. The use of an 
automated platform will potentially  facilitate higher output capabilities, whilst 
reducing  variability  due  to  operator  manipulations  (Terstegge  et  al.,  2005, 
Joannides  et  al.,  2006,  Bernard  et  al.,  2004).    In  addition,  rigid  control  of 
determining parameters for growth will result in a robust cell expansion process 
for industrial applications in the emerging regenerative medicine sector. Study of 
the effect of physical conditions experienced by the cultures during automated 
manipulations  will  generate  a  set  of  Standard  Operating  Procedures  for  an 
appropriate range of conditions,  aimed at  ensuring  cells  are maintained in  an 
undifferentiated and still multipotent state. 
Despite recent efforts devoted to better understanding of the effect of different 
parameters  on  cell  growth  and  differentiation  of  hMSC,  there  are  some       Chapter Four 
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differences  amongst  laboratories  concerning  process  steps  during  the  cell 
expansion process which may have an added effect on the results reported in 
literature in relation to cell growth kinetics and yields. Friendesntein et al., (1976) 
initially isolated and propagated hMSC, and essentially the same laboratory scale 
protocol  has  been  used  by  all  subsequent  investigators  (Colter  et  al.,  2000; 
Pittenger  et  al,  1999).  However,  some  parameters  controlled  during  the  cell 
expansion  process  vary  from  laboratory  to  laboratory  and  from  operator  to 
operator. These include inoculation cell density, when passages are executed as a 
split  ratio  of  the  harvested  cultures  (1:3  or  1:4),  the  frequency  of  medium 
exchanges (3 to 4 days), time of exposure to environmental conditions of the 
cultures  while  microscopic  observations  are  taking  place,  etc.  All  these 
parameters are expected to have an impact on cell growth kinetics and therefore 
they must be controlled and understood in order to obtain reproducible results and 
to decouple the effect of process variations from any other parameter under study. 
It is therefore the aim of this Chapter to define the optimal culture conditions for 
the effective clinical scale production in an automated platform of large numbers 
of hMSC, to serve for cellular therapy in transplantation, immunotherapy and 
regenerative medicine. The specific objectives of the work are: 
  To assess the impact of inoculation seeding densities on doubling time for 
hMSC over sequential passages. 
  To  examine  the  effect  of  different  media  addition  rates  on  hMSC  growth 
kinetics, and to determine optimum values for such rates. 
  To evaluate the effect of environmental excursions that the cells are exposed 
to during the expansion process on growth kinetics. 
4.2  The effect of Inoculation Cell Density and Population Doubling on 
hMSC growth rates and yields 
The most common protocol for expansion of hMSC states the use of inoculation 
cell densities of 5x10
3 cells/cm
2 in T-flasks with medium exchanges every three 
to four days (Friendstein et al., 1976). This practice has been shown to result in 
variable doubling times depending on the cell source and the laboratory in which 
the work was performed (Castro-Malaspina et al., 1980; Phinney et  al., 1999;       Chapter Four 
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Lazarus  et  al.,  1995).  The  wide  variation  between  measured  doubling  times 
thought  to  be  due  to  the  donor  age  and  health  at  the  time  of  bone  marrow 
extraction,  culture  media,  and  the  number  of  doublings  that  the  cells  have 
undergone at the time of the study. These doubling times can be slower than most 
of the doubling times characteristic of  immortalised mammalian cell lines for 
which the doubling times remain constant over passages (Westermark, 1974). As 
a result, the culture of hMSC requires longer times to complete a cell expansion 
process and an increase in the amount of resources needed such as culture media 
and plastic ware. A reduction in the doubling time for hMSC while maintaining 
them  in  an  undifferentiated  state  could  therefore  have  a  significant  process 
benefit. The number of cells per unit surface area at inoculation has also been 
proven to have an impact on the growth rates of hMSC. It has been reported that 
ICDs lower than 5x10
3 cells/cm
2 result in an increase in doubling times (Sekiya, 
2002). 
To  further  investigate  these  phenomena,  doubling  times  were  determined  for 
hMSC  cultured  in  T-25  flasks  as  per  the  protocol  indicated  in  Section  2.4. 
Calculations  based  on  initial  and  final  cell  densities  are  indicated  in  Section 
2.6.4.1. hMSC isolated from two different donors (labelled donor X and donor Y 
to  protect  the  identity  of  each  patient)  and  expanded  up  to  different  passage 
numbers were inoculated at cell densities ranging from 5x10
1 to 1x10
4 cells/cm
2. 
In addition, growth curves were obtained from a common pool of hMSC when 
seeded in 12 well plates at cell densities of 5x10
1, 1x10
2, 1x10
3, 5x10
3, and 1x10
4 
cells/cm
2 as per the protocol indicated in Section 2.4. 
The results obtained indicate that not only do hMSC doubling times increase with 
increasing  cell  density,  but  that  this  behaviour  is  characterised  by  a  linear 
relationship  between  inoculation  cell  density  and  doubling  time  as  shown  in 
Figure 4.1 (Data provided in Appendix I). The coefficients of the linear equation 
that characterises this trend are dependent on the source (Donor) of the cells and 
on the passage number for the same cell source. There is a considerable variation 
in the slope of the linear correlation from different donors for cells at the same 
passage with values of 0.81x10
-2 and 2.69x10
-2 for Donor X and Y respectively at 
Passage 2.  There is, however, a larger difference in the slope between cells from       Chapter Four 
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the  same  donor  when  seeded  at  different  passage  numbers,  with  a  value  of 
7.61x10
-2 at passage 9 versus 0.81x10
-2 at passage 2 for donor X. Clearly the 
results show that hMSC growth rates are slower when seeded at a later passage 
for  all  inoculation  cell  densities,  and  that  the  linear  correlation  between 
inoculation cell density and doubling time still applies regardless of the age of the 
culture. Still remains to be determined if the decrease in proliferative potential of 
these cells over time is a result of the adaptation to environmental conditions in 
culture by which the cells remain at a G0 or quiescent stage for a longer period of 
time just as they would do in vivo, or if the duration of the cell division cycle 
becomes slower over passages. Self-selection of a population over time would be 
less likely to occur, since the result of such phenomenon would be an increase in 
growth rate by the faster growing cell population. All cultures retained hMSC 
morphology at the time of harvest, and results for the surface marker expression 
over  the  different  passages  to  characterise  identity  of  the  cultures,  will  be 
described later in Chapter 5. 
y = 0.0081x + 35.246
R
2 = 0.8957
y = 0.0269x + 35.775
R
2 = 0.9796
y = 0.0761x + 60.865
R
2 = 0.9871
0
50
100
150
200
250
300
350
400
450
500
0 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 10,000
ICD (cells/cm
2)
D
o
u
b
l
i
n
g
 
T
i
m
e
 
 
(
h
r
)
P2 - Donor X
P2 - Donor Y
P9 - Donor X
 
Figure 4.1 Effect of inoculation cell density (ICD), passage number, and donor 
on doubling time for the cell expansion process of hMSC seeded on T-25 flasks. 
Cells  obtained  from  Donor  X  and  Donor  Y  were  expanded  up  to  passage  9 
following the protocol indicated in Section 2.4. At passage 2 for donor X, and 2 
and 9 for donor Y, T-25 were seeded at ICD 5x10
1, 1x10
2, 1x10
3, 5x10
3, and 
1x10
4 cell/cm
2 and doubling times were calculated for each culture as described 
in Section 2.6.4.1. Solid lines fitted by linear regression.       Chapter Four 
121 
The implications of this finding are that faster doubling times achieved at lower 
inoculation cell densities and lower passage numbers could reduce the total cell 
expansion  process  time  considerably.  This  process  optimisation  would  bring 
autologous stem cell therapy closer to the clinic as a cost effective treatment, 
whilst  reducing  the  waiting  time  for  patients  that  are  in  need  of  autologous 
regenerative medicine treatment. Calculations based on the time required to reach 
a final cell number of 1x10
8 depending on the doubling time of the culture and 
assuming constant growth rates for the overall cell expansion process are shown 
on Table 4.1. The final cell number is based on a previously published case study 
for the number of cells required in an undifferentiated state to seed a tubular 
reactor for the construction of an artificial artery (Mason et al., 2006). 
For the slowest growing culture observed for Donor Y when cells were seeded at 
5x10
3  cell/cm
2  at  Passage  9,  it  would  take  29  weeks  to  collect  the  required 
number of hMSC for therapy. As the doubling time decreases for cultures seeded 
at lower ICD and lower passage number, the overall cell expansion time shortens. 
The fastest doubling time obtained from Donor X when Passage 2 cells were 
seeded at low ICD of 5x10
1 cell/cm
2, resulted in a decrease of the overall cell 
expansion time to just 4 weeks. These results show a reduction of 5 months in the 
overall delivery time of stem cell therapy to the clinic due to process optimisation 
as a result of a reduction in inoculation cell density and age of the cell source.  
Table 4.1 Overall hMSC expansion process time required to achieve 1x10
8 cells 
from a starting sample containing 1x10
5 cells. Process times calculated based on 
the  results  obtained  from  two  donors  at  different  passages  with  and  without 
optimised operating conditions based on modifications of inoculation cell density 
as shown in Figure 4.1.  
hMSC Doubling Time 
(hr) 
Cell Expansion Process 
Time (hr) 
Cell Expansion Process Time 
(weeks) 
445  202  29 
100  59  8 
75  48  7 
50  38  5 
30  29  4 
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The increase in doubling time as the age of the culture or passage time increases 
had  been  demonstrated  in  Section  3.6  and  it  has  also  been  reported  in  the 
literature (Kang et al., 2004; Bruder et al, 1997). A decrease in doubling time 
with  decreasing  inoculation  cell  density  had  also  been  observed  in  hMSC  by 
Melero-Martin et al. (2005) with chondroprogenitor cells, and Sekiya et al. with 
hMSC (2002). However, the linear relationship between these two parameters has 
not been previously demonstrated. Understanding that such a relationship exists, 
enables process modifications that can be made forward predicting the decrease 
in doubling times when inoculation cell densities are varied for a given culture of 
known characteristics. 
This correlation suggests that hMSC growth rates at a specific passage may be 
sensitive  to  the  physical  distance  between  cells  when  all  other  cell  culture 
parameters  remain  constant,  such  as  frequency  of  medium  exchange  and 
incubation time and temperature. The study that corroborated this hypothesis was 
conducted in T-25 flasks with cell density measurements taken at inoculation and 
at harvest once the cells had reached 90% coverage of the culture surface. Cell 
growth characteristic such as lag phase or time period of the exponential growth 
phase  could  not  be  studied  in  T-25  flasks,  and  these  parameters  will  aid  the 
understanding on how inoculation cell density impacts cell behaviour in hMSC 
cultures in vitro. To further investigate this phenomenon, follow up experiments 
were conducted to understand cell growth behaviour on a daily basis in relation to 
the surface coverage at a given time in culture. 
The growth curves from a common pool of hMSC, seeded at inoculation cell 
densities of 5x10
1, 1x10
3, and 5x10
3 cells/cm
2 are shown on Figure 4.2. When 
investigating  the  effect  of  ICD  on  cell  growth  whilst  observing  growth 
characteristics of the culture at time intervals of two to three days over the course 
of the passage, it is clear that the growth rate changes over time. The trend shown 
in  Figure  4.1  still  applies,  showing  faster  growth  rates  when  fewer  cells  are 
covering the surface. However, growth rates are not constant over the period of 
the culture, slowing down as the cell density increases. This indicates that cell 
growth rates are dependent on the cell surface coverage at a given time, and that 
these  growth  rates  decrease  as  the  number  of  cells  per  cm
2  increases.  This       Chapter Four 
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modification in cell growth rates according to culture surface coverage did not 
seem  to  affect  hMSC  morphology.  All  cultures  exhibited  the  characteristic 
spindle-shaped morphology at all stages of culture regardless of the number of 
doublings they had undergone by the end of the passage. 
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Figure 4.2 Effect of inoculation cell density (ICD) on hMSC growth kinetics. 
Passage 6 of hMSC was seeded at 5x10
1, 1x10
3, and 5x10
3 cell/cm
2 in 24 well-
plates  as  described  in  Section  2.4.  Three  wells  from  each  condition  were 
harvested and counted at 2 to 22 days. Doubling times calculated as indicated 
later in Section 5.2. Error bars represent one standard deviation about the mean 
(n=3).  Maximum  cell  densities  from  empirical  data  reached  were  3.53x10
4, 
1.75x10
4,  and  0.96x10
4  cell/cm
2  for  ICDs  5x10
3  ,  1x10
3,  and  5x10
1  cell/cm
2 
respectively. 
By looking at the shape of the curves in Figure 4.2 it is apparent that the culture 
seeded at the lowest ICD experiences an initial phase of rapid growth, but as time 
progresses the growth rate decreases before reaching stationary phase. Because of 
the difficulty in determining the beginning and end of the exponential growth 
phase for growth rate calculations, a 4 parameter sigmoidal Gompertz model was 
fitted to the data to obtain quantitative parameters for growth characteristics as       Chapter Four 
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indicated  later  in  Section  5.2.  Results  of  growth  kinetics  obtained  by  the 
unmodified Gompertz equation as well as the parameters obtained are shown in 
table 4.2, where a comparison between doubling times (Td) calculated from the 
Gompertz parameters versus the doubling times (Td*) calculated from the best 
assessment of the duration of the exponential growth phase shows similar trends 
in the behaviour of the cultures. Overlap of the growth rate curves when a similar 
cell density is reached regardless of the initial cell density validates this as shown 
in Figure 4.3. 
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Figure 4.3 Overlay of hMSC growth curves seeded at 1x10
3, and 5x10
3 cell/cm
2 
over a culture inoculated 5x10
1 cell/cm
2. Data taken from Figure 4.2. The growth 
curve for ICD 5x10
1 cell/cm
2 is shown starting at time 0 hr as it was performed 
experimentally. The growth curve for ICD 1x10
3 cell/cm
2 was plotted starting at 
time 165 hr i.e. the time at which the cell density for the culture seeded at 5x10
1 
cell/cm
2 had reached 1x10
3 cell/cm
2. Similarly, the growth curve for ICD 5x10
3 
cell/cm
2 was plotted starting at time 309 hr, the time at which the cell density for 
the culture seeded at 5x10
1 cell/cm
2 had reached 5x10
3 cell/cm
2.       Chapter Four 
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Analysis  of  overlapping  cell  growth  curves  at  common  cell  densities 
demonstrates that hMSC cell growth rate changes over time as the number of 
cells  per  surface  area  in  the  culture  vessel  increases.  The  faster  growth  rate 
observed  when  fewer  cells  are  present  per  surface  area  is  lost  once  the  cell 
density reaches the same value as that one used to inoculate under the baseline or 
control condition of 5x10
3 cell/cm
2. Furthermore, cultures seeded at low ICD of 
5x10
1 cell/cm
2 reached a lower cell density at the end of the culture than the 
baseline condition. From empirical data, only 0.96x10
4 cell/cm
2 were recovered 
from  the  culture  seeded  at  the  lowest  ICD  whilst  3.53x10
4  cell/cm
2  were 
recovered from the culture seeded at the baseline ICD at the time of harvest, with 
no clear indication of the stationary phase having been reached then. Because of 
the limited number of  wells,  not  enough  cells  were available for cell density 
determination after twenty days in culture. Therefore based on the data available 
it is not possible to ensure that growth arrest had been reached by all populations 
at harvest, although the growth rate during the last days in culture had decreased 
severely..
 
Table 4.2. Effect of inoculation cell density (ICD) on hMSC growth kinetics. 
Passage 6 of hMSC was seeded at 5x10
1, 1x10
3, and 5x10
3 cell/cm
2 in 24 well-
plates as described in Section 2.4 . Kinetic parameter values obtained from fitting 
the  modified  four-parameter  Gompertz  model  (Equation  3.1)  in  Figures  4.2. 
Growth rates () and Doubling Time (Td) calculated from Gompertz parameters, 
and  Doubling  Time  (Td*)  was  calculated  from  empirical  data  for  comparison 
purposes 
ICD  a 
Xmax 
(cells/cm
2)  X0  b  t0  μ (hr
-1)  Td  Td* 
50  6.87x10
4  6.87 x10
4  5.10x10
1  126  209  0.0210  33  38 
1000  3.31 x10
4  3.39 x10
4  7.96x10
2  151  202  0.0091  76  65 
5000  3.03 x10
4  3.35 x10
4  3.20x10
3  119  139  0.0073  95  85 
 
Sekiya et al. (2002) implied that the decrease in viable cell density at  the end of 
the culture may be due to an increase in cell mass as the cell doubling number 
increases. The hypothesis is based on the assumption that although the cells 
utilise the same amount of resources they use them to build biomass within the 
cell and not to divide. If this was true and it was also accountable for the decrease 
of  cell  growth  as  the  population  doubles,  size  determination  over  time  as  a       Chapter Four 
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measurement for an increase in cell mass will confirm this. For this purpose, 
harvested material for a culture at Passage 1 and Passage 5 but from the same cell 
source  was  analysed  for  cell  size  with  a  Malvern  Mastersizer  as  indicated  in 
Section 2.11.1. 
 
(a) Particle size distribution for hMSC at Passage 1, measured in duplicate from the 
same cell suspension (red and green lines) 
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(b) Particle size distribution for hMSC at Passage 5 
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Figure  4.4  Particle  size  determination  for  suspensions  of  hMSC  in  culture 
medium harvested at (a) passage 1 and (b) passage 5. Cells cultured as described 
in Section 2.4 and sized using a Malvern Mastersizer following the procedure in 
Section 2.11.1. Both cultures yield a D50 or 2.92 m, indicating no size increase 
over population doubling increase.        Chapter Four 
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Cell size analysis corroborated that as the population doubling increases, the size 
of the cells in culture remains constant. For hMSC measured at the end of the first 
and fifth passages the mean diameter observed was identical, as shown in Figure 
4.4. Cell size determination through image analysis was also performed with a 
Cedex counter as per the protocol described in Section 2.11.2, and the results 
confirmed no difference in size (results not shown).  
It  is  possible  the  increase  in  cell  growth  rate  with  decreasing  ICD  is  a 
consequence of cell to cell physical distance or to the amount of media available 
per cell at a given time. Published data by Sekiya et. al. (2002) showing the same 
trend, failed to extend the period of the hMSC cultures seeded at low ICD until 
the  stationary  phase  was  reached.  Consequently,  although  it  is  true  that  cells 
seeded at low densities of 5x10
1 to 1x10
2 cells/cm
2 double at a faster rate than 
those seeded at 5x10
3 cells/cm
2, it is important to notice that they have to be 
maintained at such a low surface coverage before the growth rate slows down. 
This means that hMSC inoculated at 5x10
1 cells/cm
2 would have to be harvested 
at  cell  densities  below  1x10
3  cells/cm
2  in  order  to  accelerate  the  overall  cell 
expansion time to reach the same number of cells at the end of the process. The 
implication for this process change is a considerable increase in raw materials 
such as culture media, trypsin, and plastic ware, in order to complete the cell 
expansion process, whilst reducing the overall processing time. The increase in 
open  aseptic  manipulations  with  the  associated  risk  of  contamination,  cost  of 
materials, and manual labour, does not justify the reduction of the overall cell 
expansion time achieved by this process parameter change. 
4.3  Effect of feeding strategy on hMSC expansion 
The effect of inoculation cell density during the cell expansion of hMSC in an 
undifferentiated state was investigated in Section 4.2. Faster growth rates than 
those obtained by the standard growth protocol - inoculation cell density of 5x10
3 
cells/cm
2  with  medium  exchange  every  three  to  four  days  -  were  shown  for 
hMSC  when  cell  surface  coverage  was  maintained  between  5x10
1  and  1x10
3 
cells/cm
2.  It  is  unlikely  for  the  physical  distance  between  cells  to  be  an 
explanation for this decrease in doubling time for low cell surface coverage since       Chapter Four 
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microscopic observation reveals that there is no contact between cells at densities 
of 5x10
3 cells/cm
2. However, a possible reason for this effect is the accumulation 
of inhibitory factors secreted by the cells or the competition for growth factors or 
nutrients in the media as more cells per ml of media are present in the culture. 
Metabolic  analysis  of  the  spent  media  for  all  cultures  did  not  reveal  nutrient 
limitations – glucose and glutamine - or accumulation of toxic products – lactate 
and glutamate - for any of the conditions tested (data provided in Appendix II) 
but other media components such as growth factors, lipids, or amino acids were 
not analysed and could be responsible for this differences in growth rates. If this 
is the case, it would be possible to achieve the same high growth rates obtained 
when seeding hMSC at low ICD, by providing the same addition rate of media in 
a per cell basis for cultures seeded at 5x10
3 cells/cm
2. 
To test this hypothesis, media requirements for hMSC cultures seeded at low ICD 
of 1x10
2 cells/cm
2 were calculated, based on media exchanges of every four days, 
to be 2.08x10
-5 ml media/cell.hr. In order to match the same media availability to 
cultures  seeded  at  a higher  ICD of  4x10
3  cells/cm
2 in  6 well plates,  medium 
exchanges were performed every 2.5 hours for the initial 48 hours of the culture. 
After the initial 48 hours, medium exchange rates were decreased to one every 6 
hours for the remaining 21 day of the culture for logistical reasons. As a positive 
control, hMSC were inoculated at 1x10
2 cells/cm
2 with medium exchanges every 
four days. As a negative control, hMSC were inoculated at 4x10
3 cells/cm
2 with 
medium exchanges every four days also. Three wells were sacrificed from each 
condition at every time point to generate growth curves, as shown in Figure 4.5.       Chapter Four 
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Figure 4.5 Effect of feeding strategy and inoculation cell density (ICD) on hMSC 
growth kinetics. hMSC from a common cell inoculum were seeded in 6 well-
plates at 1x10
2, and 4x10
3 cells/cm
2 as described in Section 2.4. Feeding rates for 
ICD  4x10
3  cell/cm
2  with  frequent  refeed  matched  the  medium  supplied  in 
ml/cell.hr provided to the condition seeded at 1x10
2 cell/cm
2 when refed every 
four days. Error bars represent one standard deviation about the mean (n=3). The 
data  was  fitted  to  a  4-parameter  sigmoidal  Gompertz  model  (solid  lines)  to 
determine quantitative growth kinetic parameters as indicated later in Section 5.2. 
Analysis of the cell growth characteristics for each of the conditions tested (Table 
4.3) corroborates the hypothesis that hMSC growth rate is dependent on medium 
addition rates and not on ICD as previously reported (Sekiya et al., 2002). The 
calculated growth rate of 0.53 days
-1 achieved by hMSC seeded at low ICD of 
1x10
2 cells/cm
2 was closely reproduced at a rate of 0.42 days
-1 for cells seeded at 
4x10
3 cells/cm
2 by normalizing the medium addition rate in a per cell per hour 
basis for the same cell source. The small discrepancy between the two values can 
be explained, as normalised media flow rates were calculated for the cell density 
of 1x10
2 cells/cm
2 at inoculation time, and it was not recalculated over time to 
account for the increase of the number of cells in culture as the cells divided. For 
each cell doubling, the addition rate of media was not exactly equal in a per cell       Chapter Four 
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per time basis for each condition. This resulted in a discrepancy of 0.1 days
-1 in 
growth rates for hMSC when seeded at 1x10
2 versus 4x10
3 cells/cm
2. However, 
the growth rates were considered close enough to prove that a higher frequency 
of medium exchanges resulted in an increase cell growth rates. Results showed an 
improvement in cell growth rate increasing from 0.16 days
-1 to 0.42 days 
-1 when 
comparing the control culture seeded with ICD of 4x10
3 cell/cm
2 with medium 
exchange frequency of four days with the optimised medium exchange strategy 
for the culture seeded at the same  ICD of  4x10
3 cell/cm
2.  
To highlight the significance of this process optimisation parameter, quantitative 
values  for  growth  rate  obtained  with  a  four-parameter  sigmoidal  Gompertz 
equation (Equation 5.1), and doubling time for each bioprocess condition tested 
are  shown  in  Table  4.3  along  with  the  time  implications  for  delivery  of 
undifferentiated  hMSC  to  the  clinic.  A  feeding  strategy  that  would  provide 
2.08x10
-5 ml media/cell.hr could easily be implemented in an automated robotic 
platform,  yielding  optimum  hMSC  growth  rates  of  0.5  day
-1  in  an 
undifferentiated state. The advantage of this process parameter implementation is 
that the overall cell expansion times will be reduced from 59 to 30 days (Table 
4.3), while maintaining the same culture surface area over the completion of the 
cell growth within a passage. The use of an automated culture platform would 
also  reduce  the  risk  of  contamination  due  to  operator  errors  during  open 
manipulations, as well as reducing the cost of manual labour.        Chapter Four 
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Table 4.3 Effect of inoculation cell density (ICD) and feeding strategy on growth 
kinetics and overall cell expansion process time for hMSC. Process time indicates 
the number of days that would take for 1x10
5 cells to be expanded to 1x10
8 cells 
for  each  process.  Calculations  based  on  four  parameter  sigmoidal  Gompertz 
model as indicated in Section 5.2 from data shown in Figure 4.5. 
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4x10
3  4 days  8.50x10
+3  1.14x10
+4  2.91x10
+3  2.4  5.6  0.16  102  59 
4x10
3  6 hours  4.13x10
+4  4.38x10
+4  2.50x10
+3  2.5  7.8  0.42  40  34 
1x10
2  4 days  1.36x10
+4  1.37x10
+4  8.70x10
+1  3.5  12.7  0.53  32  30 
 
The only  drawback associated with  an   increase in  the frequency of  medium 
exchanges is the associated increase in cost due to the larger amount of media 
requirements  for  the  completion  of  the  cell  expans ion  process.  The  most 
expensive component in the media formulation used for the cell expansion is 
FBS. Due to the cost of this raw material as well as the undesired source (animal 
derived component) as explained in Section 1.3.2, an alternative supplementation 
to the media was tested.  FBS was replaced by protein hydrolysates from the 
growth medium to determine if a non-animal derived complex component would 
sustain hMSC growth in a comparable way. Four different protein hydrolysates 
from Kerry Bio-Science were tested, HyPep 4601, HyPep 1511, HyPep 1510, and 
H-Soy  as  indicated  in  Section  2.5.  Four  different  media  formulations  were 
prepared by adding one of the protein hydrolysates at a concentration of 4 g/L. A 
common pool of cells was used for growth comparison in parallel cultures with 
each one of these four media compositions as well as with the control media 
formulation with 10% FBS. The cultures were inoculated at 5x10
3 cells/cm
2 in 24 
well-plates, with medium exchanges every three days. Growth curves from each 
condition were generated as shown in Figure 4.6. 
       Chapter Four 
132 
Time (hr)
0 50 100 150 200 250 300 350
V
iab
le 
Cell
 Den
sity
 (cells/
cm
2
)
1e+2
1e+3
1e+4
1e+5
10% FBS 
HyPep 4601 
HyPep 1511 
HyPep 1510 
Hy-Soy 
 
Figure 4.6. Effect of FBS replacement by Protein Hydrolysate on hMSC growth 
kinetics. hMSC from a common cell inoculum were seeded in 24 well-plates at 
5x10
3 cells/cm
2 with medium exchanges every three days. The control condition 
was cultured with the basal medium formulation containing 10% FBS. Four other 
formulations  had  FBS  replaced  with  4  g/L  of  each  of  the  following  protein 
hydrolysates: HyPep 4601, HyPep 1511, HyPep 1510, and Hy-Soy. 
Growth curves generated from each one of the cultures with protein hydrolysate 
showed  that  neither  of  these  commercially  available  components  can  support 
growth for hMSC. To corroborate this finding, the same cell source cultivated 
with 10% FBS did support growth, proving that no other parameter other than 
protein hydrolysates were responsible for the negative growth in these cultures. 
Results indicate that protein hydrolysates are not a viable replacement for FBS 
replacement for the lots of materials tested at 4 g/L concentration. No further 
efforts were dedicated to the replacement of FBS with non-animal derived or with 
chemically defined components, since such studies are outside the scope of this 
thesis.       Chapter Four 
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4.4  Effect of Temperature and pH Deviations on hMSC expansion 
As shown in Section 4.3, the feeding strategy for the culture of hMSC has a very 
significant  impact  on  cell  growth  kinetics.  As  the  frequency  of  medium 
exchanges increases, the growth rate of the culture increases significantly. The 
cause for this increase in growth rate due an increase in medium exchange rate is 
not  fully  understood,  since  there  were  no  measurable  chemical  factors  being 
depleted in the culture media when sampling the spent media for metabolites 
(Section  2.7).  However,  during  each  medium  exchange  there  are  not  just 
chemical changes in the environment of the cells, but physical changes as well 
which maybe in part responsible for variations in growth rates.   
During  every  full  medium  exchange  the  cultures  are  removed  from  the 
environmentally  controlled  incubators  and  placed  in  a  non-environmentally 
controlled biosafety cabinet. Every time this happens, there is a step change in 
temperature  from  37˚C  to  room  temperature,  and  a  step  change  in  gas 
composition from 5% CO2 to atmospheric concentration. It normally takes from 
15 to 30 minutes to replace the media from all the wells in a 12 well-plate, and 
during  that  time  the  step  change  variations  in  the  environment  translate  into 
changes in the pH and temperature in the culture media. It is therefore possible 
that exposure to these different, or fluctuating, environmental conditions had an 
effect on cell growth that it is independent on the media being replaced.  
In order to test this hypothesis, the temperature and pH of the medium during the 
step  changes  experienced  during  a  medium  exchange  were  recorded.  Control 
experiments were executed to decouple the effect of such pH and temperature 
variations  on  cell  growth  kinetics.  The  results  of  these  studies  are  shown  in 
Section 4.4.1 and 4.4.2.  
4.4.1 Effect of Environmental Excursions on Temperature and pH of 
Culture Media 
Cultures of hMSC are placed in humidified incubators at 37˚C, and a gas mixture 
containing 5% CO2 to regulate the pH in the media. Every time a culture vessel is 
removed  from  the  incubator  the  cultures  are  exposed  to  a  step  change  in       Chapter Four 
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temperature dropping from 37˚C to a room temperature of 20˚C to 22˚C, as well 
as an atmospheric gas composition.  These step changes take place every time a 
culture vessel is removed from the incubator for a microscopic observation, to 
perform medium exchanges, or to harvest one or more wells from a well plate. 
However, the cells attached to the surface are protected by the layer of medium 
covering them, and they will only be exposed to the variation of temperature and 
pH that occur in the medium above them.  
To  study  the  variations  of  temperature  in  the  media  for  12  well-plates, 
thermocouples  were  submerged  in  the  media  of  one  well  and  also  placed  10 
inches  over  the  plate  to  record  the  temperature  profiles  during  temperature 
excursions  as  explained  in  Section  2.8.  To  record  pH  variations,  small 
fluorescence-based pH sensor patches were placed at the bottom of the well as 
indicated  in  Section  2.9.  The  standard  amount  of  time  that  a  plate  is  placed 
outside the incubator during a medium exchange or a microscopic observation is 
approximately 15 minutes. This operation was mimicked by loading a 12 well-
plate with 2 ml of culture media per well with thermocouples and pH sensors 
attached to the plate. The 12 well-plate was placed in a 37˚C incubator with 5% 
CO2 until the readings equilibrated at the set-point conditions. 
Once the media was equilibrated the plate was removed from the incubator and 
placed in a biosafety cabinet for 15 minutes, after which the plate was placed 
back in the incubator. Values for temperature and pH were recorded until both of 
the values equilibrated back to the initial values. Profiles generated from these 
temperature and CO2 deviations are shown in Figure 4.7.       Chapter Four 
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Figure 4.7 Effect of a 15 minute step change in environmental temperature and 
gas  composition  on  culture  media  in  a  12  well-plate.  Temperature  and  pH 
variations in the culture media of one well from a 12 well-plate filled with 2 ml of 
culture media on each well were measured as described in Section 2.9.1. The 
plate  was  equilibrated  in  a  humidified  incubator  with  5%  CO2  at  37˚C  and 
removed into a biosafety cabinet for 15 minutes before placing back into the 
incubator. 
From  the  profiles  recorded  during  a  15  minute  step  change  in  environmental 
conditions,  the  medium  pH  is  seen  to  increase  from  7.5  up  to  8.0  and  the 
temperature in the media decreased down to 26˚C from the initial 37˚C. Once the 
plate  was  placed  back  into  the  incubator  the  pH  went  back  to  7.5  almost 
immediately. However it took approximately one hour for the temperature of the 
media  to  regain  the  set-point  temperature  of  37˚C.  This  is  not  a  significant 
amount of time if medium exchanges were to be performed every three to four 
days. However, in the case of frequent medium exchanges every 6 hours or less, 
which  it  has  been  proven  to  increase  cell  growth  rates  (Section  4.3),  these 
environmental changes will represent 17% of the culture time taking place under 
37˚C. Temperature stress has been shown to produce positive effects in murine 
MSC,  up-regulating  heat  shock  proteins  and  down-regulating  pro-apoptotic 
proteins  as  well  as  decreasing  proteasome  activity  (Stolzing  et  al,  2006).       Chapter Four 
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Extracellular pH also plays an important role in cell growth in hMSC, showing a 
decrease in number of cells recovered when exposed to pH variations (Gaus et 
al., 2002). 
The time taken for the plate to equilibrate within the biosafety cabinet, under non-
environmentally  controlled  conditions  was  also  established.  This  represents  a 
more extreme deviation, for example when harvesting or staining some of the 
wells  from  a  well-plate,  or  when  taking  photographs  of  the  wells  at  an 
intermediate time-point during the culture. In this case it takes  50 minutes to 
reach room temperature and one hour and forty minutes for re-equilibration to the 
initial  set  points  as  shown in  Figure 4.8. The  pH was  seen to  re-equilibrated 
almost immediately according to the percentage of CO2 in the environment going 
from 7.5 to 8.0.  
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Figure  4.8  Effect  of  a  maximum  environmental  temperature  step  change  on 
culture media in a 12 well-plate. Temperature and pH variations in the culture 
media of one well from a 12 well-plate filled with 2 ml of culture media on each 
well were measured as described in Section 2.9.1. The plate was equilibrated in a 
humidified incubator with 5% CO2 at 37˚C and removed into a biosafety cabinet 
until the temperature of the well reached room temperature. After equilibration at 
room temperature, the 12 well-plate was placed back into the incubator until it 
equilibrated again to the set values.       Chapter Four 
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The recovery time for the temperature of the culture media to equilibrate back to 
37˚C after manipulations in a biosafety cabinet can be minimised by increasing 
the  heat  transfer  rate  to  the  medium  upon  return  to  the  incubator.  This  was 
evaluated by placing the 12 well-plate on an orbital shaker inside a controlled 
incubator and recording temperature and pH profiles while transferring the well-
plate from equilibrium at room temperature and atmospheric conditions back to 
37˚C and 5% CO2 in the humidified incubator. Two different shaking speeds 
were tested, 140 and 250 rpm. The profiles are shown in Figures 4.9 and 4.10 
respectively. 
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Figure 4.9 Effect of a temperature step change in culture media of a 12 well-plate 
with shaking during incubation. Temperature and pH variations in the culture 
media of one well from a 12 well-plate filled with 2 ml of culture media on each 
well were measured as described in Section 2.9.1. The plate was equilibrated in a 
biosafety  cabinet  and  then  placed  into  a  shaker  at  140  rpm  in  a  humidified 
incubator with 5% CO2 at 37˚C.       Chapter Four 
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Figure 4.10 Effect of a maximum temperature step change in culture media of a 
12 well-plate with shaking during incubation. Temperature and pH variations in 
the culture media of one well from a 12 well-plate filled with 2 ml of culture 
media on each well were measured as described in Section 2.9.1. The plate was 
equilibrated  in  a  biosafety  cabinet  and  placed  into  a  shaker  at  250  rpm  in  a 
humidified incubator with 5% CO2 at 37˚C. 
From the profiles obtained with shaking in the incubator at 140 and 250 rpm, an 
improvement in heat transfer rate for both conditions was observed in comparison 
with  the  normal  static  condition.  It  took  1  hour  and  40  minutes  for  the 
temperature  of  the  culture  media  to  reach  37˚C  in  the  incubator  under  static 
condition after being equilibrated at room temperature. However, it only took one 
hour when the plate was placed in a shaker inside the incubator. There was not a 
considerable difference in the overall time taken for temperature re-equilibration 
between 140 to 250 rpm, although the initial increase in temperature in the media 
was  faster  for  250  rpm  than  for  140  rpm  as  would  be  expected  due  to  the 
increased gas-liquid surface area available for heat transfer at the higher shaking 
speed (Zhang., et al., 2008). Even with improved heat transfer in the system, the 
temperature  variation  of  the  culture  media  as  a  result  of  a  step  change  in 
environmental  conditions  can  be  minimised  but  it  cannot  be  eliminated. 
Consequently, the effect of these variations in the temperature and pH of the       Chapter Four 
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culture  media  during  hMSC  cell  expansion  process  have  to  be  addressed,  as 
described in Section 4.4.2.  
4.4.2 Decoupling the Effect of Feeding Strategy from Environmental 
Variations During Medium Exchanges on hMSC Growth Kinetics 
For the cell expansion process of hMSC under static conditions, more frequent 
medium exchanges result in faster growth rates as shown in Section 4.3. Two 
feeding strategies were implemented for the same cells source from Passage 1; 
medium  exchanges  every  three  days  and  every  six  hours.  Considering  the 
chemical  and  physical  changes  that  occur  in  the  cell  environment  during  a 
medium exchange, it is important to understand which of these parameters is 
contributing  to  the  measured  increase  in  growth  rates.  In  addition  to  the 
replacement  of  spent  medium  by  formulated  culture  medium,  during  every 
medium  exchange  there  is  a  variation  in  the  pH  and  temperature  of  the  cell 
environment that last for at least one hour, as shown in Section 4.4.1. The effect 
of  pH,  feeding  strategy,  and  cumulative  repetition  of  step  changes  on  hMSC 
growth kinetics was thus attempted to be decoupled in the following experiments. 
Two different feeding strategies were compared to the control baseline, which 
consists of medium exchanges every three days for a culture of hMSC seeded at 
5x10
3  cells/cm
2  in  24  well-plates.  Growth  kinetics  were  studied  for  hMSC 
cultures seeded at the same inoculation density from the same source of cells with 
higher frequencies of medium exchanges of 24 and 12 hours. As shown in Figure 
4.11 a higher frequency of medium exchanges results in not just higher growth 
rates but also in a higher maximum viable cell density reached by the stationary 
phase. From the three feeding strategies studied, medium exchanges every 12 
hours resulted in  the fastest  growth rates of 0.63 day
-1 with  a maximum  cell 
density of 1.2x10
5 cells/cm
2, followed by medium exchanges every 24 hours with 
growth rates of 0.51 day
-1 and a maximum cell density of 1.0x10
5 cells/cm
2 . Both 
of these represent an improvement over the control or baseline condition which 
gave a growth rate of 0.32 day
-1 and a maximum cell density of 6.3x10
4 cells/cm
2 
. The quantitative results from each condition are listed in Table 4.4 for easier 
comparison.       Chapter Four 
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To understand if the pH step changes that occur during a medium exchange had 
any  impact  on  the  improvement  in  process  performance  with  more  frequent 
feeding  these  pH  changes  were  reproduced  at  a  12  hour  frequency  but  the 
medium  was  replaced  once  every  three  days  matching  the  baseline  control 
feeding strategy. A CO2 controlled humidified incubator at 37˚C was set at 0% 
CO2  gas  mixture  balanced  with  O2  and  N2  for  this  purpose.  Pre-equilibrated 
medium for 24 hours at 0% CO2 and 37˚C resulted in a pH of 8.6. Cultures of 
hMSC  were  seeded,  plated,  and  cultured  in  identical  fashion  as  the  control 
baseline condition with medium exchanges every three days. However, every 12 
hours, the plates were transferred to the 0% CO2 incubator for 15 minutes, and 
then placed back into the 5% CO2 incubator. One plate was seeded for each time 
point of data recorded, to ensure that no extra exposure to ambient temperature 
was taking place on the culture while harvesting individual wells during each 
time point. Interestingly, these series of pH variations every 12 hours alone did 
not result in comparable cell growth rates to the ones obtained when performing 
medium  exchanges  every  12  hours.  By  exposing  the  culture  to  higher  pH 
conditions every 12 hours, a growth rate of 0.34 days
-1 was obtained, comparable 
to the growth rate of the control culture of 0.32 day
-1 (Table 4.4). No decrease in 
the maximum number of viable cells at the end of the exponential phase was 
observed by exposure to these pH variations. 
The possibility of higher pH having a detrimental effect on hMSC was studied by 
culturing hMSC in a humidified incubator at 37˚C with 2% CO2 gas mixture 
balanced with O2 and N2. This gas composition resulted in a pH reading of 8.2 at 
37˚C.  The  cultures  were  kept  with  a  baseline  condition  feeding  strategy  of 
medium exchanges every three days. The same procedure was followed in an 
incubator with 0% CO2 gas mixture, however no cells survived the first 24 hours 
at  this  high pH of 8.6  and the well-plates  were discarded. For the culture of 
hMSC incubated at pH of 8.2 in the 2% CO2 incubator, the slowest growth rates 
of 0.19 day
-1 was observed over the period of the culture. However, a maximum 
cell density of 1.1x10
5 cells/cm
2 was obtained at the end of the culture which is 
comparable  to  the  maximum  cell  densities  achieved  by  the  faster  frequency 
feeding strategies (Table 4.4). Higher pH in the medium resulted in  a slower 
growth during the first days in culture which may be in part due to an adaptation       Chapter Four 
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process of the cells to new environmental conditions. However looking at the cell 
growth curve in red in Figure 4.11 it does not appear as if the culture has reached 
stationary phase after the last time point was recorded. Because no more plates 
had been seeded the culture could not be continued any longer. Nevertheless, in 
spite  the  initial  slower  growth  rate,  the  fact  that  high  cell  densities  could  be 
reached within the first passage suggest that hMSC can grow at higher pH and 
that it may be beneficial over a baseline condition once the cultures overcome an 
initial adaptation period.  
Table 4.4. Effect of % CO2, pH and feeding strategy on hMSC growth kinetics 
and  maximum  cell  density  reached  for  cell  expansion  in  24  well-plates. 
Experimental  data  taken  from  Figure  4.10.  Growth  rate  and  maximum  cell 
density  were  calculated  using  a  4-parameter  sigmoidal  Gompertz  equation  as 
described later in Section 5. 2 for the growth curves generated for each condition. 
The control baseline is highlighted in bold. 
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This data suggest that a combination of an increase in medium replacement as 
well as exposure to pH values higher than 7.5, results in an increase in hMSC 
growth rate as well as maximum cell numbers recovered from the culture. From 
these encouraging results, it is reasonable to believe that further optimisation of 
pH  culture  conditions  in  combination  with  frequent  medium  exchanges  will 
provide  even  more  satisfactory  conditions  of  growth  of  hMSC  in  an 
undifferentiated state for sequential passages while reducing the amount of media 
and culture vessels required for the overall cell expansion process.       Chapter Four 
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While these process optimisation parameters would be tedious to implement in 
cultures  expanded  manually,  they  can  be  easily  implemented  in  automated 
robotic platforms. The feasibility of this concept is further investigated in Section 
4.5. 
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Figure 4.11. Effect of feeding strategy and percentage CO2 resulting in different 
pH,  and  transient  environmental  variations  on  hMSC  growth  kinetics.  hMSC 
from a common cell inoculum were seeded in 24 well-plates at 5x103 cells/cm2 
as described in Section 2.4. Three feeding strategies with frequencies of 3 days, 
12 hours, and 24 hours were compared when incubated in 5% CO2 and 37˚C 
incubator. Three different pH conditions resulting for different exposures to CO2 
were also compared for cultures undergoing medium exchanges every 3 days. 
Error bars represent one standard deviation about the mean (n=3). Quantitative 
parameters derived from these growth curves are presented in Table 4.4. 
4.5  hMSC Cell Growth in an automated robotic platform 
One  of  the  main  hurdles  for  the  implementation  of  a  robust  process  for  cell 
expansion of large numbers of hMSC for use in regenerative medicine therapies, 
is  the  high  number  or  manual  operations  required  over  the  course  of  several 
passages and the consequent variation, high cost, and contamination risk that this       Chapter Four 
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generates (Mason, 2006). There are also some process implementations, such as 
tight  control  of  environmental  conditions,  that  would  be  not  possible  to 
implement in open system cultures. 
To demonstrate the advantages and feasibility of performing the cell expansion 
processes for hMSC under controlled environmental parameters, an automated 
system was used to culture hMSC with no manual manipulations involved. As 
indicated in Section 2.12, a Tecan robotic platform was enclosed in a biosafety 
cabinet with the capability to control temperature and gas composition. Two 12 
well-plates were inoculated with hMSC at an inoculation cell density of 5x10
3 
cells/cm
2. The plates were placed in an automated incubator integrated with the 
biosafety cabinet, at 5% CO2 and 37˚C. As shown in Figure 2.5, the incubator 
could be opened to the outside of the cabinet in order to load and unload the 
cultures, and it could also open to the inside of the biosafety cabinet where a 
robotic  arm  removed  the  well-plates  and  placed  them  in  a  platform  inside  a 
controlled  environment.  Once  the  plates  were  loaded  into  the  incubator,  no 
manual manipulations were required during the cell expansion process.  
From  the  two  plates  placed  in  the  incubator,  one  was  scheduled  to  undergo 
medium  exchanges  every  4  hours,  and  the  other  one  every  12  hours.  The 
biosafety cabinet was not environmentally controlled for this experiment, and the 
front  was  kept  open  during  this  preliminary  test.  The  medium  exchange 
operations could be completed within 5 minutes for each plate, during which time 
the robotic arm could aspirate the spent medium from each well and replace it 
with culture medium before placing it back into the incubator. Due to the fact that 
the culture medium was kept inside the open biosafety cabinet during the three 
days that the experiment took place, a contamination of the medium prevented 
completion of the passage. The system is now set up to keep the culture medium 
refrigerated  and  to  place  it  into  a  container  for  temperature  adjustment  and 
dispensing before a medium exchange. This piece of equipment was not ready at 
the  time  of  this  experiment.  However,  daily  microscopic  observations  of  the 
plates indicated higher cell surface coverage for the plate with medium exchanges 
every 4 hours compared to the plate with medium exchanges every 12 hours. This 
was a good indication that hMSC were proliferating and that the same effect       Chapter Four 
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observed  with  manual  manipulations  (Section  4.3)  could  be  obtained  in  an 
automated platform with the added advantage of reducing the need of an operator 
to perform the manual operations every 4 and 12 hours. 
With  appropriate  implementation  of  an  enclosed  system  within  the  biosafety 
cabinet that will hold culture media sterile and pre-warm to 37˚C before medium 
exchanges, culture of hMSC with no need of manual operations will be possible 
in  this  automated  platform  based  on  the  preliminary  experiment  already 
performed. Further adjustment of environmental conditions within the platform 
will  allow  for  a  high  throughput  of  experimental  conditions  and  ensure  the 
development and operation of a robust cell expansion process for hMSC cultures. 
4.6  Summary 
Process  parameters  for  the  cell  expansion  process  of  hMSC  in  automated 
microwells have been characterised. Also, optimum values for inoculation cell 
density,  medium  exchange  strategies,  and  environmental  control  have  been 
proven  to  reduce  the  overall  time  to  reach  1x10
8  hMSC,  for  their  use  in 
regenerative  medicine  therapies.  Reduction  in  doubling  times  of  hMSC  was 
found  to  be  mainly  attributed  to  an  increase  in  the  frequency  of  medium 
exchanges, yielding doubling times of 32 hours when medium addition rates were 
normalized to 2.08x10
-5 ml media/cell.hr. A modified version of the Gompertz 
equation was found to represent hMSC growth curves accurately, and it was used 
to determine growth rate, doubling time, maximum cell density, duration of lag 
phase and time to reach the stationary phase. 
The effect of ICD on cell growth rates, duration of lag phase, and cell density 
achieved in the stationary phase showed a trend indicating highest growth rates 
for  low  ICDs  of  1x10
2  cell/cm
2  (figure  4.2)  compared  to  the  established  cell 
expansion protocol that operates at an ICD of 5x10
3 cells/cm
2. Further studies 
revealed that the source of this increase in cell growth rates is not dependent on 
an increase of cell-cell distance, but on an increase in medium exchange rates. 
Consequently,  growth  rates  achieved  at  low  ICD  were  reproduced  for  higher 
inoculation cell densities by matching feeding requirements in ml/cell.hr. This 
information was used to determine the duration of a cell expansion process that       Chapter Four 
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requires 1x10
8 of undifferentiated multipotent hMSC from an autologous source 
for their usage in regenerative medicine applications.  
Environmental variations of pH and temperature during medium exchanges were 
recorded  with  the  aid  of  temperature  and  pH  sensors.  These  environmental 
variations persisted for over one hour after the operation was performed, and they 
were minimised when shaking the culture vessels at 140 and 250 rpm inside an 
incubator, although they could not be eliminated. The effect of these variations in 
growth kinetics of hMSC was evaluated, indicating that repeated exposures to pH 
step changes from 7.5 to 8.2 resulted in an increase in growth rates although they 
were not the only contributor to increased growth rates when similar frequency of 
step changes in conjunction with medium exchanges were performed in parallel. 
Having proven that higher frequency of medium exchanges with repeated step 
change exposure to higher pH during the cell expansion of hMSC resulted in an 
increase in growth rates, an automated platform was used as a proof of concept 
for the implementation of such operations. The automated platform successfully 
performed medium exchange operations at higher frequencies of 4 and 12 hours, 
that  otherwise  would  have  required  the  use  of  two  operators  to  accomplish. 
Further modifications of this automated platform will prove to be an effective 
way  to  ensure  production  of  hMSC  for  autologous  therapies  with  optimum 
growth in an undifferentiated state. 
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5  MODELLING AND PREDICTION OF HMSC GROWTH KINETICS 
AND PERFORMANCE OF A MULTISTAGE CELL EXPANSION 
PROCESS 
5.1  Introduction and Aims 
The  use  of  autologous  hMSC  for  regenerative  medicine  therapies  presents  a 
suitable alternative for cell and gene therapy (Prockop, 1997) and regeneration of 
tissue (Oreffo et al., 2007; Caplan et al., 2001) for the treatment of degenerative 
diseases.  One  advantage  of  using  autologous  progenitor  cells  over  any  other 
source of cells is the lack of immunosuppressant requirements, since these cells 
are  provided  by  the  patients  themselves.  In  the  case  of  patients  with 
immunological  compromised  systems  the  use  of  hMSC  will  provide  a  great 
alternative of care, not available to them otherwise. However, the disadvantage in 
terms of making this therapy available to satisfy market needs, is that the process 
of generating a final product varies from patient to patient due to the different cell 
growth characteristics from each donor. 
The procedure involving patient specific autologous cell therapy requires a series 
of steps that must be carefully timed for the success of the treatment. First of all, 
the  patient  must  be  scheduled  for  the  surgical  collection  of  a  bone  marrow 
sample. Then the sample must be transferred to a laboratory where the hMSC are 
isolated  from  the  bone marrow  extract  as  indicated  in  Section  3.2.  After  cell 
isolation, hMSC must undergo a cell expansion process with the initial purpose to 
generate sufficient undifferentiated cells for treatment. Once the number of cells 
required  have  been  reached,  a  differentiation  step  may  be  required  if  tissue 
regeneration is intended to occur in vitro or they can be returned to the hospital if 
tissue  regeneration  is  intended  to  occur  in  vivo.  Finally,  the  patient  must  be 
scheduled  for  implantation  of  the  cellular  material  or  regenerated  tissue  to 
coincide  with  arrival  of  the  final  product  into  the  clinic.  The  timing  of  this 
process is critically dependant on the cell growth rate of the isolated cells which, 
as it has been shown in Chapters 3 and 4, depends on the donor and on the 
processing parameters. The process parameters can be fixed so as to implement 
optimum cell growth rate as shown in Section 4.3 to 4.5. However until data from 
the first passage is available, knowledge of the intrinsic growth characteristics       Chapter Five 
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that depend on the source of the cells remains variable and unknown for each 
patient. This variability will result in an unknown delivery time for the therapy 
back to the patient, or an unrealistically broad timeframe. 
For the success of this therapy, the surgical team, the patient, and the cells must 
be scheduled to coincide at a pre-arranged time. Any delay in the delivery of the 
cellular product into the clinic may jeopardize the success of the treatment and 
risk the health of the patient. It will also incur significant costs if the surgical 
team and facilities are assembled and the hMSC are not available. 
For clinical applications the inability to predict the growth rate of isolated cells 
from  a  patient  at  each  stage  of  the  cell  expansion  provides  a  major  obstacle 
towards  the  design  of  a  time  based  automated  bioprocess.  In  order  to  define 
processing times for the overall cell expansion of hMSC in an undifferentiated 
state, a simple mathematical model that can describe the kinetics of growth for 
each passage based on the parameters obtained from passage one after hMSC 
isolation from an individual patient would be extremely valuable. Such a  model 
should be able to reliably forward predict processing times at each passage for 
each donor, taking into consideration the decrease in growth rates associated with 
the increase in cell doublings. 
The aim of this chapter is to develop a mathematical model that could describe 
the kinetics of growth for each passage based on the parameters obtained from 
passage one after hMSC isolation from an individual patient. The intention of 
generating such tool is to forward predict the overall cell expansion process time 
for each individual patient. The validity of the model was  tested with  hMSC 
isolated from three different donors, and proven to be accurate in all cases. The 
specific objectives of the work are: 
  To establish a mathematical model for hMSC growth kinetics. 
  To  generate  quantitative  values  for  model  kinetic  parameters  based  on  an 
established mathematical model.  
  By using cells from different sources show how model kinetic  parameters 
vary with passage / donor.        Chapter Five 
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  Finally demonstrate accurate forward prediction of the growth rate of cells 
from different donors over multiple passages as well as examining the surface 
marker expression of hMSC throughout the expansion process.  
5.2  Development of Mathematical Model for Cell Growth Quantification 
Diploid  mammalian  cells  cultured  without  nutrient  limitations  undergo  three 
distinct phases of growth: a lag phase, exponential growth, and stationary phase 
(Hayflick et al., 1961). One of the main parameters to characterise the growth of 
mammalian  cell  cultures  in  vitro  is  the  growth  rate.  Growth  rate  is  usually 
calculated from the slope of the exponential phase when plotted on a logarithmic 
scale. Unlike suspension cultures, anchorage dependent cells such as hMSC have 
growth curves that do not always exhibit three clear regions, attributed to lag, 
exponential, and stationary phases (Freshney, 1994). There are several reasons 
for this phenomenon, one of them being the difficulty in acquiring cell density 
readings. Cell suspension samples can easily be withdrawn from a shake flask or 
stirred-tank bioreactor without disruption of the rest of the culture in the vessel. 
However, the only way to determine cell densities for anchorage dependent cells 
is to sacrifice the culture vessel by enzymatic detachment of the cells from the 
surface.  In order to  collect  sufficient  time points  to  generate a  growth  curve, 
several  culture  vessels  must  be  seeded  in  parallel  to  support  sacrifice  of  the 
culture and collection of data at all the time points at which samples will be 
collected. 
For  the  specific  case  of  hMSC,  the  low  number  of  cells  available  after  their 
separation  from  bone  marrow  samples  (1  in  1x10
7  to  10
8  cells  from  a  bone 
marrow sample is a hMSC (Reyes et al., 2001; Silva et al., 2003)), makes the 
generation of growth curves very challenging. The number of cells available to 
conduct an experiment with hMSC that have not undergone several doublings is 
very  limited,  and  therefore  makes  it  difficult  to  seed  many  parallel  culture 
vessels, especially when several sets of analysis requiring a high number of cells 
are  usually  required.  For  example,  surface  marker  characterisation  by  flow 
cytometry. This, accompanied by the long culture time for hMSC that can extend 
for up to 25 days, requires a large amount of cells seeded in parallel, allowing       Chapter Five 
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sacrificial samples to be taken over such a long period of time. Consequently, it is 
not  always  possible to  generate growth curves  revealing cell density  readings 
taken on a daily basis. Even when enough data points are analysed to generate a 
cell growth curve, the resulting data make it difficult to determine the points that 
mark  the  start  and  end  of  the  exponential  growth  phase  for  growth  rate  and 
doubling time calculations. This can be seen, for example, in the growth curves 
generated in Figure 4.2, and subjective judgments are often required to calculate 
such parameters. The same problem occurs when trying to determine the duration 
of the lag phase and time to reach stationary phase.  
To eliminate ambiguity and to help determine accurate growth rates, doubling 
times, and duration of the lag phase that characterise hMSC growth, it is of great 
interest to adopt a mathematical model that would accurately represent the shape 
of  the  growth  curve.  The  Gompertz  model  has  been  used  to  accurately 
characterise cell growth kinetic parameters, such as growth rate and maximum 
cell  density  at  stationary  phase,  while  accounting  for  the  duration  of  the  lag 
phase, and the time needed to reach maximum cell densities. 
The Gompertz model (Melero-Martin, 2004) not previously used with hMSC is 
described by the following equation: 
 
 


 







  
   
b
t t
a X X
o exp exp 0   5.1 
Where X is the cell density, X0 is inoculation cell density, a is the increase in cell 
density (all in cells/cm
2), t is time, t0 is related to the duration of the lag phase, 
and b is related to the duration of the exponential phase.  
The graphical representation of the model kinetic parameters generated by the 
Gompertz model is shown in Figure 5.1. 
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Figure 5.1 Schematic representation and approximate qualitative meaning of a 
four  parameters  generalisation  of  the  Gompertz  function  [Equation  5.1]  in 
relation to the growth curve of a hypothetical culture of cells. (figure reproduced 
from Melero-Martin et al., 2005) 
From the parameters given by Equation 5.1, more accurate values for the model 
kinetic  parameters  than  the  approximations  shown  on  Figure  5.1  can  be 
calculated. Maximum growth rate can be obtained from the first derivative of 
Equation 5.1 at the point of inflection, and the lag time can be calculated as the 
intercept of the inflection line through the t axis (Zwietering et al., 1990). From 
this mathematical analysis, growth rate () and lag time () are calculated by 
Equations 5.2 and 5.3 where e is exp(1) and Xmax is the maximum viable cell 
density reached at the stationary phase of growth. 
b e
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X
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 
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max ln
   5.2 
b t   0    5.3 
To illustrate the advantage of using this mathematical model to determine cell 
growth  characteristics  a  hMSC  growth  curve  was  generated  with  cells  from 
Passage 1 in 24 well-plates. The experimental data is shown in Figure 5.2.       Chapter Five 
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Figure 5.2 Typical  cell growth  curve  generated from  hMSC seeded  at  5x10
3 
cells/cm
2  in  24  well-plates  at  Passage  1  with  daily  medium  exchanges. 
Experiments performed as described in Section 2.4. 
Calculating  growth  rates  using  Equation  2.5  requires  the  process  operator  or 
scientist to decide which point will mark the beginning of the exponential phase 
and which one will determine the end. If no growth curve had been generated, 
and only initial and final cell densities were available as it is the case with data 
obtained when passaging T-flasks i.e. much of the information currently available 
in  the  literature,  the  resulting  growth  rate  from  this  culture  would  have  been 
calculated as 0.15 day
-1 or a doubling time of 114 hr. This calculation ignores the 
length of time when the cells remained in lag phase or stationary phase. However, 
having generated the cell growth curve, it is a subjective decision to pick the 
duration of the exponential phase. Table 5.1 indicates a series of possibilities in 
the  selection  of  such  data  points  and  the  growth  rates  and  doubling  times 
regenerated from each one of such selections.       Chapter Five 
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Table 5.1. Calculation of cell growth rates and doubling times for the typical 
hMSC growth curve shown in Figure 5.2, based on different selections of initial 
and final time points of the exponential cell growth phase. The pair of points 
chosen  as  (a,  b)  indicate  the  initial  (a)  and  final  (b)  points  selected  for  each 
calculation. The numerical value for a and b indicate the order of the points on 
the cell growth curve, where 1 is the first time point of the curve at inoculation 
and 21 is the final point on the graph as the last time point collected for the 
growth curve. 
Initial and Final 
Points Chosen to 
Define 
Exponential 
Growth  
Phase (a, b) 
Initial Point 
Values (X0 
(cells/cm
2) , t0 
(hr)) 
Final Point 
Values (Xf 
(cells/cm
2) , tf 
(hr)) 
μ (day
-1)  Td (hr) 
(2, 7)  (4491, 19.8)  (29474, 143)  0.365  45.5 
(2,12)  (4491, 19.8)  (36632, 285)  0.190  87.4 
(4,11)  (10105, 70.9)  (45895, 264)  0.187  88.6 
(4,12)  (10105, 70.9)  (42315, 307)  0.145  114.3 
 
As indicated in Table 5.1, different selection of the initial and final time points 
that determine the beginning and end of the exponential growth phase in a cell 
growth curve may result in different cell growth rate and doubling time values. 
The decision on what value best represents the growth kinetics of the culture lays 
on the subjective opinion of the bioprocess engineer, and it is dependent also on 
the number of time points collected during the generation of the cell growth curve 
and on the intrinsic variability of the data. 
When  fitting  a  4-parmeter  sigmoidal  Gompertz  model  to  the  data  shown  on 
Figure 5.2, a more objective determination of growth characterisation parameters 
can  be  obtained.  Figure  5.3  shows  the  same  cell  growth  curve  fitted  to  a 
Gompertz model. The parameters generated by the mathematical fit can then be 
utilised to calculate cell growth rates and doubling times.  
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Figure 5.3. Typical cell growth curve (circles) generated from hMSC seeded at 
5x10
3 cells/cm
2 in 24 well-plates at Passage 1 with daily  medium exchanges. 
Solid line represents best fit of the four-parameter Gompertz model. The resulting 
equation generated by the fit is shown in the inset. Experiments performed as 
described in Section 2.4. Model fitted to data as described in Section 2.13. 
From the mathematical equation obtained from the fit shown in Figure 5.3, the 
four  parameters  generated  by  non-linear  regression  analysis  executed  in 
SigmaPlot 10.0 (X0, 4240, a 40556, t0 109.7, and b 71.9) were used to calculate a 
cell growth rate of 0.28 day
-1 or doubling time of 60 hours,. As can be seen by the 
fit  (solid  line)  on  Figure  5.3,  this  equation  closely  represents  the  growth 
behaviour of the culture and the quantitative data obtained from it did not require 
subjective manipulation of the data. This method has been used to calculate cell 
growth rates towards the work generated for this thesis as indicated in previous 
Chapters, except for the cases on which only initial and final cell densities were 
generated for a passage. 
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5.3  Development of a Modified Gompertz Model to Forward Predict 
hMSC Growth Kinetics 
The intrinsic hMSC growth characteristics that are only dependent on the donor 
makes  it  hard  to  forward  predict  the  duration  of  the  cell  expansion  process 
required  to  achieve  the  required  number  of  cells  for  a  given  therapeutic 
application (Phinney, 1999). In addition, there is a decrease in the speed at which 
the cells double as the passage number progresses. However the rate at which the 
cell growth rate decreases with increasing cell doublings has not previously been 
quantified. 
To  address  the  possibility  of  finding  a  pattern  in  the  cell  growth  kinetic 
parameters as the age of the culture progresses during a cell expansion process, 
isolated hMSC from one donor were cultured over 5 sequential passages. A cell 
growth curve was generated for each individual passage, and Gompertz models 
were generated for each curve without any parameter constrain on X0, a, t0, and b. 
From each passage, the Gompertz model provided a value for each of the four 
variable coefficients, X0, a, t0, and b. 
From the four coefficients obtained from each mathematical fit, an analysis of the 
variation of  each of these four parameters  obtained over subsequent  passages 
enabled  a  correlation  of  how  these  values  change  over  time.  Analysis  of  the 
variation  of  these  parameters  over  passage  resulted  in  a  modified  Gompertz 
model  that  can  be  used  to  forward  predict  hMSC  growth  over  sequential 
passages. 
Cell  growth  curves  generated  from  this  patient's  isolated  hMSC  with  the 
Gompertz model for Passages 1, 3, and 5 are shown in Figures 5.4 through 5.6 to 
illustrate some of the data collected throughout the cell expansion process. Data 
from  Passage  4  was  collected  but  is  not  shown  for  purposes  of  clarity.  The 
parameters generated from the Gompertz model each passage from 0 to 5 are 
listed in Table 5.2.       Chapter Five 
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Figure 5.4 Cell growth curve (circles) for hMSC at Passage 1, seeded in 24 well-
plates  at  an  inoculation  cell  density  of  5x10
3  cells/cm
2  with  daily  medium 
exchanges. Solid line represents best fit of the four-parameter Gompertz model. 
Experiments  performed  as  described  in  Section  2.4.  Model  fitted  to  data  as 
described in Section 2.13. 
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Figure 5.5 Cell growth curve (circles) for the same hMSC source as shown in 
Figure 5.4 at Passage 3, seeded in 24 well-plates at inoculation cell density of 
5x10
3 cells/cm
2 with daily medium exchanges. Solid line represents best fit of the 
four-parameter Gompertz model. Experiments performed as described in Section 
2.4. Model fitted to data as described in Section 2.13       Chapter Five 
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Figure 5.6 Cell growth curve for the same hMSC source than the ones shown in 
Figure 5.4 at passage five, seeded in 24 well-plates at inoculation cell density of 
5x10
3 cells/cm
2 with daily medium exchanges. Solid line represents best fit of the 
four-parameter Gompertz model. Experiments performed as described in Section 
2.4. Model fitted to data as described in Section 2.13 
As shown in Section 3.6, the cell growth decreases with every passage along with 
the number of cells reaching stationary phase. For this particular donor it is also 
noticeable  that  an  increase  in  the  variability  of  the  data  occurs  between 
consecutive time points as the passage number increases and towards the final 
points of each growth curve. This may be due to seeding volume variations due to 
manual manipulations, and that being the case, this seeding density differences 
will  be  more  noticeable  as  the  culture  progresses.  Such  variability  would  be 
greatly reduced by the use of automation, where a liquid handling system ensures 
accurate volumes of cell suspension dispensed into each individual well (Nealon 
et al., 2005).       Chapter Five 
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Table 5.2. Calculated values of the kinetic parameters a, b, t0, and X0, from the  
Gompertz model(Equation 5.1) fitted to hMSC growth curves from a common 
donor  expanded  sequentially  from  Passage  zero  (P0)  to  Passage  5  (P5). 
Experimental data and model fits shown in Figures 5.4 to 5.6. 
  P0  P1  P3  P4  P5 
a  42510  40556  36180  29073  20893 
b  37.8  71.9  77.7  64.5  48 
t0  77.3  109.7  137.8  123.6  120 
X0  3845.8  4240.8  4074.8  4156  5043 
 
Because passage number has been taken as a time parameter, or an indicator of 
the age of the culture, it was important first of all to understand if an increase in 
passage number could be correlated to intrinsic changes in the culture such as 
cumulative population doublings since these more accurately indicate culture age. 
From the values obtained for the Gompertz model for final cell density for a and 
X0, as shown in Table 5.2, cumulative population doublings were calculated at the 
end of each passage following Equation 2.8. A good linear correlation between 
passage number and cumulative population  doublings  was  found as  shown in 
Figure 5.7.  Another linear relationship could be found when comparing passage 
number with the maximum cell density attained on each passage, as shown in 
Figure 5.8.       Chapter Five 
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Figure 5.7 Relationship between passage number and experimentally determined 
cumulative  population  doubling  (circles)for  hMSC  expanded  through  six 
passages. As the passage number increases the cumulative population doublings 
increase in a linear relation (solid line) expressed by the equation on the figure 
inset. Solid line fitted by linear regression. 
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Figure  5.8  Relationship  between  Population  Doublings  and  Maximum  Cell 
Density.  for hMSC expanded through six passages.  As cumulative population 
doubling increases the maximum cell density at the stationary phase decreases in 
a linear relation expressed by the equation on the Figure.       Chapter Five 
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Based  on  the  two  correlations  shown  in  Figures  5.7  and  5.8,  maximum  cell 
density can then be correlated to cumulative population doublings at any point in 
the  culture,  which  in  turn  can  be  correlated  to  passage  number.  From  these 
correlations and from looking at Table 5.2, some observations can be made about 
the variation of the Gompertz model kinetic parameters over each passage or as 
the population doublings increase. First of all, parameter a, which represents the 
increase in cell density follows a trend that can be expressed as: 
a = - 2014 (1.84xPn + 4.01) + 51891  5.4 
Also, model kinetic parameters b and t0 have similar values from P1 to P5, but 
vary  significantly  for  P0.  For  this  particular  donor,  the  values  obtained  for  b 
averaged to 65.5 with a standard deviation of 12.8 from P1 to P5, with a value of 
37.8 for P0. As for the value for the coefficient t0, the same trend is observed with 
an average of 122 with a standard deviation of 11.6 from passages P1 to P5 but a 
lower value of 77.3 for P0. 
The values for initial cell density X0 did not vary greatly between passages and no 
clear trend was observed. This value tends to be lower than the targeted ICD for 
all cell growth curves generated. It may be due to a percentage of cells failing to 
attach  to  the  culture  vessel  upon  inoculation,  and  being  removed  during  the 
removal  of  the  spent  medium  while  harvesting  the  vessel  for  cell  number 
determination (Section 2.6). 
Based on these observations, a modified mathematical model for the variation of 
the  Gompertz  model  kinetic  parameters  over  time  was  developed.  The 
relationship  found  for  a  cannot  be  applied  to  other  donors  because  the 
coefficients for Equation 5.4 were dependent on knowing the parameters for the 
mathematical equations of all sequential passages for that specific donor only. 
However, approximations that would reflect the same behaviour of these kinetic 
model parameters over time based on the known coefficients for P0 only were 
selected. The selection of the equations that would describe the modification of 
these parameters over sequential passages for any given donor are based on the 
analysis of the coefficients obtained for sequential passages from the empirical 
data  shown  in  this  section.  The  mathematical  expressions  chosen  as  to       Chapter Five 
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approximate  future  behaviour  of  the  four  Gompertz  model  kinetic  parameters 
from  known  values  at  P0  generated  a  modified  Gompertz  model  that  closely 
represents the unmodified Gompertz equation as shown in Figures 5.9 to 5.11. 
Approximations for the variation of the four kinetic parameters for the Gompertz 
model only for passages above zero as a function of known parameters generated 
for this passage, were then established as: 
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Where  aPo  represents  the  Gompertz  coefficient  from  passage  zero,  Pn  is  the 
passage number, t0Po is the Gompertz coefficient t0 at passage zero, bPo is the 
Gompertz coefficient b at passage zero, and X0Po is the inoculation cell density 
(ICD). Equation 5.5 was chosen as a close approximation for Equation 5.4, based 
only on terms of known values from passage zero with passage number as the 
only variable in the equation. Equation 5.6 and 5.7 were chosen knowing that 
these two parameters contribute to express the duration of the lag phase. Since b 
was the coefficient with less increase over the value recorded at passage zero, it 
was  taken  as  constant  for  subsequent  passages.  The  off-set  that  this 
approximation  may  cause  for  the  duration  of  the  lag  phase  was  taking  into 
consideration by increasing t0 progressively as a function of the passage number. 
Equation 5.8 was chosen so as to account for a notional 15% loss of cells after 
inoculation  for  all  passages  from  the  initial  inoculation  cell  density.  It  is 
important  to  highlight  that  due to  the strong dependency of the model to  the 
parameters obtained from data collected during passage zero, a full characterised 
growth  curve  must  be  determined  for  this  passage  in  order  to  obtain 
representative  parameters.  The  parameters  returned  from  a  Gompertz  fit  for       Chapter Five 
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passage zero must be obtained from a set of data that includes numerous time 
point cell density determination collected for close time intervals. 
 
Table 5.3. Modified values of the kinetic parameters a, b, t0, and X0, from the  
Gompertz model(Equation 5.1) to forward predict hMSC growth curves from a 
common donor expanded sequentially from  Passage zero (P0) inoculated with 
5x10
3 cells/cm
2 to Passage 5 (P5). Parameters calculated from equations 5.5 to 5.8 
from coefficients for Passage zero (P0) shown in Table 5.2. Experimental data 
and model fits shown in Figures 5.4 to 5.6. 
  P0  P1  P3  P4  P5 
a  42510  38259  36180  29073  20893 
b  37.8  37.8  37.8  37.8  37.8 
t0  77.3  87.3  107.3  117.3  127.3 
X0  3845.8  4250  4250  4250  4250 
 
This modified Gompertz model was first tested against the data that was used to 
generate the model, as shown in Figures 5.4 to 5.6. These approximations chosen 
for the four coefficients of the Gompertz equation (Table 5.3) resulted in new 
model predictions (shown as discontinued lines in Figures 5.9 to 5.11), closely 
representing the data as well as the Gompertz models generated from empirical 
data  shown  as  a  continuous  line.  It  appears  that  it  is  possible  to  accurately 
correlate  how  model  kinetic  parameters  will  vary  over  subsequent  stages  of 
expansion. 
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Figure 5.9 Cell growth curve (circles) for hMSC at Passage 1, seeded in 24 well-
plates at an ICD of 5x10
3 cells/cm
2 with daily medium exchanges. The data is 
fitted with  a Gompertz model (solid  line), as well as  the modified Gompertz 
equation (dashed line) with parameters calculated through Equations 5.5-5.8. 
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Figure 5.10 Cell growth curve for hMSC at passage three from the same cell 
source as the cells used at passage one for Figure 5.9. The data is fitted with a 
Gompertz model (solid line), as well as the modified Gompertz equation (dashed 
line) with parameters calculated through Equations 5.5-5.8.       Chapter Five 
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Figure 5.11 Cell growth curve for hMSC at passage five from the same cell 
source as the cells used at passage one for Figure 5.9. The data is fitted with a 
Gompertz model (solid line), as well as the modified Gompertz equation (dashed 
line) with parameters calculated through Equations 5.5-5.8. 
5.4  Patient Specific Forward Prediction of hMSC Expansion Process 
Kinetics  
A  mathematical  expression  based  on  a  Gompertz  model  was  developed  to 
describe hMSC growth behaviour for sequential passages in Section 5.4. This 
mathematical expression used correlations for each one of the four coefficients of 
the  Gompertz  equation  as  a  function  of  the  increase  in  passage  number 
throughput the cell expansion process for hMSC. The model was compared over 
the data used to generate this approximated mathematical expression and it was 
proven to generate cell growth curves that closely matched the empirical data.  
For this  modified model to  be proven successful  it was  necessary to  forward 
predict cell growth behaviour of hMSC over sequential passages under a given 
set  off  environmental  condition  of  processing  parameters.  Two  further  bone 
marrow samples (section 2.1) from different donors were used for this further 
experimentation. The goal is to isolate hMSC from a donor and generate a cell       Chapter Five 
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growth curve during P0. From this cell growth curve, the four Gompertz model 
kinetic  parameters  can  be  obtained.  Based  on  this  information,  the  modified 
equation developed in Section 5.3 should be able to forward predict the shape of 
the cell growth curves that could be generated during sequential passages from 
that  same  cell  source.  This  information  will  allow  for  process  bioprocess 
engineers to determine the duration of the cell expansion process, as well as the 
number  or  passages  required  to  reach  the  target  cell  number.  After  this  is 
calculated,  future  arrangements  for  the  delivery  of  the  final  product  can  be 
scheduled  along  with  the  hospitalisation  of  the  patient  that  awaits  the 
implantation  of  these  cells  or  for  the  tissue  engineered  organ  generated  from 
them. The flow diagram in Figure 5.12 demonstrates this procedure in detail. 
 
Figure 5.12. Flow diagram for the cell expansion process of autologous hMSC 
isolated from bone marrow for regenerative medicine therapy. The main trends 
observed during sequential passaging of the culture are highlighted on the right 
hand side of the figure, along with the application of the model developed in 
Section 5.3 for this process.       Chapter Five 
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The process diagram indicated in Figure 5.12 was followed with two different 
donors labelled as Donor C and Donor A (Data from donor A also shown in 
Section  3.6,  figures  3.6  to  3.10).  From  each  donor,  cell  growth  curves  were 
generated at P0 and Gompertz models were applied to the data to generate the 
first four coefficients that determine the kinetics of growth for that passage the 
same  way  than  detailed  in  Section  5.3.  Once  these  first  coefficients  were 
obtained, the mathematical approximations stated in Equations 5.5 through 5.8 
were used to  generate  Gompertz  models  for subsequent  passages.  The results 
from this exercise for the two donors are shown in Figures 5.13 and 5.15. To 
validate the results, cell growth curves were generated for sequential passages 
and the empirical data was added to the forward predicted cell growth curves. 
Those results are shown in Figures 5.14 and 5.16.       Chapter Five 
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Figure  5.13.  Forward  prediction  of  hMSC  growth  kinetics  during  the  cell 
expansion process in 24 well-plates for Patient C. Cell growth curves for P0, P1, 
P3,  and  P5  have  been  predicted  based  on  the  modified  Gompertz  model  as 
indicated  in  Section  5.3.  The  cell  growth  curve  generated  for  P0  shows  the 
empirical data (circles) collected during the first passage of hMSC after isolation. 
This data is first fitted (solid line) with the Gompertz model (Equation 5.1) to 
determine  patient  specific  hMSC  growth  kinetic  parameters.  The  model 
coefficients obtained from this fit were then used to forward predict the growth 
curves for subsequent passages (dashed lines) following Equations 5.1 and 5.5 
through 5.8. 
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Figure 5.14 Agreement of forward predicted (dashed lines) cell growth kinetics 
with  subsequently  obtained  experimental  data  (circles)  for  the  prediction  of 
hMSC growth kinetics during the cell expansion process in 24 well-plates for 
Patient C compared to empirical data obtained for subsequent passages of growth. 
The developed modified mathematical model is shown by discontinued lines. A 
Gompertz  equation  fitted  through  the  data  obtained  during  P0  is  shown  by  a 
continuous line. 
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Figure  5.15  Forward  prediction  of  hMSC  growth  kinetics  during  the  cell 
expansion process in 24 well-plates for Patient A. Cell growth curves for P0, 
P1,P3 and P4 have been predicted based on the modified Gompertz model as 
indicated  in  Section  5.3.  The  cell  growth  curve  generated  for  P0  shows  the 
empirical data (circles) collected during the first passage of hMSC after isolation. 
This data is first fitted (solid line) with the Gompertz model (Equation 5.1) to 
determine  patient  specific  hMSC  growth  kinetic  parameters.  The  model 
coefficients obtained from this fit were then used to forward predict the growth 
curves for subsequent passages (dashed lines) following Equations 5.1 and 5.5 
through 5.8. 
P0
Time (hours)
0 100 200 300 400 500
Xv
 (cell/c
m
2
)
0
10000
20000
30000
40000
50000
60000
P1
Time (hours)
0 100 200 300 400 500
Xv
 (cell/c
m
2
)
0
10000
20000
30000
40000
50000
60000
P3
Time (hours)
0 100 200 300
Xv
 (cell/c
m
2
)
0
10000
20000
30000
40000
50000
60000
P4
Time (hours)
0 50 100 150 200 250 300
Xv
 (cell/c
m
2
)
0
10000
20000
30000
40000
50000
60000      Chapter Five 
170 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.16 Agreement of forward predicted (dashed lines) cell growth kinetics 
with  subsequently  obtained  experimental  data  (circles)  for  the  prediction  of 
hMSC growth kinetics during the cell expansion process in 24 well-plates for 
Patient  A  compared  to  empirical  data  obtained  for  subsequent  passages  of 
growth. The developed modified mathematical model is shown by discontinued 
lines. A Gompertz equation fitted through the data obtained during P0 is shown 
by a continuous line.  
The  validity  of  the  modified  Gompertz  model  (Equation  5.1  together  with 
Equations 5.5 to 5.8) has thus been proven by the results shown in Figures 5.13 
through 5.16, as an effective tool to forward predict the cell growth behaviour of 
hMSC  during  sequential  passages.  Accurate  determination  of  the  overall  cell 
expansion process time, as well as the cell density obtained at the end of each 
passage can be predicted using this model after the patient specific hMSC kinetic 
parameters are determined in Passage 0. 
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Furthermore, processing decisions can be made early on based on the graphical 
representation of this model. So for example, if the growth rates obtained are 
slower than required for the prompt delivery of the cell therapy back to the clinic 
for a specific patient, process parameters can be altered so  as to increase the 
growth  rate  of  the  culture  taking  advantage  of  the  process  optimisation 
parameters already known to affect growth such as increasing the frequency of 
medium exchanges (Section 4.3). Such changes can be easily programmed in an 
automated  platform,  where  the  frequency  of  medium  exchanges  can  occur  as 
often as required with no need for further staffing requirements. 
5.5  Characterisation of hMSC During the Automated Cell Expansion 
Process 
Phenotypic characterisation of hMSC can be determined by levels of expression 
of surface markers as well as by their functionality. However, despite expanding 
knowledge on the biology of these cells, there has not yet been found one single 
receptor expressed solely on undifferentiated hMSC that can be used as a marker 
for characterisation (Fickert et al., 2004). Several surface markers are expressed 
on hMSC but also on fibroblast and other differentiated progenitors which can be 
found  in  bone  marrow.  It  is  necessary  then  to  select  more  than  one  surface 
marker, to ensure homogeneity of the culture as hMSC. The latest results reported 
on the expression levels of different surface markers indicate that expression of 
CD90, CD105 (SH2), and CD166 are positive indicators of the identity of the 
cells as hMSC. The selection of these surface markers to characterise hMSC has 
been selected based on the data reported by Fickert et al., in 2004, showing that a 
population  derived  from  initially  sorted  CD90+  and  CD166+  cells  showed 
multipotency for chondrogenic, adipogenic, and osteogenic differentiation after 
cultivation. Surface marker CD105 is  widely used in  most publications  as  an 
established marker for hMSC (Honczarenkoa et al., 2006). 
CD90 (Thy-1) is expressed in hematopoietic and mesenchymal cells (Lodie et al., 
2002,  Pittenger  et  al.,  1999).  CD105  (SH2)  is  expressed  in  endothelial  cells, 
activated  monocytes  and  stromal  cells,  but  it  will  not  be  expressed  in 
hematopoietic cells (Haynesworth et al., 1992, Barry et al., 1999). CD166 is a       Chapter Five 
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Type 1 glycoprotein expressed on activated T cells, B cells and monocytes and 
appears to be the ligand for CD6. Human CD166 is used as a marker for hMSC 
as well, and it is thought to play a role for activation of T cells. Expression has 
been shown to be lost over passage but regained at low confluency levels (Yeh et 
al., 2005).  
The level of expression of CD90, CD105, and CD166 on hMSC at passages zero 
and five for cells recovered before the end of the exponential growth phase are 
shown in Figures 5.17 and 5.18. Flow cytometry analysis with Guava Easycyte 
was performed for recovered cell pellets of no less than 5x10
5 cells/cm
2 incubated 
with 10 l of FITC-conjugated antibodies as indicated in Section 2.10. A mouse 
IgG1  FITC  conjugated  antibody  was  used  as  isotype  control,  to  detect 
background staining. 
The  population  of  isolated  cells  at  passage  zero  expresses  all  three  markers 
characteristic  of  hMSC.  However,  expression  of  CD166  was  almost  lost  by 
passage five, and a decrease of expression of CD105 started to appear at that 
passage as well, as shown in Figure 5.18. The decrease of expression of CD166 at 
passage five is the main reason why cell growth curves above five passages have 
not been modelled in Section 5.4 using the predictive mathematical model shown 
in  Sections  5.3.  Functionality assays to  determine the differential  potential  of 
hMSC at this passage would have added information about the quality of the 
population, and it could have been the case that the decrease in expression of 
CD166 does not necessarily translates into the loss of differential potential for the 
cells,  especially  since  the  expression  of  this  marker  has  been  proven  to  be 
regained at low cell densities (Yeh et al., 2005). Having no other data to support 
such hypothesis for this particular culture of hMSC, the observed decrease of 
expression of CD166 was interpreted as an indication of undesirable changes in 
the cell population.       Chapter Five 
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Isotype       CD90       CD105       CD166 
Figure  5.17  Surface  marker  expression  of  freshly  isolated  hMSC  from  bone 
marrow after the first passage in culture (P0). FITC conjugated antibodies against 
CD90, CD105, and CD166 were used for flow cytometry analysis by Guava as 
indicated in Section 2.10.  
 
Isotype       CD90       CD105       CD166 
Figure  5.18  Surface  marker  expression  of  freshly  isolated  hMSC  from  bone 
marrow at passage five (P5). FITC conjugated antibodies against CD90, CD105, 
and  CD166  were  used  for  flow  cytometry  analysis  by  Guava  as  indicated  in 
Section 2.10. 
5.6  Summary  
Characterisation  parameters  of  cell  growth  were  obtained  through  a  four-
parameter sigmoidal Gompertz model, which proved to provide accurate values 
to evaluate lag phase, exponential growth rates, and maximum cell density at the 
stationary phase. The use of this mathematical model to fit empirical data has 
proven to eliminate variability of results due to subjective evaluation of a cell 
growth curve (Table 5.1), when the number of data points collected is limited to 
daily measurements over the course of a cell passage. A modified version of the 
Gompertz  model  was  found  to  represent  hMSC  growth  curves  accurately 
(Equations 5.5 to 5.8), and it was used to determine and predict growth rate,       Chapter Five 
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doubling time, maximum cell density, duration of lag phase and time to reach the 
stationary phase.  
Isolated  hMSC  from  bone  marrow  were  cultured  sequentially  for  up  to  five 
passages, and cell growth curves were generated for each passage (Figures 5.9 to 
5.11). Gompertz fits  were  generated for each passage, and  an analysis of the 
coefficients  generated  from  the  fits  analyzed.  From  this  analysis,  a  modified 
Gompertz model was developed to forward predict the variation of the Gompertz 
kinetic model parameters as the population doublings, or passage number of the 
culture increased. The validity of the modified equation was tested with hMSC 
isolated from two other patients, for which the growth curves for passages one to 
five were successfully predicted while comparing to the empirical data (Figures 
5.13 to .5.16). 
The cultures were characterised with surface marker expression of CD90, CD105, 
and CD166 to determine their undifferentiated state. Results showed that the cells 
remained undifferentiated until passage five, but that expression of multipotency 
by expression levels of CD166 was being lost at the end of passage five.  
This modelling approach will allow the process engineer to forward predict the 
cell growth pattern of patient specific cells, as well as to ensure the quality of the 
final product generated. Processing time, operation schedule, and logistics of the 
cell expansion process for undifferentiated hMSC will be much improved by the 
use  of  this  modified  mathematical  expression,  taking  the  use  of  hMSC  as  a 
therapy for regenerative medicine applications one step closer to reality. 
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6  CONCLUSIONS AND FUTURE WORK 
6.1  Conclusions 
The development of an automated cell expansion process for the production of 
vast number of hMSC in an undifferentiated state has been explored in this thesis. 
Several  parameters  affecting  isolation  and  cell  growth  kinetics  have  been 
identified and evaluated, and optimum values for controlled variables during the 
bioprocess  of  hMSC  have  been  determined.  The  knowledge  acquired  through 
these  studies  about  the  chemical  and  physical  cues  that  occur  during  the 
cultivation of hMSC and their affect on cell growth and differentiation, has led to 
a  quantitative  analysis  of  the  growth  kinetic  variations  observed  throughout 
sequential passages. This quantitative analysis resulted in the development of a 
mathematical  expression  that  forward  predicts  growth  kinetics  for  up  to  five 
passages for a patient-dependent cell population. 
Several isolation techniques have been studied in recent years, with the intention 
to  develop  a highly selective technique for the isolation of hMSC from  bone 
marrow  aspirates.  Some  of  these  isolation  techniques  have  given  rise  to 
subpopulation of progenitor cells with characteristics that differ from the ones 
exhibited by hMSC, such as MIAMI (D‟Ippolito et al., 2004) or MAPC (Jiang et 
al., 2002). Interestingly, such results have been difficult to reproduce by other 
groups.  It  is  not  therefore  unrealistic  to  believe  that  some  other  parameter 
changes during these novel isolations other than the ones reported, are in part 
responsible  for  the  growth  kinetics  and  differentiation  potential  of  the  cell 
populations obtained. The effect of extensive centrifugation, magnetic sorting, 
and the prolonged exposure of cells  to  environmental conditions  during these 
isolations  have  not  been  taken  into  consideration  while  performing  such 
isolations.  Consequently  for  most  of  these  studies,  only  limited  cell 
characterisation of the isolated cells tends to be reported, and no information on 
cell  growth  characteristics  or  proliferative  potential  is  available  (Hung  et  al., 
2002; Lagar'kova et al., 2005). The effect of eliminating any environmental stress 
imposed to hMSC during isolation from bone marrow aspirates by performing 
Direct isolations was identified and studied in Section 3.2.1. For this purpose,       Chapter Six 
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Ficoll density gradient centrifugation and Direct isolation, were compared. Both 
techniques  were  successful  for  hMSC  recovery.  A  comparison  of  the 
performance of the cells recovered from these two methods concluded that Direct 
isolation exhibited higher recovery yields than density gradient centrifugations, 
with a 34% increase in cell recovery from bone marrow aspirates. Direct isolation 
is  also  a faster method  with  less centrifugation steps involved, which present 
itself as an advantage from an operations and automation point of view. 
The most common method for subcultivation of hMSC was first developed by 
Friendstein et al., in 1976 and it is still being used for routine cell expansion 
protocols.  Characterisation  of  the  growth  kinetics  for  hMSC  expanded  under 
these culture conditions has been performed in this work, being taken as baseline 
or  control  process  for  all  studies.  With  all  the  process  conditions  remaining 
constant, the effect of culture surfaces for the attachment and proliferation of 
hMSC in vitro were studied with the intention to evaluate any variability added to 
future results if these were to be performed in vessels of different geometries. 
Under constant operating parameters of temperature, aeration, humidity, culture 
medium, and incubation time, growth characteristics were shown to be similar for 
static cultures regardless of the geometry of the culture vessel (T-flask versus. 
well-plates) and the dimensions (24, 12, and 6 well-plates) as shown in Figures 
3.1 and 3.2.  
Microcarrier cultures were also tested as an attractive alternative to increase the 
cell growth yield with reduced medium requirements and aseptic manipulations. 
From the three types of microcarriers tested, MicroHex, Cytodex 1, and Cytodex 
3, only one of them, Cytodex 3 supported cell attachment and proliferation under 
an optimised set of process conditions (Section 3.5). However, results for the 
conditions tested did not show any improvement of hMSC growth over static 
cultures and so microcarrier cultures were not investigated further. Although the 
use of Cytodex microcarries has been proven successful for the propagation of 
other animal-derived stem cells, there has been no reported success in their use in 
hMSC (Schop et al., 2008).       Chapter Six 
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The scarce number of hMSC obtained from bone marrow aspirates (Reyes et al., 
2001; Silva et al., 2003), makes of cell quantities for experimentation a limiting 
factor. The effect of cryo-preservation was studied on hMSC that had undergone 
processing  steps  to  create  a  cell  bank  versus  cells  that  had  been  sequentially 
passaged  after  isolation  from  a  bone  marrow  aspirate.  Cell  banking  is  an 
important  process  that  allows  storage  of  a  cell  source  for  subsequent 
experimentation or future us such as transport of cells to a cGMP manufacturing 
facility, or to retain the cells during a halt in the cell expansion process. The 
effect  of  such  procedure  on  cell  growth  was  demonstrated  to  exhibit  some 
detrimental effect on cell growth rate and maximum cell density reached at the 
end  of  the  first  passage  (Section  3.2.2).  This  effect  may  not  be  cumulative, 
however it has a negative impact on cells seeded right after thawing from storage 
in liquid nitrogen. 
Subcultivation of hMSC was evaluated, confirming a decrease in growth rates 
and maximum viable cell densities as the passage number increases (Table 3.2) in 
agreement  with  results  reported  by  Bruder  et  al.,  1997.  A  novel  quantitative 
analysis  for  the  expansion  of  hMSC  was  performed  by  using  a  mathematical 
Gompertz model (Equation 3.1) that accurately represents the growth kinetics of 
hMSC. Results were confirmed by experimenting with two different sources of 
cells from two donors, showing excellent agreement between the empirical data 
and the mathematical model. The implications of the decrease in growth rate and 
cell  recovery  as  the  cell  expansion  progresses,  was  assessed  for  the  overall 
completion of the process (Table 3.3). 
Having  established  hMSC  growth  characteristics  under  baseline  culture 
conditions and a method to quantify cell growth kinetics, comparison of results 
from cultures exposed to different conditions of growth will be possible. Given 
the vast number of process parameters involved in the expansion of hMSC, and 
the  uncertainty  of  their  combinatory  effects  on  cell  growth  characteristics,  a 
design-of-experiments  (DOE)  approach  was  not  chosen  to  evaluate  optimum 
values  for  control  parameters  of  an  automated  process.  Instead,  the  effect  of 
individual parameters on cell growth kinetics was investigated while keeping all 
other process conditions as defined by the baseline culture protocol.        Chapter Six 
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Optimum  conditions  for  the  cell  expansion  process  of  hMSC  in  automated 
microwells  were  characterised.  As  a  result,  the  optimised  values  obtained  for 
inoculation cell density, medium exchange strategies, and environmental control 
proved  that  the  overall  time  for  the  cell  expansion  process  was  reduced 
considerably in comparison with the values dictated by the baseline condition for 
the same set of parameters. Reduction in doubling times of hMSC was found to 
be mainly attributed to an increase in the frequency of medium exchanges (Figure 
4.5), and not to a decrease in inoculation cell density as it had been previously 
reported by Sekiya et al., 2002. The Gompertz model was found to represent 
hMSC  growth  curves  accurately,  and  it  was  used  to  quantitatively  determine 
growth rate, doubling time, maximum cell density, duration of lag phase and time 
to  reach  the  stationary  phase.  This  information  was  used  to  determine  the 
duration  of  a  cell  expansion  process  that  requires  1x10
8  of  undifferentiated 
multipotent  hMSC  from  an  autologous  source  for  their  usage  in  regenerative 
medicine  applications.  Results  on  Table  4.2  showed  that  low  ICD  of  100 
cells/cm
2 as well as frequent media addition rates of 6 hours resulted in shorter 
doubling times when compared to the baseline condition of growth, reducing the 
overall duration of the cell expansion process from 59 to 30 days. 
Having shown that faster media addition rates of 6 hours resulted in a decrease in 
the overall cell expansion time, the contributing parameters to this result were 
evaluated. As well as the rapid addition of nutrients and removal of accumulated 
by-products,  the  cell  monolayer  is  exposed  to  environmental  variations  every 
time  a  medium  exchange  is  performed.  With  the  added  advantage  of  an 
automated  platform  with  temperature  and  gas  control  for  the  cell  expansion 
process, the effect of these parameters on hMSC growth kinetics were evaluated. 
Environmental variations of pH and temperature during medium exchanges were 
recorded with the aid of temperature and pH sensors (Section 4.4). The effect of 
these variations in growth kinetics of hMSC was studied, indicating that repeated 
exposures to pH step changes from 7.5 to 8.2 were not detrimental to cell growth 
but they did not contribute to an increase in cell growth rates in the absence of 
medium exchanges at a similar frequency.       Chapter Six 
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As  a  result  of  these  studies,  an  automated  platform  was  used  for  the  cell 
expansion process of hMSC under optimised feeding strategies of 4 and 12 hours 
addition rates. The automated platform successfully performed medium exchange 
operations eliminating the use of open manipulations throughout the duration of 
one passage. The robotic platform will be further modified to accomplish all the 
operations involved in sequential subcultivation of autologous hMSC on the basis 
of these promising results. 
The advantage of using the Gompertz model to accurately determine cell growth 
kinetic  parameters  was  demonstrated.  Comparison  of  growth  rate  calculations 
performed  with  or  without  this  mathematical  expression  highlighted  the 
advantage of using the Gompertz model. The use of this mathematical model to 
fit empirical data has proven to eliminate variability of results due to subjective 
evaluation of a cell growth curve (Table 5.1), when the number of data points 
collected is limited to daily measurements over the course of a cell passage.  
Cell  growth  kinetic  model  parameters  for  growth  curves  generated  over  five 
sequential  passages  were  obtained  to  study  the  growth  kinetic  changes  over 
subcultures of hMSC (Figures 5.9 to 5.11). Gompertz fits were generated for each 
passage,  and  an  analysis  of  the  coefficients  generated  from  the  fits  was 
performed.  From  this  study,  a  modified  Gompertz  model  was  developed  to 
forward predict the variation of the Gompertz kinetic model parameters as the 
population doublings, or passage number of the culture increased (Equations 5.5 
to 5.8). The validity of this modified Gompertz model was tested with hMSC 
isolated from two other patients, for which the growth curves for passages one to 
five were successfully predicted when compared to the empirical data (Figures 
5.13 to .5.16). Prediction of the cell growth characteristics of hMSC have not 
been  reported  previously  in  the  literature.  The  variability  of  growth  rates 
depending on the donor or the population doubling of the culture has made such a 
quantitative  approach  a  challenge  when  designing  a  robust  cell  expansion 
process. The use of the model reported here, will allow prediction not just of the 
duration of a cell expansion process, but will also facilitate the cost analysis of 
such a process prior to completion. The requirements of raw materials such as       Chapter Six 
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media,  culture  vessels,  and  staffing  requirements  will  be  known  for  each 
individual patient-targeted process. 
The  characterisation  of  hMSC  remains  a  topic  in  the  developmental  stage. 
Several surface markers have been shown to be expressed on the cytoplasmic 
membranes  of  the  anchorage-dependent  subpopulation  of  cells  obtained  from 
bone marrow aspirates. However, many of the markers being expressed on hMSC 
are also expressed in other cell lines and/or they have been shown to decrease in 
expression levels over the cell expansion process. The cultures were characterised 
with surface marker expression of CD90, CD105, and CD166 to determine their 
undifferentiated state. These surface markers are characteristic of hMSC and are 
indicative  of  their  multipotency.  Results  showed  that  the  cells  remained 
undifferentiated  until  passage  five,  but  that  expression  of  multipotency  by 
expression levels of CD166 was lost at the end of passage five. This result alone 
is not indicative of a differentiating cell population, since the levels of expression 
of CD166 decrease with increasing cell density in culture (Yeh et al., 2005). 
In conclusion, quantitative results on the hMSC growth kinetics of sequential 
passages have been presented. The effect of different control parameters on cell 
growth  characteristics  have  contributed  to  the  design  of  an  automated  cell 
expansion process for the robust expansion of autologous hMSC. A mathematical 
expression  has  been  developed  to  forward  predict  the  duration  and  growth 
characteristics of hMSC in culture over serial subcultivation. Finally, this model 
has been shown to accurately predict such parameters of growth for cell cultures 
originated from different donors. 
6.2  Future Work 
The results shown in this thesis provide solid bases for the development of a 
robust  automated  cell  expansion  process  for  autologous  hMSC  in  an 
undifferentiated  state.  Many  parameters  such  as  ICD,  vessel  surface 
characteristics, feeding strategies, pH, and temperature have been optimised for 
the implementation of such a robotic platform as a tool for cell expansion. Further 
studies will be able to contribute to a greater understanding of the chemical and       Chapter Six 
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physical  parameters  controlling  cell  fate  during  the  cell  expansion  process  of 
hMSC in an automated process. In particular: 
  A first priority should be the further biological characterisation of hMSC at 
different stages of growth in an automated platform. As studies of the biology 
of hMSC improve, specific markers for the characterisation of these cells will 
become available. Also functionality studies of the differentiation potential 
and  performance  in  vivo  should  be  carried  out.  These  will  determine  the 
potential of hMSC, expanded using the procedures developed in this work, 
for use in regenerative medicine applications.  
  Growth  studies  of  hMSC  on  microcarrier  cultures  deserves  further 
investigation given the promising results showing attachment to Cytodex 3 
spheres. Optimisation of culture parameters and feeding strategies evaluated 
in  this  thesis  may  be  applied  to  microcarrier  cultures  and  lead  to  the 
development of an automated process in well-plates or stir-tank bioreactors. 
  Feeding strategies that maximise cell growth rate have been shown, proving 
that  faster  addition  rates  were  the  main  contributor  towards  developing  a 
faster expansion process. However, the factor or factors in the culture media 
composition  contributing  to  growth  rate  limitations  other  than  glucose, 
glutamine, lactate, and glutamate have not been investigated. As analytical 
tools for biological analysis develop, further studies on the characterisation of 
media components (as well as the ones provided for the chemically undefined 
serum) and their contribution to cell fate will be of great interest. 
  A  mathematical  model  to  forward  predict  hMSC  characteristics  has  been 
developed. Future work with this modelling tool should investigate possible 
correlations of the expressions obtained for the coefficients a, b, X0, and t0 of 
the modified Gompertz  model (Equations 5.1 and 5.5 to 5.8)  not just as a 
function of passage number but also as a function of process parameters such 
as frequency of medium exchanges, pH levels, or any other factor that can be 
controlled and can influence growth.  
  Further adjustment of environmental conditions  within the Tecan platform 
used  for  these  studies  will  allow  for  a  high  throughput  of  experimental 
conditions  and  ensure  the  development  and  operation  of  a  robust  cell       Chapter Six 
183 
expansion  process  for  hMSC  cultures.  Studies  carried  over  sequential 
passages  with  hMSC will demonstrate the feasibility of a fully  automated 
process  that  will  add  robustness  and  will  eliminate  any  requirement  for 
manual interventions. 
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APPENDIX I 
Relationship between inoculation cell density (ICD in cells/cm
2) and doubling 
time (Td) for hMSC from Donor X and Donor Y. Data collected for passage 2 for 
Donors X and Y and for passage 9 for Donor X. 
 
Passage 2 - Donor X 
Passage 2 -  Donor 
Y  Passage 9 - Donor X 
ICD  Td (hr)  ICD  Td (hr)  ICD  Td (hr) 
6864  84  10000  318  5000  446 
3520  77  5000  142  1000  112 
704  43  1000  74  100  89 
70  33  100  44       
35  30  50  36       
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APPENDIX II 
Metabolic concentrations of Glutamine, Glutamate, Glucose, and Lactate (g/L) in 
the spent medium collected during frequent medium exchanges during the cell 
expansion process of hMSC inoculated at 4x10
3 cells/cm
2 for the data represented 
in Figure 4.2. 
 
Date Time  Glutamine  Glutamate  Glucose  Lactate 
Feb 9, 2006 3:30PM  2.47  0.00  1.00  0.00 
Feb 9, 2006 6:00PM  2.52  0.01  1.06  0.00 
Feb 9, 2006 11:10PM  2.41  0.00  0.98  0.00 
Feb 11, 2006 9:00AM  2.28  0.01  1.06  0.00 
Feb 11, 2006 7:00PM  2.16  0.00  0.99  0.00 
Feb 12, 2006 12:00AM  2.67  0.45  1.97  0.02 
Feb 12, 2006 6:00AM  2.23  0.00  1.00  0.00 
Feb 12, 2006 12:30PM  2.22  0.01  0.99  0.00 
Feb 12, 2006, 1:50PM  2.28  0.06  1.08  0.01 
Feb 13, 2006 6:15AM  2.49  0.04  1.05  0.01 
Feb 14 2006, 12:15PM  2.33  0.01  0.95  0.00 
Feb 14 2006, 6:00PM  2.31  0.02  1.01  0.00 
Feb 15 2006, 5:40PM  2.37  0.02  1.01  0.00 
Feb 16 2006, 5:00PM  2.33  0.05  1.07  0.06 
Feb 17 2006, 1:00PM  2.45  0.01  0.99  0.00 
Feb 17 2006, 5:00PM  2.61  0.00  1.01  0.00 
Feb 19 2006, 12:10AM  2.18  0.02  0.89  0.03 
Feb 19 2006, 7:00AM  2.27  0.05  0.94  0.00 
Feb 19 2006, 7:10PM  2.32  0.04  0.99  0.00 
Feb 20 2006, 12:05AM  2.43  0.09  1.17  0.13 
Feb 20 2006, 8:00AM  2.33  0.08  1.01  0.02 
Feb 20 2006, 1:10PM  2.32  0.03  0.94  0.00 
Feb 20 2006, 11:20AM  2.53  0.00  0.94  0.00 
Feb 21 2006, 7:15AM  2.50  0.01  0.88  0.00 
Feb 21 2006, 12:15PM  2.56  0.00  0.94  0.00 
Feb 21 2006, 6:00PM  2.61  0.05  1.03  0.35 
Feb 23 2006, 5:20PM  1.96  0.00  0.41  0.21 
Feb 28 2006, 6:00PM  2.12  0.00  0.50  0.04       References 
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Metabolic concentrations of Glutamine, Glutamate, Glucose, and Lactate (g/L) in 
the spent medium collected during medium exchanges performed every 3 days, 
during the cell expansion process of hMSC inoculated at 4x10
3 cells/cm
2 for the 
data represented in Figure 4.2. 
 
Date Time  Glutamine  Glutamate  Glucose  Lactate 
Feb 9, 2006 3:30PM  2.47  0.00  1.00  0.00 
Feb 11, 2006 9:00AM  1.82  0.15  1.03  0.10 
Feb 12, 2006 1:50PM  1.71  0.29  1.15  0.13 
Feb 13, 2006 6:15AM  2.42  0.06  1.01  0.25 
Feb 14 2006, 4:30PM  2.01  0.07  1.02  0.10 
Feb 15 2006, 5:40PM  1.72  0.04  0.82  0.04 
Feb 16 2006, 5:00PM  1.64  0.06  0.89  0.21 
Feb 17 2006, 5:00PM  1.91  0.00  0.79  0.00 
Feb 19 2006, 7:10PM  1.59  0.04  0.72  0.03 
Feb 20 2006, 1:10PM  1.42  0.03  0.73  0.29 
Feb 21 2006, 3:50PM  2.24  0.06  0.97  0.45 
Feb 23 2006, 5:20PM  1.81  0.00  0.64  0.02 
Feb 24 2006, 4:00PM  1.65  0.00  0.58  0.35 
Feb 28 2006, 6:00PM  1.65  0.00  0.46  0.18 
 
 
Metabolic concentrations of Glutamine, Glutamate, Glucose, and Lactate (g/L) in 
the spent medium collected during medium exchanges performed every 3 days, 
during the cell expansion process of hMSC inoculated at 1x10
2 cells/cm
2 for the 
data represented in Figure 4.2. 
 
Date Time  Glutamine  Glutamate  Glucose  Lactate 
Feb 9, 2006 3:30PM  2.47  0.00  1.00  0.00 
Feb 11, 2006 9:00AM  1.89  0.02  1.02  0.00 
Feb 12, 2006 1:50PM  1.79  0.07  1.06  0.00 
Feb 13, 2006 6:15AM  2.30  0.08  1.11  0.20 
Feb 14 2006, 4:30PM  2.04  0.01  1.02  0.00 
Feb 16 2006, 5:00PM  1.72  0.07  1.06  0.00 
Feb 17 2006, 5:00PM  2.36  0.00  1.02  0.00 
Feb 19 2006, 7:10PM  1.77  0.05  1.01  0.00 
Feb 20 2006, 1:10PM  1.54  0.07  1.07  0.01 
Feb 21 2006, 3:50PM  2.36  0.07  0.99  0.21 
Feb 23 2006, 5:20PM  1.86  0.01  0.84  0.00 
Feb 24 2006, 4:00PM  1.62  0.04  0.83  0.00 
Feb 28 2006, 6:00PM  1.70  0.00  0.57  0.08       References 
202 
APPENDIX III 
 
The effect of cell growth phase on subcultivation. Cells recovered from passage 
zero during mid-exponential phase, as well as cells recovered from the same 
culture during stationary phase were seeded into 24 well-plates at a seeding 
density of 5x10
3 cells/cm
2. Growth curves from the two cultures, passage one 
with inoculum from stationary phase, and passage one with inoculum from mid-
exponential phase are shown in figure below. 
 
 
 
 
The growth curves generated from each of these cultures indicate a difference in 
growth, showing slower growth for those cells originated from the stationary 
phase of growth from the previous passage. This culture also appears to exhibit a 
longer lag phase during the first 100 hr in culture when compared to the culture 
seeded from cells originated from the mid-exponential phase from the previous 
passage. 
 
 